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ABSTRACT 
Enterohemorrhagic Escherichia coli (EHEC) colonizes the intestine and produces the 
phage-encoded Shiga toxin (Stx) which is absorbed systemically and can lead to 
hemolytic uremic syndrome (HUS) characterized by hemolytic anemia, 
thrombocytopenia, and renal failure.  EHEC, and two related pathogens, 
Enteropathogenic E. coli (EPEC), and the murine pathogen, Citrobacter rodentium, are 
attaching and effacing (AE) pathogens that intimately adhere to enterocytes and form 
actin “pedestals” beneath bound bacteria.  The actin pedestal, because it is a unique 
characteristic of AE pathogens, has been the subject of intense study for over 20 years.  
Investigations into the mechanism of pedestal formation have revealed that to generate 
AE lesions, EHEC injects the type III effector, Tir, into mammalian cells, which 
functions as a receptor for the bacterial adhesin intimin.  Tir-intimin binding then triggers 
a signaling cascade leading to pedestal formation.  In spite of these mechanistic insights, 
the role of intimin and pedestal formation in EHEC disease remains unclear, in part 
because of the paucity of murine models for EHEC infection.  We found that the 
pathogenic significance of EHEC Stx, Tir, and intimin, as well as the actin assembly 
triggered by the interaction of the latter two factors, could be productively assessed 
during murine infection by recombinant C. rodentium expressing EHEC virulence 
factors.  Here we show that EHEC intimin was able to promote colonization of C. 
rodentium in conventional mice.  Additionally, previous in vitro data indicates that 
intimin may have also function in a Tir-independent manner, and we revealed this 
function using streptomycin pre-treated mice.  Lastly, using a toxigenic C. rodentium 
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strain, we assessed the function of pedestal formation mediated by Tir-intimin interaction 
and found that Tir-mediated actin polymerization promoted mucosal colonization and a 
systemic Stx-mediated disease that shares several key features with human HUS. 
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CHAPTER I. 
INTRODUCTION 
I.  Overview of attaching and effacing pathogens 
Enterohemorrhagic Escherichia coli (EHEC)  
EHEC belongs to the group of pathogenic Escherichia coli and is a member of the 
larger group of Shiga-toxin (Stx) producing E. coli (STEC).  STEC strains produce Stx 
and may or may not contain the Locus of Enterocyte Effacement (LEE), which will be 
explained in detail below.  EHEC was initially described in the early 1980’s and the first 
infection in the United States was reported in 1983 (Riley et al., 1983).  Today, EHEC 
remains a frequent cause of food-related outbreaks of diarrhea nationwide as well as in 
Europe and Japan (reviewed in (Kaper et al., 2004)).  Cattle and other ruminants are 
important reservoirs of EHEC carriage (Borczyk et al., 1987; Caprioli et al., 2005a), and 
human infection usually occurs from the ingestion of contaminated food such as beef, 
produce, and dairy products, or through direct contact with infected animals (Cody et al., 
1999; Crump et al., 2002).  Serious outbreaks resulting in life-threatening hemolytic 
uremic syndrome (HUS) in the United States and worldwide are commonly due to 
serotype O157:H7 (Croxen and Finlay, 2010; Gansheroff and O'Brien, 2000; Kaper et al., 
2004).  In fact, it has been estimated by the Centers for Disease Control and Prevention 
(CDC) and others that EHEC O157:H7 causes more than 73,000 cases of illness, 2,000 
hospitalizations, and 50-60 deaths annually in the United States (Mead and Griffin, 
1998).  Several non-O157 serotypes such as O26, O103, O55, and O111 have also 
associated with human disease (Jenkins et al., 2003; Pearce et al., 2004), and these 
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serotypes have been suggested to account for up to 20-50 percent of all STEC infections 
(Johnson et al., 2006).  However, the prevalence of human infection by non-O157 STEC 
is probably underestimated due to the fact that many laboratories do not screen for these 
strains.  Importantly, the CDC estimates that approximately 265,000 STEC infections 
(including EHEC O157:H7 and other STEC serotypes) occur each year.   
Upon infection, EHEC localizes to the large intestine, colonizing the intestinal 
mucosa.  Most infections result in local disease with severe abdominal cramping, watery 
diarrhea, and/or hemorrhagic colitis (bloody diarrhea).  These infections are typically 
self-resolving, yet approximately five-to-ten percent of infected individuals go on to 
develop HUS that may be accompanied by long-term sequelae (Chandler et al., 2002; 
Siegler, 2003).  Interestingly, an ever higher incidence of HUS (16 percent) was reported 
during a particularly virulent outbreak of EHEC associated with spinach in the United 
States in 2006 (Kulasekara et al., 2009).  HUS occurs more often in children than adults 
and is the leading cause of renal failure in children in United States, with a mortality rate 
of five percent (Gerber et al., 2002).  The clinical symptoms of HUS include the triad of 
hemolytic anemia, thrombocytopenia (low platelet count), and renal failure (for review, 
see (Paton and Paton, 1998; Proulx et al., 2001; Ruggenenti et al., 2001)).  In severe 
cases, HUS can result in central nervous system (CNS) impairment (Cimolai et al., 1992; 
Neild, 1994).  Unfortunately, there is no specific treatment of HUS and current 
management of infections usually consists of supportive therapy (MacConnachie and 
Todd, 2004). 
 
3 
 
Enteropathogenic E. coli (EPEC) and Citrobacter rodentium 
EHEC, along with two related pathogens, Enteropathogenic E. coli (EPEC), and 
Citrobacter rodentium, are referred to collectively as attaching and effacing (AE) 
pathogens.  EPEC colonizes the small intestine and is a major etiological agent of 
infantile diarrhea in the developing world (Chen and Frankel, 2005; Spears et al., 2006).  
C. rodentium is murine pathogen that causes transmissible colonic hyperplasia 
characterized by colonic epithelial cell proliferation and high mortality in suckling mice 
(reviewed in (Borenshtein et al., 2008; Luperchio and Schauer, 2001; Mundy et al., 
2005)).  In addition, C. rodentium is the only AE pathogen that is capable of efficiently 
colonizing conventional mice and therefore, has been used extensively as a small animal 
model for EHEC and EPEC pathogenesis (Barthold et al., 1978; Borenshtein et al., 2008; 
Deng et al., 2003; Luperchio and Schauer, 2001; Mundy et al., 2005).  All three 
pathogens induce striking, ultra-structural changes on intestinal epithelial cells known as 
AE lesions (for review see (Kaper et al., 2004) (Figure 1)).   
 
Attaching and effacing lesions 
Unique changes in the intestinal epithelium following E. coli infection were first 
observed in piglets by Staley and co-workers in 1969 (Staley et al., 1969).  Several years 
later, Takeuchi and colleagues described similar lesions on the intestinal epithelium of 
rabbits infected with E. coli O15 (Takeuchi et al., 1978) and following this, Moon and 
co-workers named the lesions “attaching and effacing” (Moon et al., 1983).  These  
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Figure 1.  AE lesion formation by C. rodentium.  An electron micrograph of the distal 
mouse colon upon infection by C. rodentium (λstx2dact) revealing the presence of actin-
rich pedestals (see white arrows).  Magnification is at 20,500x and scale bar represents 
0.5 μm.  
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remarkable lesions consist of intimate attachment of the bacteria to the host cells, 
localized effacement of brush-border microvilli, and the formation of highly organized 
filamentous (F-) actin pedestals beneath bound bacteria that lift bacteria above the plane 
of the host cell membrane (Figure 1).  The detailed mechanisms of actin pedestal 
formation will be discussed below.   
 
Effects of AE lesions on host cells 
AE lesions and bacterial effector proteins (which will be described below; see 
Table 1) dramatically alter the function of intestinal cells, leading to the development of 
diarrhea.  For instance, effacement of microvilli and formation of actin pedestals modifies 
the apical cytoskeletal domain of the intestinal enterocyte, which functions to maintain 
epithelial cell integrity and regulate fluid and solute exchange.  Additionally, it has been 
predicted that microvillar effacement diminishes the absorptive capacity of the intestine.  
Furthermore, certain effector proteins secreted from the bacteria into the host cell disrupt 
tight junctions, which govern the paracellular movement of water and ions.  Indeed, all 
three AE pathogens have been shown to diminish transepithelial electrical resistance 
(TEER) of polarized monolayers, an indication of tight junction disruption (Flynn and 
Buret, 2008; Hanajima-Ozawa et al., 2007; Ma et al., 2006).  This has also been 
demonstrated in vivo (Canil et al., 1993; Dean and Kenny, 2004; Guttman et al., 2006a; 
Guttman et al., 2006b; Shifflett et al., 2005).   
 
II.  Host cell attachment by AE pathogens 
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Infection and passage through stomach 
Once ingested, AE pathogens encounter a critical barrier to bacterial infection—
the stomach, which has a pH as low as 1.5 – 2.5 (Gorden and Small, 1993).  Therefore, an 
important property of AE pathogens is the ability to pass through this acidic environment 
and colonize the mammalian gastrointestinal tract to cause disease.  The infectious dose 
of EHEC is extremely low (<100 organisms), which implies that it is able to pass through 
the stomach with high efficiency (Doyle and Pariza, 2001; Nataro and Kaper, 1998; 
Tilden et al., 1996; Yoon and Hovde, 2008).  Indeed, EHEC and EPEC are extremely 
acid-resistant, similar to commensal E. coli (Lin et al., 1996), and adapt to acidic 
conditions by enabling acid resistance systems ((Richard and Foster, 2003), for review, 
see (Foster, 2004)).  These acid resistance systems secrete protons from the bacteria, 
prevent extracellular protons from entering the bacterial cytoplasm, and induce changes 
in the membrane composition of the bacteria (Castanie-Cornet et al., 1999; Lin et al., 
1995; Small et al., 1994).  In addition to low pH, in order to cause infection, AE 
pathogens must also resist other harsh conditions including antimicrobial and digestive 
enzymes, peristalsis, cellular exfoliation, and innate immune responses (which will be 
discussed briefly in Appendix B). 
 
Initial adhesins and non-intimate attachment 
Upon transit through the stomach, AE pathogens must adhere to intestinal 
epithelial cells in order to effectively colonize the host and compete with normal 
microbiota.  EHEC and C. rodentium establish infection on the luminal surface of the 
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large bowel, while EPEC colonizes the mucosal surface of the small intestine.  Like many 
other pathogens, AE pathogens encode a multitude of surface factors which mediate the 
initial interaction with the host mucosa.  Initial adhesins include: fimbriae (including pili 
and curli), outer-membrane proteins, surface proteins, effector proteins, and flagella (for 
review, see (Bardiau et al., 2010; Nougayrede et al., 2003; Torres et al., 2005)).  For the 
purpose of this introduction, initial, non-intimate adhesins will be divided into two main 
groups: (1) fimbrial adhesins and (2) non-fimbrial adhesins. 
 
Fimbrial adhesins   
Fimbriae are filamentous structures that protrude from the bacterial surface and 
enable bacteria to adhere to host cells.  Despite the assortment of EHEC genes putatively 
involved in fimbriae synthesis, as well as evidence suggesting some defined fimbriae 
promote colonization and disease (La Ragione et al., 2000; Lane and Mobley, 2007; 
Perna et al., 2001), the role these adhesins play in attachment has not been entirely 
clarified.  One defined EHEC adhesin, however, long polar fimbriae (LPF) (Perna et al., 
2001; Torres et al., 2002; Torres et al., 2004) was recently implicated in intestinal 
colonization of infant rabbits (Lloyd et al., 2012).  Additionally, a Type IV pilus 
restricted to EHEC O157:H7, termed hemorrhagic coli pilus (HCP) (Xicohtencatl-Cortes 
et al., 2007), has been recognized in the serum of patients with HUS, but not healthy 
patients, suggesting that these pili are produced during infections in vivo.  Moreover, 
infection of bovine gut explants with bacteria deficient in HCP production resulted in a 
significant reduction of bacterial adherence (Xicohtencatl-Cortes et al., 2007).   
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 Like EHEC, EPEC and Citrobacter have putative and defined fimbriae and pili 
associated with colonization and virulence (Adams et al., 1997; Bieber et al., 1998; 
Fiederling et al., 1997; Giron et al., 1991; Mundy et al., 2003).  C. rodentium has a type 
IV pilus termed colonization factor Citrobacter (CFC) that is required for intestinal 
colonization in mice (Mundy et al., 2003).  EPEC is unique from EHEC and C. 
rodentium because it harbors the bundle-forming pilus (Bfp), a type IV pilus, expressed 
from 14 genes located on EPEC adherence factor (EAF) plasmid (Giron et al., 1993; 
Giron et al., 1991).  While Bfp is important for localized adhesion and microcolony 
formation in vitro (Giron et al., 1993; Giron et al., 1991), its role in vivo is unclear (Hicks 
et al., 1998; Knutton et al., 1991).  Nevertheless, a volunteer study demonstrated that Bfp 
plays an important role in human disease (Bieber et al., 1998) and humans develop Bfp-
specific immune responses (Loureiro et al., 1998; Martinez et al., 1999). 
 
Non-fimbrial adhesins 
One non-fimbrial adhesin present in EHEC and EPEC is the outer-membrane 
protein, OmpA, which is important for binding to cells in culture (Torres and Kaper, 
2003).  This phenotype, however, has not been further investigated in vivo.  Bacterial 
factors secreted from the type III secretion system (T3SS) of AE pathogens, most notably 
EspA, have also been suggested to be adhesins because they mediate the initial 
interaction between host cells and bacteria (Cleary et al., 2004; Daniell et al., 2001; Ebel 
et al., 1998; Knutton et al., 1998).  In addition, there is evidence that proteins secreted 
independently of the T3SS play a role in adherence of AE pathogens to mammalian cells.  
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For example, EHEC harbors a type II secretion system (T2SS) and two secreted effectors, 
YodA and StcE, have been recognized to promote EHEC adherence in vitro as well as in 
vivo during colonization of infant rabbits (Grys et al., 2005; Ho et al., 2008).  Finally, AE 
pathogens utilize flagella to adhere to host cells and data suggests that EPEC flagellar 
expression can be induced by eukaryotic factors secreted from host cells (Giron et al., 
2002).  Specifically, H7 of EHEC and H6 of EPEC have been hypothesized to adhere to 
mucus within the host intestinal tract and also bind host extracellular matrix proteins 
(Erdem et al., 2007). 
 
Intimin-dependent adhesion 
Despite the plethora of adhesins described above, the most thoroughly 
characterized adhesin absolutely required for attachment and intimate adherence of AE 
pathogens to epithelial cells, as well as for intestinal colonization and virulence 
(Donnenberg et al., 1993a; Donnenberg et al., 1993b; Marches et al., 2000; McKee et al., 
1995; Schauer and Falkow, 1993b), is intimin (a ~94 kDa outer-membrane protein), 
encoded by the gene eae.  The most distinguished function of intimin is to bind its own 
receptor, the translocated intimin receptor (Tir) (Hartland et al., 1999; Kenny et al., 
1997).  The interaction between Tir and intimin, referred to as intimate adherence, will be 
discussed below.   
Biochemical and biophysical studies revealed that intimin can be divided into 
three domains: the flexible N-terminal region (including a periplasmic domain), a central 
membrane β-barrel, and a surface-exposed C-terminal domain (Ross and Miller, 2007; Yi 
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et al., 2010).  This 280 amino acid C-terminal domain is considered the receptor binding 
domain (Frankel et al., 1995) and because of allelic differences within this domain, at 
least ten different intimin subtypes have been described (Adu-Bobie et al., 1998; Oswald 
et al., 2000; Torres et al., 2005).  EPEC, C. rodentium, and EHEC O157:H7 produce 
intimin-α, intimin-β, and intimin-γ, respectively.   
 
Allelic variation in intimin and tissue tropism and species host range 
Although EPEC and EHEC intimin have proven interchangeable for pedestal 
formation on cultured cells, intimin exhibits considerable allelic variation in the C-
terminal domain responsible for adhesive activity (Frankel et al., 1994).  Because of this 
variation, intimin alleles from canonical EHEC, EPEC, and C. rodentium strains are 
distinct and have been associated with differences in function, such as tissue tropism.  For 
example, infection of intestinal tissue ex vivo suggests that intimin of EHEC O157:H7 
(intimin γ) promotes colonization of different epithelial types than intimin of canonical 
EPEC (intimin α) or C. rodentium (intimin β) (Fitzhenry et al., 2002; Girard et al., 2005; 
Mundy et al., 2007; Phillips and Frankel, 2000).  In addition, whereas wild type EHEC 
colonizes the large bowel of gnotobiotic piglets, an EHEC strain harboring a plasmid 
expressing EPEC intimin acquired the additional ability to colonize the small intestine 
(Tzipori et al., 1995).  Allelic differences in intimin have also been shown to contribute to 
species host range.  For example, while C. rodentium expressing EPEC intimin is able to 
efficiently colonize Swiss NIH and C3H/HeJ mice (Frankel et al., 1996b; Hartland et al., 
2000; Schauer and Falkow, 1993b), C. rodentium expressing a derivative of EPEC 
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intimin harboring the adhesive domain of EHEC intimin provided only poor colonization 
in these animals (Hartland et al., 2000; Mundy et al., 2007).  Chapter II of this thesis 
will explore the allele-dependent and independent functions of intimin in vitro and in vivo 
and determine if these differences result in variation in tissue tropism and species host 
range. 
 
Tir-independent functions of intimin 
In addition to binding Tir, it has been suggested that intimin from both EPEC and 
EHEC can bind to uninfected, cultured epithelial cells (Frankel et al., 1994; Hartland et 
al., 1999; McKee and O'Brien, 1995).  Additionally, it has been hypothesized that intimin 
possesses host receptor adhesive activities that also contribute to colonization and based 
on mutagenesis studies, the regions within intimin that mediate adherence to host cells 
are distinct from the Tir-binding region of intimin (Frankel et al., 1998).  For example, 
the intimin-related Yersinia pseudotuberculosis invasin protein binds to β1-chain integrins 
(Isberg et al., 1987), and EPEC intimin was shown to be capable of recognizing β1-chain 
integrins, albeit with apparently much lower affinity (Frankel et al., 1996a).  The 
eukaryotic protein nucleolin which is expressed on the surface of many cell types 
(Ginisty et al., 1999) and has also been implicated in serving as a receptor for some 
viruses (Callebaut et al., 1998; de Verdugo et al., 1995), is recognized by EHEC intimin 
(Sinclair and O'Brien, 2002) and localized beneath cell-associated EPEC during infection 
of cultured monolayers (Dean and Kenny, 2011).  Finally, intimin, but not Tir contributes 
to the disruption of epithelial barrier function (Dean and Kenny, 2004), suggesting that 
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Tir-independent functions of intimin exist.  Chapter II of this thesis will address the Tir-
independent functions of intimin for the first time in vivo using a murine model.   
 
Locus of enterocyte effacement and type III secretion  
Generation of AE lesions depends on the ~35 kb, chromosomally-encoded 
pathogenicity island termed the Locus of Enterocyte Effacement (LEE), which is present 
in EHEC, EPEC, and C. rodentium (Barba et al., 2005; Deng et al., 2001; McDaniel et 
al., 1995; McDaniel and Kaper, 1997).  (It should be noted that some STEC strains do not 
possess a LEE and have Stx as their main virulence factor, specifically STEC strains such 
as B2F1 and EC1720a that produce mucus-activatable toxin (Gobius et al., 2003; Ito et 
al., 1990; Melton-Celsa et al., 2002).)  The LEE encodes the bacterial outer membrane 
adhesin intimin (described above) (Donnenberg and Kaper, 1991; Jerse, 1990), the T3SS 
machinery (Jarvis et al., 1995; Lee, 1997), and many effector proteins (see Table 1).  The 
T3SS is a multiprotein basal export complex that including an ATPase, EscN, critical for 
the function of the apparatus, spans the inner and outer membranes of the bacterium 
(Daniell et al., 2001; Wilson et al., 2001).  Distal to the basal body are components that 
form a filamentous appendage extending from the bacteria to the host cell (Knutton et al., 
1998).  Two translocators, EspB and EspD, that promote pore formation in mammalian 
membranes, are thought to be localized at the tip of this appendage, allowing the T3SS to 
act as a conduit through which effectors are delivered directly into the host cell cytoplasm 
(Ide et al., 2001; Ogino et al., 2006; Sekiya et al., 2001).   
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Tir and intimate attachment 
Tir is an essential bacterial effector protein absolutely required for AE lesion 
formation and for colonization in many animal models (Deng et al., 2003; Marches et al., 
2000; Ritchie et al., 2003).  Upon injection into the host cell via the T3SS, Tir integrates 
into the host cell membrane in a hairpin loop conformation and serves as the receptor for 
the bacterial adhesin intimin, through its extracellular domain (Batchelor et al., 2000; Liu 
et al., 2002; Luo et al., 2000).  Tir-intimin interaction induces Tir clustering (Touze et al., 
2004) and permits the cytoplasmic N- and C-terminal domains of Tir to  coordinate a 
downstream signaling cascade resulting in the formation of F-actin pedestals (Caron, et 
al., 2006; Hayward et al., 2006, Campellone et al., 2004).  While the N-terminus of Tir 
has been shown to interact with actin-binding proteins such as α-actinin and cortactin 
(Cantarelli et al., 2002; Goosney et al., 2000; Mousnier et al., 2008), Tir mutants lacking 
the N-terminus are still able to generate actin pedestals, suggesting the key residues 
necessary for actin assembly reside in the C-terminus (Brady et al., 2007; Campellone et 
al., 2006; Campellone et al., 2004a).  Although the requirement of Tir for colonization in 
animal models has been well established, the role of Tir-mediated actin assembly and 
pedestal formation in colonization and disease remains to be well characterized and will 
be discussed in Chapters III and IV of this thesis.   
 
Additional effector proteins 
Other effector proteins encoded on the LEE include the cytoskeletal modulating 
proteins EspF, Map, EspH, EspG, and EspK.  EspF and Map disrupt epithelial barrier 
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function (Dean and Kenny, 2004; McNamara et al., 2001).  EspH downregulates 
filopodium formation and promotes pedestal formation (Tu et al., 2003) and has been 
implicated in promoting colonization in animal models (Deng et al., 2004; Mundy et al., 
2004; Ritchie and Waldor, 2005).  EspG is responsible for destabilizing microtubule 
networks, triggering actin stress fiber assembly, and damaging the Golgi apparatus 
(Clements et al., 2011; Matsuzawa et al., 2004).  Finally, EspK was reported to have no 
effect on actin nucleation in HeLa cells, but seems to promote persistence in an orally 
infected calf model (Vlisidou et al., 2006b).  Table 1 lists the common LEE and non-LEE 
encoded effector proteins and their functions in EHEC, EPEC, and C. rodentium.  The in 
vitro and in vivo function of some of these cytoskeletal-modulating effectors in C. 
rodentium will be discussed in Appendix A. 
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Table 1.  LEE-encoded and non-LEE encoded effector proteins. 
Effector Size or 
predicted 
molecular 
weight, 
location 
Function or activity and associated AE 
pathogen 
Reference(s) 
Tir 56-68 
kDa, LEE-
encoded 
bacterial receptor for intimin; required for AE 
lesion formation and for colonization and 
virulence in many animal infection models 
(EHEC, EPEC, Citro) 
(Deng et al., 2003; 
Garmendia et al., 
2005; Kenny et al., 
1997; Marches et al., 
2000; Ritchie et al., 
2003)  
    
EspFU/ 
TccP 
 
42.4 kDa, 
prophage 
encoded 
 
required for AE lesion formation (EHEC); not 
typically present in EPEC or Citro 
(Campellone et al., 
2004b; Garmendia et 
al., 2004) 
  no measurable effect on colonization of 
bovine intestine 
(Vlisidou et al., 2006a) 
  important for late stage colonization of rabbit 
intestine; may promote expansion beyond 
initial sites of infection in gnotobiotic piglets 
(EHEC) 
(Ritchie et al., 2008) 
 
  Can cooperate with C. rodentium Tir but 
addition of EspFU has no effect on 
colonization 
(Girard et al., 2009a) 
  binds to the autoinhibitory GBD in WASP 
proteins and displaces it from the VCA 
domain to activate N-WASP 
(Cheng et al., 2008) 
    
Map ~20-23 
kDa, LEE-
encoded 
WxxxE family member; Targeted to and 
disrupts function of mitochondria (EPEC, 
EHEC); Disrupts tight junctions (EPEC); 
involved in intimin-dependent, Tir-
independent barrier dysfunction (EPEC) 
(Dean and Kenny, 
2004; Kenny and 
Jepson, 2000) 
 
  Functions as the active form of Cdc42; 
Promotes transient, Cdc42-dependent 
filopodia (EPEC) 
(Alto et al., 2006; 
Kenny et al., 2002) 
  Promotes colonization of small intestine of 
infant rabbits (EHEC) 
(Ritchie and Waldor, 
2005) 
  Binds EBP50/NHERF1 which regulates ion 
channels in the intestine 
(Simpson et al., 2006) 
  Contributes to diarrhea and causes 
mitochondrial dysfunction and epithelial 
(Ma et al., 2006; 
Simpson et al., 2006) 
16 
 
barrier disruption in vivo (Citro) 
  C-terminal region of the protein is necessary 
for actin disruption and toxicity, but not for 
mitochondrial localization 
(Rodriguez-Escudero 
et al., 2005) 
  Not required for colonization but may confer 
competitive advantage in murine infection 
(Citro) 
(Deng et al., 2004; 
Mundy et al., 2004);  
    
EspH 21 kD, 
LEE-
encoded 
 
Diminishes filopodium formation and 
enhances pedestal formation (EHEC and 
EPEC); plays role in brush border remodeling 
and production of AE lesions 
(Shaw et al., 2005a; 
Tu et al., 2003) 
  Promotes colonization and diarrhea in infant 
rabbits (EHEC); not required for colonization 
or disease (Citro); Marginally promotes 
colonization in mice (Citro) 
(Deng et al., 2004; 
Mundy et al., 2004; 
Ritchie and Waldor, 
2005) 
    
EspF 20-31, 
LEE-
encoded 
required for loss of TER, increased monolayer 
permeability; disrupts epithelial barrier 
function by altering distribution of occludin in 
tight junctions (EPEC) 
(Guttman et al., 2006a; 
McNamara et al., 
2001; Viswanathan et 
al., 2004a) 
  induces apoptosis in HeLa cells (EPEC) (Crane et al., 2001) 
  Mild colonization defect early in infection 
(Citro); Appears to control inflammation in 
infant rabbit infection (EHEC); disrupts 
barrier function in vivo (EPEC) 
(Deng et al., 2004; 
Mundy et al., 2004; 
Nagai et al., 2005; 
Ritchie and Waldor, 
2005; Shifflett et al., 
2005)  
  required for inhibition of bacterial 
phagocytosis (EHEC, EPEC) 
(Marches et al., 2008; 
Martinez-Argudo et 
al., 2007; Quitard et 
al., 2006) 
  modulates architecture of the IF network 
within cells 
(Viswanathan et al., 
2004b) 
  Binds sorting nexin 9 (EPEC) (Marches et al., 2006) 
    
EspG 44 kDa, 
LEE-
encoded 
 
destabilizes microtubule networks and 
triggers actin stress fiber assembly (EPEC) 
(Matsuzawa et al., 
2004) 
 
  Possibly contributes to colonization and 
disease/colonic hyperplasia in mice (Citro) 
(Hardwidge et al., 
2005; Mundy et al., 
2004) 
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  alters epithelial paracellular permeability 
(EPEC) 
(Matsuzawa et al., 
2005) 
  promotes colonization in rabbit small intestine 
(EHEC) 
(Ritchie and Waldor, 
2005) 
  Localizes to Golgi apparatus and disrupts 
Golgi function 
(Clements et al., 2011) 
    
EspG2 42 kDa, 
encoded 
on EspC 
PAI 
interacts with tubulin and triggers the 
dissociation of microtubules beneath adherent 
bacteria 
(Shaw et al., 2005b; 
Smollett et al., 2006) 
  alters epithelial paracellular permeability 
(EPEC) 
 
(Matsuzawa et al., 
2005; Matsuzawa et 
al., 2004) 
    
EspK 
 
~47 kDa, 
non-LEE 
encoded; 
encoded 
on cryptic 
prophage 
CP-933N 
inactivation of espK affected persistence of 
EHEC in intestines of orally inoculated 
calves; localizes to cytoplasm when expressed 
in COS-7 cells 
(Vlisidou et al., 
2006b) 
    
EspI 
(NleA) 
 
54 kDa, 
prophage- 
encoded 
 
plays role in bacterial colonization and 
hyperplasia in mice (Citro) 
(Mundy et al., 2004) 
 
  targeted to Golgi apparatus (Gruenheid et al., 
2004) 
    
EspZ 
(SepZ) 
9.5 kDa, 
LEE-
encoded 
Contributes to protection against rapid cell 
death (EPEC); targeted to mitochondria 
(Kanack et al., 2005; 
Shames et al., 2011; 
Shames et al., 2010)  
  sepZ mutant has an intermediate colonization 
phenotype in some mouse strains (Citro) 
(Deng et al., 2004) 
    
EspM ~21 kDa, 
non-LEE 
encoded 
Member of WxxxE family; modulates actin 
dynamics by activating RhoA signaling 
pathway 
(Arbeloa et al., 2008) 
  induces stress fibers (Alto et al., 2006) 
  More commonly found in EHEC and EPEC 
serotypes that are associated with severe 
disease 
(Arbeloa et al., 2009) 
  Inhibits pedestal formation (EHEC and (Simovitch et al., 
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EPEC) 2010) 
    
EspJ 
 
25 kDa, 
prophage 
encoded 
 
C. rodentiumΔespJ showed altered 
colonization and clearance dynamics in 
murine infection; EHEC espJ  mutant has a 
clearance defect in infection of lambs late in 
infection; possible role in host survival and 
pathogen transmission (Citro (mice); EHEC 
(lambs)) 
(Dahan et al., 2005) 
 
  responsible for trans-inhibition of 
macrophage opsonophagocytosis; impairs 
CR3-mediated uptake (EPEC, EHEC) 
(Marches et al., 2008) 
    
EspC 
 
110 kDa, 
non-LEE 
encoded 
 
secreted from cells by TVSS secretion; 
translocated into cells by T3SS (EPEC) 
causes cytotoxic effects including cytoskeletal 
damage 
(Vidal and Navarro-
Garcia, 2006, 2008) 
 
    
NleH 
 
33 kDa, 
non-LEE 
encoded 
 
shares identity with the OspG effector in 
Shigella and YspK of Y. entercolitica; mutant 
has moderate defects in colonization of mice 
at early stages of infection (Citro) 
(Garcia-Angulo et al., 
2008; Hemrajani et al., 
2008) 
  Blocks apoptosis (EPEC) (Hemrajani et al., 
2010) 
    
NleF 
 
24 kDa, 
encoded 
on O 
island 71 
 
localizes to host cytoplasm, important for 
bacterial colonization in mice (Citro) and 
gnotobiotic piglets (EHEC) 
(Echtenkamp et al., 
2008)  
    
NleB 
 
39 kDa, 
encoded 
on O-
island 
122/CP-
933K 
important for colonization and colonic 
hyperplasia of mice (Citro) 
 
(Kelly et al., 2006) 
    
NleC 
 
40 kDa, 
encoded 
on 
prophage 
Not required for AE lesion in vitro or for 
colonization of calves of lambs (EHEC) 
(Marches et al., 2005) 
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CP-933K 
    
NleD 
 
28 kDa, 
encoded 
on 
prophage 
CP-933K 
Not required for AE lesions in vitro and or for 
colonization in calves of lambs (EHEC) 
(Marches et al., 2005) 
  identified by signature-tagged mutagenesis 
screen as essential for full virulence in the gut 
by EHEC 
(Dziva et al., 2004)  
    
Cif 
 
~32 kDa, 
encoded 
on 
lambdoid 
prophage 
 
cycle inhibiting factor; not required for AE 
lesion formation; induces host cell cycle 
arrest and reorganization of actin cytoskeleton 
(EPEC, EHEC) 
(Marches et al., 2005) 
  required for inducible cytopathic effect, 
progressive recruitment of focal adhesion 
plaques, assembly of stress fibers, inhibition 
of cell cycle G2/M transition; leads to 
accumulation of inactive phosphorylated 
Cdk1 
(Marches et al., 2003) 
    
EspT ~22 kDa, 
non-LEE 
encoded 
Member of WxxxE/SopE family of GEF’s; 
activates RhoGTPases; induces formation of 
lamellipodia and membrane ruffles through 
activation of Rac-1 and Cdc42 
(Bulgin et al., 2009) 
  Has not been found in EHEC isolates; rarely 
found in EPEC and Citro 
(Arbeloa et al., 2009) 
  Triggers expression of immune mediators in 
an Erk/JNK and NF-Kb dependent manner 
(Raymond et al., 2011) 
 
20 
 
Mechanisms of pedestal formation 
Though EHEC, EPEC, and C. rodentium translocate highly related Tir molecules 
that are required for the formation of morphologically indistinguishable pedestals, the 
signaling pathway by which EHEC triggers F-actin assembly differs from that of EPEC 
and C. rodentium (Campellone, 2010; Caron et al., 2006; Hayward et al., 2006).  In fact, 
even though the three AE pathogens have nearly identical LEEs and highly similar Tir 
proteins, EPEC Tir is not interchangeable with EHEC Tir (Kenny, 1999; Kenny, 2001) 
and EPEC Tir, but not EHEC Tir, can complement a C. rodentium tir mutant for pedestal 
formation in vitro or colonization in vivo (Deng et al., 2003).  A key difference in the Tir 
proteins of EHEC and those of EPEC and C. rodentium, is that EPEC and C. rodentium 
contain tyrosine residues at positions 474 and 471 (see Figure 2) (Campellone et al., 
2002; Gruenheid et al., 2001; Kenny, 1999), respectively, that are phosphorylated early in 
infection by host cell kinases (Phillips et al., 2004; Swimm et al., 2004b).  This 
phosphorylation event recruits the host adapter protein, Nck, which binds and activates 
N-WASP (neuronal Wiskott–Aldrich Syndrome protein) (Campellone et al., 2002; 
Campellone et al., 2004a; Gruenheid et al., 2001).  N-WASP, in turn, recruits and 
activates Arp-2/3, a heptameric complex that nucleates branched actin filament networks 
in eukaryotic cells (reviewed in (Goley and Welch, 2006; Stradal and Scita, 2006)), and 
leads to actin polymerization (Rivera et al., 2004; Rohatgi et al., 2001).  Moreover, EPEC 
and C. rodentium possess an asparagine-proline-tyrosine (NPY) motif (Brady et al., 
2007) and recruitment of IRTKS (insulin receptor tyrosine kinase substrate) to NPY454 
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of EPEC Tir or NPY451 of C. rodentium Tir, results in low level, Nck-independent actin 
polymerization (Campellone and Leong, 2005).   
EHEC Tir also contains an NPY motif, but, unlike EPEC and C. rodentium Tir, it 
does not have a tyrosine residue that becomes phosphorylated upon intimin-Tir binding 
and therefore, does not recruit Nck.  Instead, EHEC harbors an additional effector 
protein, EspFU, encoded on the prophage CP-933U/Sp14 (Campellone et al., 2004b; 
Garmendia et al., 2004).  EspFU binds Tir through IRTKS (insulin receptor tyrosine 
kinase substrate) and/or IRSp53 (insulin receptor substrate p53) (Vingadassalom et al., 
2009; Weiss et al., 2009) and activates N-WASP by directly binding to its GTP-ase 
binding (GBD) region (Sallee et al., 2008; Campellone, 2010).  Normally, N-WASP is in 
the autoinhibited state where the GBD is bound to the VCA (veroprolin homology, 
central hydrophobic, and acidic regions) domain, however, EspFU directly competes for 
the VCA binding site on the GBD and displaces it (Cheng et al., 2008), thereby allowing 
actin polymerization to occur.    
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Figure 2.  Mechanisms of actin pedestal formation in EPEC, C. rodentium, and 
EHEC.   (A-B) Tir of EPEC and C. rodentium possess a tyrosine motif (Y474 and Y471, 
respectively) that becomes phosphorylated upon Tir-intimin interaction and then recruits 
the adaptor protein, Nck.  Nck recruits N-WASP, followed by Arp-2/3 and initiates a 
signaling cascade leading to actin polymerization.  EPEC and C. rodentium Tir also 
contain an NPY motif (454 and 451, respectively) that upon phosphorylation, can lead to 
low-level actin polymerization through IRTKS.  (C) Pedestal formation in EHEC 
requires EspFU which binds to Tir NPY458 through IRTKS.  EspFU activates N-WASP, 
which activates Arp-2/3, leading to actin polymerization. IRTKS can also weakly activate 
N-WASP in the absence of EspFU. 
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Significance of actin pedestal formation 
 AE lesions have proven to be important for infection and pathogens incapable of 
generating AE lesions display severe colonization defects and disease phenotypes (Deng 
et al., 2003; Donnenberg et al., 1993b; Marches et al., 2000; Ritchie et al., 2003; Tacket 
et al., 2000; Tzipori et al., 1995).  The role of Tir-mediated actin assembly and pedestal 
formation in Stx-mediated disease, however, remains elusive.  Some evidence suggests 
that the ability to generate actin pedestals aids in colonization, specifically at later time 
points in infection.  Notably, Ritchie and colleagues found an EHEC mutant deficient in 
pedestal formation to be defective for colonization late in infection of infant rabbits 
(Ritchie et al., 2008).  Additionally, this same pedestal-deficient mutant formed smaller 
than wild type bacterial aggregates on the intestine of gnotobiotic piglets (Ritchie et al., 
2008).  Recently, a study by Crepin and co-workers used a C. rodentium mutant unable to 
generate actin pedestals and found that it was out-competed by wild type bacteria in 
murine co-infection studies (Crepin et al., 2010).  Chapters III and IV of this thesis will 
describe a novel murine model that we utilized to probe the function of Tir-mediated 
actin assembly in colonization and toxin-mediated disease. 
 
 
III. EHEC Stx-mediated disease 
Stx 
EHEC elaborates a potent cytotoxin, Stx (for review, see (Tarr et al., 2005)), that 
is responsible for causing the extensive tissue damage that results during HUS (O'Brien et 
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al., 1992; Schuller et al., 2004; Tarr et al., 2005).  Stx is encoded on a lambdoid prophage 
and toxin production is often increased upon phage induction (Muhldorfer et al., 1996; 
Schmidt, 2001; Waldor and Friedman, 2005).  Stx is an AB toxin consisting of five B 
subunits and one enzymatically active A subunit (O'Brien et al., 1992).  The B subunit 
binds to host cell surface globotriaosylceramide (Gb3) receptors, allowing entry of the 
active A subunit to the cytosol via endocytosis and retrograde transport through the Golgi 
apparatus.  The A subunit has N-glycosidase activity and cleaves 28S rRNA at a site 
specific adenine residue thereby directly inhibiting protein synthesis and inducing 
apoptosis of the host cell (Cohen et al., 1987; Endo et al., 1988; Lingwood et al., 1987; 
Romer et al., 2007).   
Two main serotypes of Stx exist: Stx1 and Stx2, and EHEC strains that possess 
Stx2 are often associated with more severe disease and HUS (Donohue-Rolfe et al., 2000; 
Lindgren et al., 1993; Tesh et al., 1993).  In fact, a large outbreak of diarrhea-associated 
HUS was recently documented in deaths in Northern Germany caused by an E. coli strain 
containing Stx2 (Bielaszewska et al., 2011; Frank et al., 2011).  However, the strain was 
identified as enteroaggregative (EAEC) E. coli serotype O104:H4, as opposed to typical 
enterohemorrhagic (EHEC) E. coli O157:H7 usually responsible for diarrheal outbreaks 
resulting in HUS.  It is thought that this EAEC strain acquired the stx2 gene via 
horizontal gene transfer (Rasko et al., 2011).  Nonetheless, the acquisition of stx2 greatly 
enhanced the virulence of EAEC, and infection with this strain resulted in over 40 deaths 
(Bielaszewska et al., 2011; Frank et al., 2011).      
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Many variants of Stx1 and Stx2 exist including Stx1c, Stx1d, Stx2c, Stx2d, 
Stx2dact, Stx2e, and Stx2f.  Interestingly, Stx2dact has been identified as a mucus-
activatable toxin and in the presence of intestinal mucus, it becomes more cytotoxic 
following the cleavage of the two C-terminal amino acids of the A2 peptide in the context 
of the appropriate B subunit (Melton-Celsa et al., 2002).  Interestingly, it has been 
hypothesized that toxin production by STEC and EHEC strains increases bacterial 
adherence to host cells and subsequent intestinal colonization (Robinson et al., 2006), 
possibly by increasing the expression of intimin-binding host cell receptors such as β1-
chain integrins (Liu et al., 2010) and/or nucleolin (Sinclair et al., 2006; Sinclair and 
O'Brien, 2002). 
 
Stx translocation across intestinal epithelium 
Upon intestinal colonization by EHEC, Stx translocates across intestinal 
epithelium by a mechanism not well known.  While it has been shown that certain 
intestinal cell lines possess Gb3 receptors (e.g. Caco-2) and Stx induces apoptosis and 
inhibits protein synthesis in these cell lines (Schuller et al., 2004), the majority of the 
intestinal epithelium is devoid of Gb3 receptors.  Therefore, the mechanism by which Stx 
traverses these cells differs from the retrograde transport pathway associated with 
endothelial cell intoxication.  Early studies using immunoelectron microscopy confirmed 
that Stx passes through the intestinal epithelium via a transcellular pathway (Acheson et 
al., 1996; Philpott et al., 1997).  It has been established that Stx induces secretion of the 
neutrophil chemoattractant, IL-8 (KC is the mouse homologue), from human colonic 
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epithelial cells (Thorpe et al., 1999), and there is evidence suggesting that neutrophil 
transmigration enhances Stx translocation across the intestinal epithelium (Hurley et al., 
2001).  Changes in the actin cytoskeleton have also been thought to facilitate transcytosis 
of Stx across monolayers (Maluykova et al., 2008).  Both infiltration of neutrophils and 
changes in the actin cytoskeleton are believed to compromise the intestinal barrier and 
increase Stx uptake.  Furthermore, evidence also exists suggesting that macropinocytosis 
facilitates and stimulates transcellular toxin translocation across Gb3 negative intestinal 
epithelial cells (Malyukova et al., 2009).  Finally, recent evidence suggests that outer 
membrane vesicles, which are naturally shed from gram negative bacteria, may play a 
possible role in toxin delivery into eukaryotic cells (Amano et al., 2010; Ellis and Kuehn, 
2010).  Interestingly, EHEC broth cultures have been shown to contain outer membrane 
vesicles containing Stx1 and Stx2 (Kolling and Matthews, 1999; Yokoyama et al., 2000). 
Intestinal damage is a common finding in EHEC infection and has histological 
manifestations similar to colitis and inflammatory bowel disease (Bekassy et al., 2011; 
Moon, 1997).  This damage is thought to be a direct result of Stx (although secondary 
intestinal damage may be due to ischemia and inflammation), despite the lack of Gb3 
receptors in most enterocytes.  Therefore, the mechanism by which Stx-mediated 
intestinal damage occurs is not well known.  Additionally, many small animal models of 
EHEC infection and HUS lack this important manifestation of disease, making it difficult 
to study.  Chapter III of this thesis will describe a novel murine model of EHEC Stx-
mediated disease that results in intestinal damage similar to that seen in human infection.       
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Once in the blood stream, Stx targets the vasculature and eventually reaches other 
organs expressing Gb3 receptors.  Endothelial cells, particularly those in the kidney, are 
exceptionally sensitive to Stx.  One potential mechanism of Stx delivery to target cells is 
via binding to polymorphonuclear PMN’s (for which it has relatively high affinity) and 
use of these cells for transport through the blood stream to target cells with Gb3 receptors 
(which Stx binds with much higher affinity) (Brigotti et al., 2010; te Loo et al., 2000; Te 
Loo et al., 2001).  In humans, Gb3 receptors are predominantly found on glomerular 
vascular endothelial cells and cortical tubules of the kidney (Ergonul et al., 2003; Meyers 
and Kaplan, 2000).  In mice however, they are found predominantly in the renal tubules 
(Psotka et al., 2009).  
 
Systemic disease 
Upon binding to cells, Stx induces the release of pro-inflammatory cytokines and 
activates transcription factors that encode them (O'Loughlin and Robins-Browne, 2001; 
Paton and Paton, 1998; Ray and Liu, 2001), leading to a systemic inflammatory response. 
Serum pro-inflammatory cytokines and chemokines are elevated in both humans 
suffering HUS and mice intoxicated with Stx (Keepers et al., 2007; Keepers et al., 2006; 
Proulx et al., 2001; Ray and Liu, 2001; Rovin and Phan, 1998; Sauter et al., 2008) and 
this inflammatory response seems crucial for development of the vascular damage 
observed in EHEC infection resulting in HUS.  Indeed, circulating leukocytosis and 
increased neutrophil and macrophage counts are considered risk markers for developing 
HUS, and are associated with severity of renal failure (Bell et al., 1997; Buteau et al., 
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2000; Coad et al., 1991; Walters et al., 1989; Wong et al., 2000).  Moreover, monocyte 
chemoattractant protein (MCP-1) and granulocyte colony stimulating factor (G-CSF), 
have been shown to be elevated in the urine and serum of patients with HUS and this 
finding correlates to disease severity, further evidence suggesting that inflammation is an 
important contributor to the development of HUS (Murata et al., 1998; Proulx et al., 
2002; van Setten et al., 1996; Vierzig et al., 1998). 
The action of Stx on endothelial cells and subsequent inflammatory response also 
leads to thrombus formation in the vasculature, hemolytic anemia, and renal damage.  
Evidence of renal damage is often observed by elevated levels of serum blood urea 
nitrogen (BUN) and creatinine as well as the presence of proteinuria (Tarr et al., 2005).  
Histologically, renal disease is prominent in the glomeruli, the site of the majority of Gb3 
receptors in humans, and findings include glomerular capillary wall thickening, 
endothelial cell wall swelling, and detachment of the basement membrane with 
deposition of fibrin and thrombi in the capillary lumens (Richardson et al., 1988).  Lastly, 
Stx can also target Gb3 receptors in the CNS, and very severe cases of HUS can result in 
neurological complications (occurring in approximately 30 percent of patients with HUS) 
(Cimolai et al., 1992; Neild, 1994). 
 
IV.  Animal models of EHEC and EPEC pathogenesis 
Many different animal models have been developed to study AE pathogenesis in 
vivo.  These models include carriage models, EHEC and EPEC colonization models, 
models studying the effects of Stx in vivo (in the absence of bacteria), and EHEC 
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infection-like models studying bacterial colonization in the context of Stx-mediated 
disease.  Animal species utilized in these studies (reviewed in (Wales et al., 2005)) 
include: chickens (Beery et al., 1985; Sueyoshi and Nakazawa, 1994), cows (Dean-
Nystrom et al., 1997; Dean-Nystrom et al., 2008), macaques (Kang et al., 2001), baboons 
(Siegler et al., 2003; Taylor et al., 1999), lambs (Vlisidou et al., 2006a), ferrets (Woods et 
al., 2002), pigs (Tzipori et al., 1985; Tzipori et al., 1986), infant rabbits (Ritchie et al., 
2003), Dutch Belted rabbits (Garcia et al., 2006; Garcia et al., 2002), and mice (for 
review, see (Mohawk and O'Brien, 2011)).  Furthermore, animal models using murine, 
bovine, and ovine intestinal loops have been used to study EHEC and EPEC pathogenesis 
(Girard et al., 2008; Vlisidou et al., 2006a; Vlisidou et al., 2004; Wales et al., 2002). 
Despite the abundance of animal models, no one model recapitulates the full 
spectrum of EHEC-related disease complete with oral infection followed by colonization 
with AE lesion formation, intestinal damage, and systemic disease including renal 
damage.  Moreover, many of these models have limitations including high costs (e.g. 
non-human primates) and/or the requirement for complex animal facilities (e.g. 
gnotobiotic animals).  This introduction will focus specifically on:  (1) the animal models 
used to study allele- and Tir- dependent and independent functions of intimin 
(gnotobiotic piglets and mice) and (2) the animal models used to study EHEC 
colonization in the context of Stx-mediated disease (infant rabbits, Dutch Belted rabbits, 
and mice).   
 
Gnotobiotic piglets 
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Gnotobiotic piglets have been used to study the pathogenesis of AE pathogens 
since the early 1980s.  This model allows for study of the interaction of the bacterium and 
its toxins with the host intestinal epithelium without the influence of other bacteria.  
Animals are orally inoculated at one-to-two days of age and once colonized, they develop 
diarrhea and the formation of AE lesions on the small (distal ileum and colon) or large 
intestine when infected with EPEC and EHEC, respectively (Tzipori et al., 1985; Tzipori 
et al., 1986).  Upon EHEC infection, animals occasionally develop signs of extraintestinal 
disease including CNS involvement (Tzipori et al., 1986).  One drawback of this model is 
that renal disease is not a common finding, however, one study reports the presence of 
microangiopathy (small vessel disease) in the kidneys (Gunzer et al., 2002).  Gnotobiotic 
piglets have been beneficial in studying the role of virulence factors, such as eae, espFU, 
and Stx in vivo (McKee et al., 1995; Ritchie et al., 2008; Tzipori et al., 1995), and also 
for the development of potential vaccines and EHEC therapeutics (Sheoran et al., 2005; 
Zhang et al., 2009).   
 
Infant rabbits 
The infant rabbit model of EHEC infection was first described in 1983 (Farmer et 
al., 1983) and has been readily used since then to study EHEC pathogenesis (Elliott et al., 
1994; Pai et al., 1986; Potter et al., 1985; Ritchie et al., 2003).  This model is attractive 
because rabbits are less expensive than larger and germ-free animals, and they also 
become easily colonized without antibiotics.  In this model, New Zealand white rabbits, 
approximately two-to-three days old, are intragastrically inoculated with EHEC (Ritchie 
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et al., 2003).  Younger animals are normally used because the severity of disease declines 
in infections of older animals (Pai et al., 1986).  EHEC colonizes the rabbit large intestine 
and infection results in diarrhea, intestinal inflammation (peaking approximately seven 
days post-infection), and death, all of which are dependent on the T3SS, Tir, intimin, and 
Stx (Ritchie et al., 2003; Ritchie and Waldor, 2005).  Nevertheless, one main limitation 
of this model is that these rabbits do not exhibit symptoms of toxigenic disease such as 
microangiopathy and renal damage (Ritchie et al., 2003), which may be due to the lack of 
Gb3 receptor on the kidneys of these rabbits (Zoja et al., 1992).  IV injection of Stx1 into 
New Zealand white infant rabbits, however, can resemble some pathology of human HUS 
including intestinal damage (with lesions specifically in the cecum), thrombotic 
microangiopathy, and CNS involvement (Richardson et al., 1992).   
 
Dutch Belted rabbits 
Dutch Belted rabbits, which are susceptible to both natural and experimental 
infection with EHEC, are also used to study EHEC pathogenesis.  However, unlike in the 
infant rabbit model, older rabbits, approximately five-to-ten weeks of age are typically 
used.  Garcia and co-workers initially identified these rabbits as a potential experimental 
system for EHEC when they observed the development of bloody diarrhea and death in 
rabbits bought from a commercial vendor (Garcia et al., 2002).  Interestingly, these 
rabbits had become infected naturally with an EHEC strain harboring both eae and Stx1, 
which they characterized as EHEC O153:H-.  Findings at necropsy revealed that these 
rabbits had intestinal and renal pathology consistent with that of EHEC-induced HUS in 
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humans.  Shortly after this observation, Garcia and Fox surveyed the prevalence of 
naturally occurring EHEC in rabbits in several different environments and confirmed that 
rabbits were indeed a new reservoir host for EHEC (Garcia and Fox, 2003).  Further 
characterization of Dutch Belted rabbits as an experimental model for EHEC revealed 
that upon infection, rabbits develop similar symptoms to humans with HUS including 
low hematocrit levels, thrombocytopenia, elevated BUN, fibrin thrombi formation, and 
intestinal and kidney lesions, particularly in the glomeruli (Garcia et al., 2006; Tarr et al., 
2005).  In addition to EHEC O153:H-, other EHEC strains have also been assessed in this 
model and a recent study characterized the virulence of different strains in these rabbits 
(Shringi et al., 2012).  Moreover, Dutch belted rabbits injected with Stx2 via IV also 
develop the extra-intestinal aspects of toxigenic disease, most notably, enteritis, 
inflammation, thrombus formation, and renal disease (Garcia et al., 2008).  While both 
the infant rabbit and Dutch Belted rabbit intragastric inoculation models have proven 
successful, the main difference between the two is the lack of renal damage in the infant 
rabbit model (for a comparison of these two models, see (Panda et al., 2010)). 
 
Mice 
Murine models are preferable for general use due to their low costs and ease of 
care, the availability of many genetic backgrounds and many different knockout animals, 
and because large numbers are easily obtainable for experimentation.  Several different 
murine models of EPEC and EHEC pathogenesis exist.  However, because EHEC and 
EPEC are unable to efficiently colonize conventional mice, elimination of normal flora is 
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often necessary in order to establish an infection.  Indeed, disruption of the normal flora 
by antibiotic pre-treatment, or its complete elimination by rearing the animals in a germ-
free environment, sensitizes mice to lethal infection after relatively low dose oral 
inoculation (Eaton et al., 2008; Lindgren et al., 1993; Melton-Celsa et al., 1996).  
Additional manipulations have been made to enhance colonization by EHEC in mice (for 
review, see (Mohawk and O'Brien, 2011)) including treatment with mitomycin C or other 
toxin-inducing agents (Asahara et al., 2004; Fujii et al., 1994; Shimizu et al., 2003; Teel 
et al., 2002), and prolonged dietary restrictions such as protein calorie malnutrition 
(Kurioka et al., 1998).  
 
Streptomycin treatment and gnotobiotic mice 
Early studies of EHEC pathogenesis utilized streptomycin treatment or 
gnotobiotic animals in order study colonization and Stx-mediated disease.  In the 
streptomycin treatment model, mice are given streptomycin in their drinking water prior 
to infection by EHEC (or both prior to infection and throughout infection with antibiotic-
resistant EHEC) (Lindgren et al., 1993; Melton-Celsa et al., 1996; Wadolkowski et al., 
1990a; Wadolkowski et al., 1990b).  In both of these models, damage to the kidney, 
particularly to the renal tubules, which is the primary site of Gb3 receptors in the mouse 
kidney (Psotka et al., 2009), is a consistent finding (Eaton et al., 2008; Melton-Celsa et 
al., 1996; Wadolkowski et al., 1990a; Wadolkowski et al., 1990b).  However, only EHEC 
that produce the mucus-activatable type of Stx, Stx2dact, are consistently able to cause 
lethal infection in streptomycin-pretreated mice (Lindgren et al., 1993; Melton-Celsa et 
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al., 1996).  Furthermore, EHEC infection of altered-flora mice does not result in well 
documented AE lesions, nor have bacterial genes that promote AE lesion formation 
proven required for intestinal colonization or disease (Eaton et al., 2008; Lindgren et al., 
1993; Melton-Celsa et al., 1996; Wadolkowski et al., 1990a; Wadolkowski et al., 1990b).  
Indeed, a laboratory E. coli K12 strain that overproduces Stx2 but lacks Tir, intimin, and 
the T3SS, is capable of lethal infection of streptomycin-pretreated mice (Wadolkowski et 
al., 1990b).  
 
Conventional mouse models 
Although EHEC does not efficiently colonize conventional mice, recent models 
have employed the use of large inoculums (~109 CFU or greater) by pipette feeding or 
gavage to obtain moderate levels of colonization (Mohawk et al., 2010a; Mohawk et al., 
2010b).  In these models, colonization as measured in feces or tissue generally peaks at 
approximately 106/gram and numbers diminish in the days following inoculation 
(Mohawk et al., 2010a; Mohawk et al., 2010b).  Mice display signs of Stx-mediated 
disease including weight loss, tubular damage, increased BUN, and neutrophilia, and 
lethal infection occurs approximately 30% of the time.  Interestingly, although intestinal 
damage and hemorrhagic colitis are prominent features of EHEC infection in humans, 
intestinal damage has not been observed in this model (Mohawk et al., 2010b; Mohawk 
and O'Brien, 2011). 
 
Stx-injection models 
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Murine models of Stx-injection, using purified toxin in the presence or absence of 
lipopolysaccharide (LPS), have been used to study the development and pathogenesis of 
HUS.  Injection of Stx into mice results in the induction of pro-inflammatory cytokines, 
vascular damage, hemolysis, and renal damage (Keepers et al., 2007; Keepers et al., 
2006; Psotka et al., 2009; Sauter et al., 2008).  However, in contrast to piglet, rabbit, and 
other mouse infection models (Garcia et al., 2006; Garcia et al., 2002; Mohawk and 
O'Brien, 2011; Panda et al., 2010; Tzipori et al., 1995), a major limitation of this model is 
that intestinal colonization and AE lesion formation are not required for disease. 
 
C. rodentium  
Due to its homology to other AE pathogens, C. rodentium is a commonly used 
infection model of EHEC and EPEC pathogenesis (Luperchio et al., 2000).  Indeed, 
murine C. rodentium infection has been used to study the in vivo functions of intimin, 
effector proteins, and actin pedestal formation (Crepin et al., 2010; Deng et al., 2004; 
Deng et al., 2003; Frankel et al., 1996b; Girard et al., 2009b; Mundy et al., 2004; Nagai et 
al., 2005; Newman et al., 1999; Schauer and Falkow, 1993b).  Upon infection, the cecum 
is colonized first, and it “seeds” the rest of the large intestine (Wiles et al., 2004).  
Similarly, bacterial clearance occurs first in the cecum, followed by the cecal patch, and 
then the colon (Wiles et al., 2004).  Bacterial levels in the colon peak at ~109 organisms 
between post-infection day five-to-14 (Mundy et al., 2005), and while mice do not 
usually develop overt diarrhea, they have increased liquid accumulation in the colon.  
Approximately ten days to two weeks post-infection, mice develop significant epithelial 
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crypt hyperplasia in the descending colon (Luperchio and Schauer, 2001; Mundy et al., 
2005).  Importantly, there is strain to strain variability in susceptibility to C. rodentium.  
While C3H/HeJ are the most susceptible and usually die by ten days post-infection, 
C57BL/6 mice are the most resistant and are able to clear infection (Vallance et al., 
2003). 
 
IV.  Summary and specific aims 
The two most notable aspects of EHEC colonization and disease are pedestal 
formation and Stx-mediated intestinal and systemic disease.  There has been much insight 
into the mechanism of intimin and Tir-mediated pedestal formation, as well as insight 
into the mechanism of toxin actin and the resultant pathology in animals.  However, we 
lack insight into the role of intimin and pedestal formation in colonization, and have 
virtually no insight into the relationship between pedestal formation and tissue damage.  
Therefore, the following questions will be addressed here: 
1. Does intimin have allele- and Tir-independent roles during infection? 
2. Does Tir-mediated actin pedestal formation promote colonization and/or Stx-
mediated disease?  
The major limitation in addressing these questions is that no conventional murine model 
exists to assess the function of different alleles of intimin or the role of Tir-mediated 
pedestal formation in EHEC.  Therefore, the AIMS of this thesis are as follows: 
1. Gain insight into the critical allele- and Tir-independent functions of intimin 
during infection of EHEC, EPEC, and Citrobacter.  
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i. Characterize these functions of intimin in vitro.  
ii. Develop animal models to assess these functions in vivo. 
2. Develop an animal model to assess the function of Tir-mediated actin pedestal 
formation in Stx-mediated disease using C. rodentium (λstx2dact). 
i. Characterize the model and determine if Tir is required for 
colonization and disease. 
3. Using this new model, determine if Tir-mediated actin pedestal formation is 
required for colonization and disease. 
i. Identify the mechanism(s) by which actin pedestal formation 
facilitates colonization and disease. 
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CHAPTER II. 
ALLELE- AND TIR-INDEPENDENT FUNCTIONS OF INTIMIN IN DIVERSE 
ANIMAL INFECTION MODELS 
Abstract 
Upon binding to intestinal epithelial cells, enterohemorrhagic E. coli (EHEC), 
enteropathogenic E. coli (EPEC), and Citrobacter rodentium trigger formation of actin 
pedestals beneath bound bacteria.  Pedestal formation has been associated with enhanced 
colonization, and requires intimin, an adhesin that binds to the bacterial effector Tir, 
which is translocated to the host cell membrane and promotes bacterial adherence and 
pedestal formation.  Intimin has been suggested to also promote cell adhesion by binding 
one or more host receptors, and allelic differences in intimin have been associated with 
differences in tissue and host specificity.  We assessed the function of EHEC, EPEC, or 
C. rodentium intimin, or a set of intimin derivatives with varying Tir-binding abilities in 
animal models of infection.  We found that EPEC and EHEC intimin were functionally 
indistinguishable during infection of gnotobiotic piglets by EHEC, and that EPEC, 
EHEC, and C. rodentium intimin were functionally indistinguishable during infection of 
C57BL/6 mice by C. rodentium.  A derivative of EHEC intimin that bound Tir but did 
not promote robust pedestal formation on cultured cells was unable to promote C. 
rodentium colonization of conventional mice, indicating that the ability to trigger actin 
assembly, not simply to bind Tir, is required for intimin-mediated intestinal colonization. 
Interestingly, streptomycin pre-treatment of mice eliminated the requirement for Tir but 
not intimin during colonization, and intimin derivatives that were defective in Tir-binding 
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still promoted colonization of these mice.  These results indicate that EPEC, EHEC, and 
C. rodentium intimin are functionally interchangeable during infection of gnotobiotic 
piglets or conventional C57BL/6 mice, and that whereas the ability to trigger Tir-
mediated pedestal formation is essential for colonization of conventional mice, intimin 
provides a Tir-independent activity during colonization of streptomycin pre-treated mice. 
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Introduction 
The family of attaching and effacing (AE) pathogens consists of 
enterohemorrhagic Escherichia coli, enteropathogenic E. coli (EPEC), and Citrobacter 
rodentium.  EHEC colonizes the large intestine and can result in diarrhea, hemorrhagic 
colitis, and life-threatening hemolytic uremic syndrome (Kaper et al., 2004; Pennington, 
2010).  The highly related EPEC colonizes the small intestine and is a causative agent of 
infantile diarrhea in the developing world (Chen and Frankel, 2005; Spears et al., 2006).  
C. rodentium is a related murine pathogen that typically colonizes the large intestine and 
causes transmissible murine colonic hyperplasia, characterized by colonic epithelial cell 
proliferation and high rates of mortality in suckling animals (reviewed in (Luperchio and 
Schauer, 2001; Mundy et al., 2005)).  
The three pathogens are so-named AE pathogens because they each colonize the 
intestinal epithelium by inducing in host cells “AE lesions”, which consist of effacement 
of brush border microvilli, intimate adherence of bacteria, and polymerization of actin 
into a pedestal-like extension of the epithelial cell beneath the bound bacterium ((Moon 
et al., 1983); for review, see (Kaper et al., 2004)).  Bacteria entirely incapable of 
generating AE lesions are severely defective for colonization and disease (Deng et al., 
2003; Donnenberg et al., 1993a; Donnenberg et al., 1993b; Ritchie et al., 2003; Schauer 
and Falkow, 1993b; Tzipori et al., 1995), while bacteria still capable of intimate 
attachment but defective selectively for pedestal formation are moderately attenuated 
(Crepin et al., 2010; Ritchie et al., 2008).  
The ability to generate the AE phenotype by these organisms requires the locus of 
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enterocyte effacement (LEE), a pathogenicity island that encodes a type III secretion 
system (T3SS) and several translocated effectors (Kenny and Finlay, 1995; McDaniel et 
al., 1995).  Tir (translocated intimin receptor), a type III translocated effector critical for 
intimate bacterial attachment and actin pedestal formation, becomes localized in the host 
plasma membrane with the N- and C-terminal domains residing in the host cell cytoplasm 
(for review see, (Campellone, 2010; Frankel and Phillips, 2008; Lommel et al., 2004)).  
The central, extracellular domain is recognized by the outer membrane adhesin intimin, 
encoded by the eae gene (Donnenberg and Kaper, 1991; Jerse, 1990).  The intimin N-
terminus promotes outer membrane localization and multimerization, whereas the intimin 
C-terminus encodes its adhesive activities (Batchelor et al., 2000; Frankel et al., 1995; 
Liu et al., 1999; Luo et al., 2000; Yi et al., 2010).  
It has been postulated that in addition to binding Tir, intimin possesses host 
receptor adhesive activities that also contribute to colonization.  For instance, the intimin-
related Yersinia pseudotuberculosis invasin protein binds to β1-chain integrins (Isberg et 
al., 1987), and EPEC intimin was shown to be capable of recognizing β1-chain integrins, 
albeit with apparently much lower affinity (Frankel et al., 1996a).  Nucleolin is 
recognized by EHEC intimin (Sinclair and O'Brien, 2002) and localized beneath cell-
associated EPEC during infection of cultured monolayers (Dean and Kenny, 2011).   
Finally, intimin but not Tir, contributes to the disruption of epithelial barrier function 
(Dean and Kenny, 2004), suggesting the existence of Tir-independent functions of 
intimin.   
Although EPEC and EHEC intimin have been demonstrated to be interchangeable 
43 
 
for pedestal formation on cultured cells, intimin exhibits considerable allelic variation in 
the C-terminal domain responsible for adhesive activity (Frankel et al., 1994), and the 
intimin alleles from the canonical EHEC, EPEC, and C. rodentium strains are distinct and 
have been associated with differences in function.  For example, although tissue tropism 
during infection of human intestinal explants is multifactorial, infection of intestinal 
tissue ex vivo suggests that intimin of EHEC O157:H7 (also known as intimin γ) 
promotes colonization of different epithelial types than intimin of canonical EPEC 
(intimin α) or C. rodentium (intimin β) (Fitzhenry et al., 2002; Girard et al., 2005; Mundy 
et al., 2007; Phillips and Frankel, 2000).  In addition, whereas wild type EHEC colonizes 
the large bowel of gnotobiotic piglets, an EHEC strain harboring a plasmid expressing 
EPEC intimin acquired the additional ability to colonize the small intestine (Tzipori et al., 
1995).  Allelic differences may also contribute to differences in species host range, 
because whereas C. rodentium expressing EPEC intimin is able to efficiently colonize 
Swiss NIH and C3H/HeJ mice (Frankel et al., 1996b; Hartland et al., 2000; Schauer and 
Falkow, 1993b), C. rodentium expressing a derivative of EPEC intimin harboring the 
adhesive domain of EHEC intimin provided only poor colonization function in these 
animals (Hartland et al., 2000; Mundy et al., 2007). 
To gain insight into the critical activities of intimin, we assessed the in vivo 
functionality of EHEC, EPEC, or C. rodentium intimin, or a set of EHEC intimin 
derivatives with varying Tir-binding abilities.  Colonization was not detectably altered by 
allele-specific differences in intimin in two animal infection models.  Notably, whereas 
the ability to trigger Tir-mediated pedestal formation was found to be essential for 
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colonization of conventional mice, intimin provided a Tir-independent function during 
colonization of antibiotic pre-treated mice.  
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Materials and Methods 
Media, bacterial strains, and growth conditions.  Bacteria were stored in Luria-Bertani 
(LB) broth (American Bioanalytical, Natick, MA, USA) with 50% glycerol at either -
80°C or -135°C.  Bacteria were grown at 37°C in LB broth, in Antibiotic Medium 3 
(Difco, Laboratories, Detroit, MI, USA), on LB agar (American Bioanalytical, Natick, 
MA, USA), on MacConkey lactose agar, or on eosin-methylene blue agar (Difco 
Laboratories, Lawrence, KS, USA).  Where indicated, kanamycin, chloramphenicol, 
gentamicin, ampicillin, and zeocin were added at final concentrations of 20 µg/ml, 10 
µg/ml, 100 µg/ml, 100 or 750 µg/ml, and 75 µg/ml respectively.  The bacterial strains 
and plasmids used in this study are listed in Tables 1 and 2. 
 
Construction of pCVD438 (pIntEPEC) derivatives.  Genomic DNA from EHEC 
O157:H7 strain EDL933 and plasmid pIntEPEC were purified using standard 
methodologies.  All primers used to construct these pCVD438 derivatives are listed in 
Table 3.  To construct pHL69 (pIntEHEC), a two-step amplification (fusion PCR) was 
performed.  First, the Pfu Turbo PCR system (Stratagene, La Jolla, CA, USA) was used 
to generate three fragments:  the region 5’ of the eaeEPEC open reading frame (ORF) in 
pIntEPEC (from the Hind III site to the eae start codon), the region 3’ of the eaeEPEC ORF 
in pIntEPEC (from the eae stop codon to the Sal I site), and the coding region of the 
eaeEHEC gene from EDL933.  To generate the first two fragments, pIntEPEC was restriction 
enzyme digested with BstE II to delete an internal 1,847-bp fragment (nucleotides 585 to 
2432 of eaeEPEC) and used as the PCR template.  The coding region of EDL933 eaeEHEC 
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was amplified from genomic DNA.  Each primer at a junction point in the fusion PCR 
was tailed with a 9- to 15-bp overhanging sequence from the neighboring fragment.  The 
amplification products were isolated using the QIAquick PCR purification kit (QIAgen 
Inc., Valencia, CA, USA), mixed, and subjected to a second round of amplification with 
the pACYC184 primers listed in Table 3.  The fusion PCR product was confirmed by 
DNA sequencing and ligated into the corresponding Hind III/Sal I site of pIntEPEC, 
effectively replacing the eaeEPEC ORF of pIntEPEC with that of EHEC EDL933.  The 
ligation mix was introduced into laboratory strains of E. coli by high-voltage 
electroporation and chloramphenicol-resistant clones were isolated. 
 
A similar methodology was used to generate pInv, pInv-Int395, pInv-Int181, and pInv-
Int100 (Table 2).  In the case of pInv, the coding region of the Y. pseudotuberculosis inv 
gene was amplified from pRI203.  For the latter three plasmids, the hybrid invasin-
intimin alleles had been previously generated and cloned into pT7-4 (Liu et al., 1999).  
These pT7-4 derivatives, pHL35, pHL49, and pHL55, respectively, were used as 
template DNA to amplify the coding region for pInv-Int395, pInv-Int181, and pInv-
Int100, respectively. 
 
Generation of C. rodentium strains.  Plasmid DNA was isolated using the QIAprep 
Spin Miniprep Kit (QIAgen, Valencia, CA, USA) and quantified by UV 
spectrophotometry.  Plasmids were introduced into the C. rodentium∆eae strain by 
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chemical transformation using calcium chloride.  Successful transformants were selected 
with chloramphenicol and were confirmed to be carrying the proper plasmid. 
 
Generation of an EHEC strain encoding EPEC intimin.  A three-way PCR was 
performed using templates encoding EHEC cesT with 3’ tail encoding EPEC eae (~750 
bp), EPEC eae (~2.8 kb) with 3’ EHEC tail, and EHEC 3’UTR (~960 bp).  The PCR 
product was cloned into pGEM7xf(+), linearized by BamH I and Xba I digestion, and 
transformed into KM48 harboring pTP223.  Transformants were screened by sucrose 
resistance and chloramphenicol sensitivity.  Candidates were confirmed by PCR 
sequencing.   
 
Generation of C. rodentiumtir.  The C. rodentium tir deletion mutant was made using 
a slightly modified version of the one-step PCR-based gene activation protocol (Datsenko 
and Wanner, 2000).  Briefly, a tertiary PCR product containing the zeocin cassette and its 
promoter flanked by 576 bp homology upstream of the start of tir and 608 base pairs 
downstream of the stop of tir was generated using three template PCR products, A+B, 
C+D, and E+F.  Product A+B was generated using primers F-A-Tir-KO and R-B-Tir-KO 
(Table 3) with genomic C. rodentium (DBS100) DNA (isolated using a kit by Promega, 
Madison, WI, USA) as a template.  Primers F-C-Tir-KO-zeo and R-D-Tir-KO-zeo were 
used to amplify a Mlu I/EcoR I cut pDONORzeo fragment to generate the 504 bp PCR 
product C+D.  Primers F-E-Tir-KO and R-F-Tir-KO were used to amplify genomic C. 
rodentium DNA to make PCR product E+F.  This 1.65 kb was electroporated into C. 
48 
 
rodentium (DBS100) containing the lambda-red plasmid, pKD46 and recombinants were 
selected for by plating on LB plates supplemented with 750 μg/ml ampicillin.  
Replacement of tir with the zeocin cassette and its promoter was confirmed by PCR using 
the following primers:  F-Tir-Ext, R-Tir-Ext, F-Tir-Int-323-342, R-Tir-Int-819-838, F-
Tir-Int-590-610, R-Tir-Int-1049-1069, F-Zeo-Int, and R-Zeo-Int (see Table 3). 
 
Purification of EHEC Tir and generation of an anti-EHEC Tir antibody.  pDV205 
(AmpR) is a derivative of pET21 that contains EHEC tir with a histidine tag.  For 
expression and purification of EHEC Tir, BL21 DE3+ pDV205 was cultured in 2xYT 
media at 37°C to an OD600 of 0.6-0.7 then induced with 1 mM IPTG for three hours at 
37°C.  The culture was spun at 4,420 x g, 20 minutes at 4C and the supernatant was 
discarded.  The pellet was resuspended in 2.5 ml lysis buffer per gram wet weight.  4 mg 
lysozyme was added and the sample was sonicated (Branson Sonifier 450, Branson 
Ultrasonics Corporation, Danbury, CT, USA) Duty cycle 70, output 3, 10 second bursts 
X 6 cycles).  The lysate was then centrifuged at 16,100 x g, 20 minutes at 4°C and the 
supernatant was run on a QIAgen Ni-NTA Agarose column (QIAgen, Valencia, CA, 
USA) and the resulting EHEC Tir was eluted and quantified using Bio-Rad Protein Assay 
kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA).  
 
For antibody production, all inoculations were completed subcutaneously with 30 ng of 
purified EHEC Tir in 50 μl with 50 μl of adjuvant for a total inoculation volume of 100 
μl.  Female BALB/c mice (Jackson Laboratories, Bar Harbor, ME, USA) were inoculated 
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with EHEC Tir supplemented with Imject Freund’s Complete Adjuvant (Thermo 
Scientific, Rockford, IL, USA).  At days 14 and 28, mice were boosted with EHEC Tir 
supplemented with Imject Freund’s Incomplete Adjuvant (Thermo Scientific, Rockford, 
IL, USA).  Mice were sacrificed on day 38 and blood was harvested via cardiac bleed, 
allowed to clot at room temperature for 30 minutes, and then was spun twice at 8,600 x g, 
15 minutes at 4°C.  Serum was then aliquoted and stored at -80°C. 
 
Invasion assays.  Entry into cultured cells was measured in a manner similar to that 
described previously (Finlay and Falkow, 1988).  Briefly, HEp-2 cells (ATCC CCL-23) 
were seeded in 24-well plates and grown overnight at 37°C in 5% CO2 and Dulbecco’s 
Modified Eagles medium supplemented with 10% heat inactivated calf serum and 2 mM 
L-glutamine (DMEM).  Bacteria were grown overnight in LB, diluted in fresh cell culture 
medium, and inoculated at an approximate multiplicity of infection (MOI) of 100.  The 
cells were incubated for 3 hours at 37°C in 5% CO2 and then washed with phosphate-
buffered saline (PBS).  Fresh cell culture medium supplemented with gentamicin was 
added to each well and the cells were incubated at 37°C in 5% CO2 for 1 hour.  The cells 
were washed with PBS, lysed with 1% Triton X-100 in PBS, and diluted to 1 ml with LB 
broth.  Percent invasion for each well was determined by plating dilution series. 
 
Infection of monolayers pre-infected with EPEC eae.  The “prime and challenge” 
assay is a modification of a previously described bacterial adherence assay (Liu et al., 
1999; Rosenshine et al., 1996) and was used to quantify intimin-Tir interactions in vitro.  
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Briefly, nearly confluent monolayers of HEp-2 cells were washed twice in PBS, and 
RHFM (RPMI-1640 supplemented with 20 mM HEPES, pH 7.0, 2% FBS, 0.5% D-
mannose) was added to the monolayers.  The monolayers were then mock-infected or 
infected with the EPEC eae-mutant strain JPN15.96 at MOI of ~200 and incubated at 
37°C in 5% CO2 for 3 hours.  JPN15.96 is capable of high efficiency translocation of Tir 
into mammalian cells, but unable to form pedestals due to the absence of intimin.  The 
monolayers were washed twice with PBS and then incubated for 1 hour at 37°C in 5% 
CO2 with 100 μg/ml gentamicin in DMEM/HEPES to kill remaining bacteria.  The 
monolayers were washed three times in PBS and then infected with the appropriate 
“challenge” bacterium, (i.e. C. rodentium, C. rodentium∆eae, or C. rodentium∆eae 
expressing EPEC intimin, EHEC intimin, invasin, or an invasin-intimin hybrid) diluted in 
fresh DMEM/HEPES at an MOI of 100 for 3 hours at 37ᵒ in 5% CO2.  At the conclusion 
of the assay, monolayers were washed 6 times with PBS, lysed with 1% Triton X-100 in 
PBS, and diluted to 1 ml with LB broth.  Percent adherence for each well was determined 
by plating dilution series. 
 
The prime and challenge assay was also adapted to evaluate actin pedestal formation 
mediated by intimin and its derivatives by seeding HEp-2 cells onto coverslips.  At the 
conclusion of the assay described above, coverslips were washed 6 times with PBS, fixed 
with 2.5% paraformaldehyde, and permeabilized with 0.1% Triton X-100 in PBS.  
Coverslips were then double fluorescently labeled for F-actin and bacteria and examined 
on a Nikon Eclipse E600 microscope.  F-actin was labeled with Texas red-conjugated 
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phalloidin (Molecular Probes, Eugene, OR, USA) and visualized with a 580-nm dichroic 
filter.  C. rodentium were labeled with an anti-C. rodentium polyclonal rabbit antibody 
raised against C. rodentium strain DBS100 and visualized with a Cascade blue-
conjugated goat anti-rabbit IgG antibody (Molecular Probes, Eugene, OR, USA) using a 
400-nm dichroic filter.  Coverslips labeled only with anti-C. rodentium primary antibody 
and the Cascade blue-conjugated secondary antibody showed no crossover when viewed 
with the 580-nm filter.  Image acquisition was performed with the Spot program 
(Diagnostics Instruments, software version 3.0.4) and imported into Adobe Photoshop 
5.0. 
 
Pedestal, bacterial binding, and Tir focusing assays.  The FAS assay of (Nicholls et 
al., 2000), as modified for C. rodentium (Newman et al., 1999) was the basis for this 
assay.  A single colony from each strain was grown in 1 ml media (+/- antibiotic) for 
eight hours.  Cultures were diluted 1:500 into 5 ml DMEM supplemented with 0.1 M 
HEPES (pH 7.0) (+/- antibiotic) and incubated at 37ᵒC without agitation with 5% CO2 for 
12-15 hours.  Cell monolayers were prepared by splitting 95-100% confluent mouse 
embryonic fibroblasts (MEFs) into 24-well culture plates containing sterile glass 
coverslips followed by overnight growth at 37ᵒC with 5% CO2.  Prior to seeding onto 
culture plates, MEFs were maintained in MEF cell culture media (DMEM (hi glucose) + 
10% fetal bovine serum (FBS) with penicillin, streptomycin, and glutamine) at 37°C, 5% 
CO2.  For infections, cell monolayers were washed twice with sterile PBS followed by 
addition of FAS media containing 25 μl of overnight cultured C. rodentium to each well.  
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Plates were spun at 700 g for 10 minutes then incubated at 37ᵒC with 5% CO2 for 3 hours.  
After 1.5 hours, plates were spun again at 700 g for an additional 10 minutes to insure 
proper bacterial binding to cells.  After three hours, cells were washed twice with sterile 
PBS and 0.5 ml pre-warmed FAS media was added to each well and cells were then 
incubated for an additional three hours.  Cells were then washed five times with sterile 
PBS, fixed with 4% PFA for 30 minutes, washed, permeabilized with 0.1% Triton-X 100, 
and stained with anti-EHEC Tir antibody (1:500) as a primary antibody for 30 minutes.  
The samples were washed and then stained for 30 minutes with anti-Mouse 488 
secondary antibody (Invitrogen, Carlsbad, CA, USA) (1:200), phalloidin (Molecular 
Probes, Eugene, OR, USA) (1:100), and DAPI (1:500).  After washing cells an additional 
three times with PBS, the coverslips were mounted on slides using ProLong® Gold anti-
fade reagent (Invitrogen, Eugene, OR, USA).  For binding assays, the number of bacteria 
per cell was counted for 25 random cells.  Counting was done in triplicate and the mean, 
median, and maximum number of bacteria bound to cells was determined.  The 
stratification of the number of cells with the given amount of bound bacteria in each 
interval (0, 1-5, 6-10, 11-15, 16-20, and >20) was also determined.   
 
Immunoblotting.  Preparation of bacterial cell lysates was performed as described 
previously (Brady et al., 2007; Campellone et al., 2002).  Samples were resolved by 10% 
SDS PAGE and transferred to PVDF membrane.  Membranes were blocked in PBS 
supplemented with 5% milk for 30 minutes prior to treatment with sheep anti-EHEC 
Intimin (1:500), goat anti-EPEC Intimin (1:2000), rabbit anti-OmpA, or rabbit anti-O157 
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antiserum (1:750, Difco Laboratories, Lawrence, KS, USA) for two hours, washed and 
treated with secondary antibody as previously described (Brady et al., 2007; Campellone 
and Leong, 2005; Campellone et al., 2004a). 
 
Immunofluorescence microscopy of EHEC strains.  To ensure an EHEC strain 
expressing EPEC intimin can generate actin pedestals and that the intimin plasmids used 
to overexpress EHEC and EPEC intimin were functional to complement a deletion of 
EHEC intimin by FAS, HeLa cell monolayers were infected with indicated strains, fixed, 
and permeabilized as described previously (Campellone et al., 2002).  For each strain, 
qualitative scoring of F-actin pedestals was performed as indicated.  Approximately equal 
numbers of actin pedestals were observed for EHECΔeae expressing EHEC intimin 
(pHL6) or EPEC intimin (pHL4). 
 
Mouse infection studies.  Mice were purchased from Jackson Laboratories (Bar Harbor, 
ME, USA) and housed in the University of Massachusetts Medical School (UMMS) 
animal facility.  All animal procedures were done in compliance with the UMMS 
IACUC.  Female, eight-week-old C57BL/6J mice were gavaged with PBS or ~2 x 109 of 
overnight culture of C. rodentium strain specified in 100 μl PBS.  Inoculum 
concentrations were confirmed by serial dilution plating.  C. rodentium fecal shedding 
was determined by serial dilution plating of fecal slurries (10% w/v in PBS) on 
Maconkey agar or LB agar with selection for zeocin, kanamycin, chloramphenicol, or 
kanamycin and chloramphenicol.  For streptomycin pre-treatment experiments, mice 
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were given 5 mg/ml streptomycin in their drinking water for 48 hours prior to infection.  
Following inoculation, non-antibiotic treated water given to the mice. 
 
Mouse tissue collection and histology.  At necropsy the large intestine (colon through 
cecum) was fixed in 10% buffered formalin, dehydrated and embedded in paraffin.  Five-
micron sections stained with hematoxylin and eosin were evaluated and scored blindly by 
a board-certified pathologist (V.V.).  Assessment of mucosal hyperplasia was targeted to 
areas of comparable muscularis propria thickness in order to reduce error from 
differences in planes of section. 
 
Transmission electron microscopy.  Mouse intestinal tissue samples were taken at 
various time points post infection and fixed in 2.5% gluteraldehyde in 0.05 M Sodium 
Phosphate buffer, pH 7.2.  Samples were processed and analyzed at the University of 
Massachusetts Medical School Electron Microscopy core facility according to standard 
procedures.  Briefly, fixed samples were moved into fresh 2.5% gluteraldehyde in 0.05 M 
Sodium Phosphate buffer and left overnight at 4oC.  The samples were then rinsed twice 
in the same fixation buffer and post-fixed with 1% osmium tetroxide for 1 hour at room 
temperature.  Samples were then washed twice with DH2O for 20 minutes at 4
oC and then 
dehydrated through a graded ethanol series of 20% increments, before two changes in 
100% ethanol.  Samples were then infiltrated first with two changes of 100% Propylene 
Oxide and then with a 1:1 mix of propylene oxide:SPI-Pon 812 resin.  The following day 
three changes of fresh 100% SPI-Pon 812 resin were done before the samples were 
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polymerized at 68oC in plastic capsules.  The samples were then reoriented and thin 
sections were placed on copper support grids and stained with lead citrate and uranyl 
acetate.  Sections were examined using the FEI Tecani 12 BT with 80Kv accelerating 
voltage, and images were captured using a Gatan TEM CCD camera. 
 
Piglet infections.  Gnotobiotic piglets were derived and infected orally with TUV93-0, 
which is deficient for the expression of Stx, thus eliminating the potentially confounding 
toxigenic effects on colonization (Tzipori et al., 1995), as described previously (Brady et 
al., 2011; Campellone et al., 2007; Ritchie et al., 2008).  To quantify bacteria in the small 
intestine, the small intestine was divided into five parts and each section was viewed 
individually for the presence of bacteria and AE lesions.  If bacteria or AE lesions were 
found in any of these sections, they were given the score of “+”.  The average score was 
then determined for the small intestines of piglets in each group.  A score of “+” indicates 
the presence of bacteria and AE lesions in at least one of the five sections of the small 
intestine in each of the piglets, a score of “+/-“ indicates the presence of bacteria and AE 
lesions in at least one of the five sections of the small intestine in at least half of the 
piglets, and a score of “-“ indicates that fewer than half of the piglets had bacteria and AE 
lesions in at least one of the five sections of the small intestine and also includes piglets 
that did not become colonized.  To enumerate bacteria in the spiral colon and cecum, 
each section was scored for the presence of bacteria and AE lesions.  A score of “+” 
indicates that every piglet in the group had bacteria and AE lesions present, a score of  
“+/-“ indicates that at least half of the piglets in the group had bacteria and AE lesions 
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present, and a score of “-“ indicates that fewer than half of the piglets had bacteria and 
AE lesions present.    
  
Statistical analysis.  Data were analyzed using GraphPad Prism.  Comparison of 
multiple groups was performed using one-way analysis of variance (ANOVA) with 
Tukey’s multiple comparison post-tests or two-way ANOVA with Bonferroni’s post-
tests.  Statistical significance of differences between two groups was evaluated using two 
tailed unpaired t tests.  In all tests p values below 0.05 (*), 0.01 (**), and 0.001 (***) 
were considered statistically significant, unless indicated otherwise.  In all graphs, error 
bars represent standard error of the mean (SEM), unless indicated otherwise. 
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Table 1.  Bacterial strains used in this study. 
Strain  Description or genotype Source or reference 
DBS100 C. rodentium (prototype TMCH isolate, 
ATCC 51459, original biotype 4280) 
(Barthold et al., 1976; Schauer 
and Falkow, 1993b) 
DBS255 C. rodentium∆eae; KanR (Schauer and Falkow, 1993a) 
DBS434 C. rodentium∆eae/pCVD438 (Frankel et al., 1996b) 
SAL31 C. rodentium ∆eae/pHL69 This study 
SAL32 C. rodentium∆eae/pHL70 This study 
SAL56 C. rodentium∆eae/pHL76 This study 
SAL57 C. rodentium∆eae/pHL79 This study 
SAL58 C. rodentium∆eae/pHL80 This study 
DH5α F- ø80dlacZ∆M15 ∆(lacZYA-argF) U169 
endA1 recA1 hsdR17 (rK
- mK
+) deoR thi-1 
phoA supE44 l-gyrA96 relA1 gal- 
Gibco BRL 
SAL35 DH5α/pHL70F- ø80dlacZ∆M15 
∆(lacZYA-argF) U169 endA1 recA1 
hsdR17 (rK
- mK
+) deoR thi-1 phoA 
supE44 l-gyrA96 relA1 gal- 
This study 
EDL933 EHEC O157:H7 (Riley et al., 1983) 
JPN15.96 EPEC eae::TnphoA (Jerse, 1990) 
BL21 DE3/ 
pDV205 
BL21 DE3 containing EHEC Tir 
expression vector 
(Vingadassalom et al., 2009) 
EDL933 EHEC O157:H7 prototype (Riley et al., 1983) 
TUV93-0 Stx- derivative of EDL933 (Campellone et al., 2002) 
KM60 EHEC TUV93-0 Δeae (Murphy and Campellone, 2003) 
KM48 EHEC TUV93-0 Δeae::cat-sacB (Murphy and Campellone, 2003) 
JPN15/pMAR7 AmpR derivative of EPEC E2348/69 
O127:H6 prototype 
(Jerse, 1990) 
LM1 KM46 derivative expressing EHEC tir-
cesT and EPEC eae 
This study 
C. rodentium 
Δtir 
DBS100 with an in-frame deletion of tir; 
ZeoR (i.e. zeocin resistance) 
This study 
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Table 2.  Description of plasmids used in study. 
Plasmid Protein Description Reference 
pCVD438 IntEPEC pACYC184-derived plasmid encoding 
eae from E2348/69 
(Donnenberg and 
Kaper, 1991) 
pHL69 IntEHEC pCVD438 with eaeEPEC ORF replaced 
by eaeEHEC ORF 
This study 
pHL70 Inv pCVD438 with eaeEPEC ORF replaced 
by inv ORF 
This study 
pHL76 Inv-
Int395 
pCVD438 with eaeEPEC ORF replaced 
by the 5’ 489 codons of inv fused to 
the 3’ 395 codons of eaeEHEC. 
This study 
pHL79 Inv-
Int181 
pCVD438 with eaeEPEC ORF replaced 
by the 5’ 793 codons of inv fused to 
the 3’ 181 codons of eaeEHEC. 
This study 
pHL80 Inv-
Int100 
pCVD438 with eaeEPEC ORF replaced 
by the 5’ 878 codons of inv fused to 
the 3’ 100 codons of eaeEHEC. 
This study 
pT7-4  AmpR P10 (Tabor and 
Richardson, 1985) 
pRI203  pT7-4 with inv from Y. 
pseudotuberculosis 
(Isberg et al., 1987) 
pACYC184  Cloning vector; CamR, TetR (Rose, 1988) 
    
pHL35  pT7-4 with inv (bp 1-1467)/eaeEHEC 
(bp 1617-2802); produces the protein 
Inv-Int395 
(Liu et al., 1999) 
pHL49  pT7-4 with inv (bp 1-2379)/eaeEHEC 
(bp 2260-2802) ; produces the protein 
Inv-Int181 
(Liu et al., 1999) 
    
pHL55  pT7-4 with inv (bp 1-2634)/eaeEHEC 
(bp 2503-2802); produces the protein 
Inv-Int100 
(Liu et al., 1999) 
pDV205 EHEC 
Tir 
pET21 containing EHEC tir (Vingadassalom et al., 
2009) 
pUC19  High-copy cloning vector, AmpR (Yanisch-Perron et al., 
1985) 
pHL4 IntEPEC pUC19 derivative encoding EPEC eae (Liu et al., 1999) 
pHL6 IntEHEC  pUC19 derivative encoding EHEC eae (Liu et al., 1999) 
pTP223  Produces λ-gam-bet-exa downstream 
of lac promoter 
(Murphy and Campellone, 
2003) 
pKD46   Expresses lambda red recombinase, 
AmpR 
(Datsenko and Wanner, 
2000) 
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Table 3.  DNA sequences of oligonucleotides used in this study.  
Primera Sequence 
eaeEPEC 5’ region
b, c  
F-pACYC184 5’ acc tga agt cag ccc cat acg ata 3’ 
R-eaeEPEC 5’ agt aat cat gtt tgg gct cca cca caa tg 3’ 
R-eaeEPEC-2 5’ aac cat cat gtt tgg gct cca cca caa tg 3’ 
eaeEPEC 3’ region
b, d  
F-eaeEPEC 5’ gtt tgt gta gaa taa att taa taa ata tct aat cat tgt ccg gct 
aa 3’ 
R-pACYC184 5’ ccg ctc gag gct ctc cct tat gcg act cc 3’ 
F-eaeEPEC-2 5’ gcg ctg tca ata taa att taa taa ata tct aat cat tgt ccg 
gct aa 3’ 
R-pACYC184-2 5’ tga ctg ggt tga agg ctc tca agg 3’ 
Open Reading Framesb,e 
F-eaeEHEC 5’ agc cca aac atg att act cat ggt tgt ta 3’ 
R-eaeEHEC 5’ aga tat tta tta aat tta ttc tac aca aac cgc at 3’ 
F-inv 5’ agc cca aac atg atg gtt ttc cag cca at 3’ 
R-inv 5’ aga tat tta tta aat tta tat tga cag cgc aca ga 3’ 
C. rodentium tir mutantf, g 
F-A-Tir-KO 5’ gtg cac aat cat caa tca gtc ac 3’ 
R-B-Tir-KO 5’ acc aaa atc cct taa cgt gag tta cgc gtc gtt cca ctg agc 
gtc aga cca cat ata tcc ttt tat tta atc gga aat ttt aca cta atc 
c 3’ 
F-C-Tir-KO-zeo 5’ ggt ctg acg ctc agt gga acg acg cgt aac tca cgt taa 
ggg att ttg gt 3’ 
R-D-Tir-KO-zeo 5’ tca gtc ctg ctc ctc ggc cac gaa gtg cac gca gtt gcc 
ggc cgg gtc gc 3’ 
F-E-Tir-KO 5’ gtg cac ttc gtg gcc gag gag cag gac tga cgc tac aac 
acc ggg agt tga acg ttt cgt cta aat ata taa tgg gta ttt tgt 
tgg ggg gga ggg gga g 3’    
R-F-Tir-KO 5’ ggc tcc acc aca atg agt tag 3’ 
F-Tir-Ext 5’ gct tgc atca taa gtt aga ctg tg 3’ 
R-Tir-Ext 5’ cgt cat tag tgt cag ata acg aga 3’ 
F-Tir-Int-323-342 5’ ttc gtg ttg aac agc agc ca 3’ 
R-Tir-Int-819-838 5’ tcg cag ctt ctg cag cat tt 3’ 
F-Tir-Int-590-610 5’ ata cac gtt ctg ttg gtg tcg 3’ 
R-Tir-Int-1049-1069 5’ cca att cct gct gac gtt tag 3’ 
F-Zeo-Int 5’ gag cgg tcg agt tct gg 3’ 
R-Zeo-Int 5’ gcc acg aag tgc acg cag t 3’ 
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aF, forward (top strand) primer; R, reverse (bottom strand) primer. 
bUnderlined sequences represent the restriction enzyme sites used for cloning.  Italicized 
sequences indicate the tails used for fusing eaeEPEC 5’ and 3’ sequences with eaeEHEC, inv, 
or hybrid allele coding regions. 
cFor pIntEHEC, F-pACYC184 and R-eaeEPEC were used.  For all others, F-pACYC184 and 
R-eaeEPEC-2 were used. 
dFor pInv, F-eaeEPEC-2 and R-pACYC184-2 were used.  For all others, F-eaeEPEC and R-
pACYC184 were used. 
eFor pIntEHEC, F-eaeEHEC and R-eaeEHEC were used.  For pInv, F-inv and R-inv were used.  
For all others, F-inv and R-eaeEHEC were used. 
fPrimers used to construct C. rodentiumΔtir.  Italicized regions indicate homology to 
zeocin cassette.  
gNumbers in primer name correspond to nucleotide positions primer is located within tir 
gene.  Int represents screening primers internal to the gene (tir or zeocin) and Ext 
represents screening primers that are external to the gene. 
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Results 
Precise chromosomal replacement of EHEC eae with EPEC eae does not alter tissue 
tropism in piglets. 
Plasmid complementation of an EHEC eae mutant with EPEC eae results in a 
strain with altered tissue tropism that colonizes the small bowel of piglets (Tzipori et al., 
1995).  To determine if EPEC and EHEC intimin might be functionally interchangeable 
when expressed from the endogenous chromosomal locus, we precisely replaced the 
EHEC eae allele in EHEC TUV93-0 with the eae allele from EPEC strain 
JPN15/pMAR7 (Figure 1A).  Immunoblotting confirmed that the resulting strain, LM-1, 
produced EPEC intimin (Figure 1B).  As predicted from previous work demonstrating 
that EHEC and EPEC intimin are functionally interchangeable for in vitro pedestal 
formation (DeVinney et al., 1999b), LM-1 generated actin pedestals on cultured cells 
(Figure 1C). 
To test the function of EPEC intimin during infection by EHEC, gnotobiotic 
piglets were infected orally with LM-1 and after 72 hours, infection was assessed by 
histological analysis of the small and large intestines.  Upon infection with wild type 
EHEC, piglets suffered diarrheal illness and bacteria were associated with extensive 
segments of the cecal and colonic epithelium (Table 4).  Wild type EHEC were only 
occasionally associated with the epithelium of the small intestine.  In contrast, infection 
of gnotobiotic piglets with EHECΔeae did not result in detectable bacterial association 
with epithelium of any intestinal segment, and correspondingly, the animals did not suffer  
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Figure 1.  An EHEC strain containing EPEC intimin on the chromosome is 
functional for pedestal formation.  (A) The endogenous EHEC eae gene was precisely 
replaced by EPEC eae to create LM-1.  (B) Expression of EHEC and EPEC intimin in 
wild type EHEC, EHECΔeae, and LM-1 was assessed by western blot.  Blotting with 
anti-OmpA was included as a loading control.  (C) HeLa cells were infected with the 
indicated strain and the monolayers were stained with DAPI (blue) to visualize bound 
bacteria and phalloidin (red) to visualize actin pedestals.  
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Table 4.  An EHEC strain carrying a precise chromosomal replacement of eae with 
EPEC eae displays piglet intestinal tropism indistinguishable from wild type. 
E. coli 
strain 
No. of 
animals 
No. of 
animals 
with 
diarrhea 
AE lesions and colonization 
Small 
intestine 
Cecum Spiral 
colon 
WT EHEC 5 5 +/- + + 
EHEC Δeae 4 0 - - - 
EHEC LM-1 4 4 +/- + + 
Gnotobiotic piglets were infected orally with 5 x 109 EHEC, EHECΔeae, or LM-1.  
Animals were sacrificed 72 hours after infection and the large intestines were removed, 
fixed, stained, and scored for colonization using a score adapted from Tzipori et al., 1995 
(see Materials and Methods).  “+” indicates bacteria and AE lesions present, “+/-“ 
indicates minimal bacteria and AE lesions present, and “-“ indicates no bacteria or AE 
lesions present.  Values represent the average colonization score of all the piglets in the 
group.  
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from diarrhea.  Notably, EHEC strain LM-1, which expresses EPEC intimin, colonized 
the epithelium of the cecum and spiral colon at levels indistinguishable from that of wild 
type EHEC, and like the wild type strain, induced diarrheal illness (Table 4).  In contrast 
to the previous finding that EHEC expressing EPEC intimin from a plasmid could 
efficiently colonize the small intestine of gnotobiotic piglets (Tzipori et al., 1995), 
bacteria were vanishingly sparse in the small intestine (Table 4).  These results 
demonstrate that EPEC intimin, when expressed in EHEC from the endogenous 
chromosomal locus, can provide intimin function during intestinal infection of piglets, 
but does not influence tissue tropism in this model. 
 
EHEC intimin can promote murine colonization and disease by C. rodentium.   
We further assessed ability of EHEC intimin to complement a C. rodentiumΔeae 
mutant for colonization and intestinal disease in mice.  Previous work demonstrated that 
C. rodentiumΔeae harboring pCVD438, which encodes EPEC intimin, was fully virulent 
in Swiss NIH and C3H/HeJ mice (Hartland et al., 2000; Mundy et al., 2007).  In contrast, 
C. rodentiumΔeae expressing an intimin hybrid carrying the N-terminal 554 residues of 
EPEC intimin and the C-terminal 380 residues of EHEC intimin colonized mice 100-fold 
less efficiently and did not cause the colonic hyperplasia that is characteristic of C. 
rodentium infection (Hartland et al., 2000; Mundy et al., 2007). 
To compare the colonization function of EPEC and EHEC intimin in mice, we 
precisely replaced the EPEC eae coding sequence of pCVD438 (which for simplicity we 
herein refer to as “pIntEPEC”) with the EHEC eae coding sequence to create pIntEHEC (i.e., 
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pHL69; Table 2).  C57BL/6 mice were infected with approximately 5 x 109 CFU of C. 
rodentium, C. rodentiumΔeae, C. rodentiumΔeae/pIntEPEC, or C. 
rodentiumΔeae/pIntEHEC.  Mice infected with C. rodentium reached peak colonization 
levels seven days post-infection with approximately 109 bacteria per gram of feces before 
being cleared from mice by approximately 15 to 20 days after inoculation, presumably 
due to the development of an adaptive immune response (Ghaem-Maghami et al., 2001; 
Simmons et al., 2003; Vallance et al., 2002) (Figure 2A and data not shown).  In 
contrast, the number of C. rodentiumΔeae in the stool peaked at three days post-infection, 
reaching less than 106 bacteria per gram of feces, and quickly diminished, never rising to 
more than 104 bacteria per gram of feces thereafter (Figure 2A).  Similar to what was 
previously reported (Frankel et al., 1996b; Hartland et al., 2000; Mundy et al., 2007). 
EPEC intimin, when expressed in C. rodentiumΔeae promoted high-level colonization 
with comparable kinetics to wild type C. rodentium (Figure 2A).  Additionally, intestinal 
sections from rodents infected with C. rodentiumΔeae expressing EPEC intimin showed 
colonic mucosal hyperplasia, goblet cell depletion, acute inflammation, erosions, and 
degenerative epithelial changes on the surface and in the crypts (Figure 2B).  
Interestingly, we also found that EHEC intimin, when expressed in C. rodentiumΔeae, 
promoted colonization, colonic hyperplasia, and damage indistinguishable from wild type 
C. rodentium (Figure 2) and generated AE lesions morphologically identical to wild type 
C. rodentium (Figure 3).  Thus, EHEC intimin, in spite of being significantly divergent 
in sequence from C. rodentium intimin, could provide complete intimin function in this 
model.   
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Figure 2.  EHEC intimin is able to restore colonization and disease in a C. rodentium 
eae mutant.  (A) Colonization of eight-week old C57BL/6 mice by C. rodentium (“Cr"), 
C. rodentiumΔeae, C. rodentiumΔeae/pIntEPEC, or C. rodentiumΔeae/pIntEHEC was 
determined by viable stool counts.  Shown are the averages CFU (± SEM) of five mice.  
Data shown are representative of one of three independent experiments.  (B) H&E-
stained large intestinal sections from mock-infected mice or mice infected with indicated 
strain are shown under 100x magnification.  Arrow heads point to ragged areas of the 
surface epithelium at sites of surface erosion.  Arrows point to areas of many goblet cells.  
Asterisks indicate areas of active inflammation.  Scale bars measure 50 μm. 
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Figure 3.  EHEC intimin can complement a C. rodentium eae mutant for AE lesion 
formation in vivo.  Transmission electron micrograph showing AE pedestal formation on 
colonic epithelial cells from the distal colon of a mouse infected with C. 
rodentium∆eae/pIntEHEC.  Original magnification, 25,000x.  Bar, 0.5 μm. 
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EHEC intimin and Tir-binding invasin-intimin fusions can mediate host cell 
adherence by C. rodentium.   
We next characterized the ability of C. rodentium∆eae expressing EHEC intimin 
to attach to host cells that express high levels of Tir on their surface, which more 
sensitively assesses Tir-intimin interactions compared to conventional infection assays 
(Liu et al., 2002).  Pre-infection (i.e. “priming”) of cells with an EPEC∆eae mutant 
permits efficient delivery of Tir to the eukaryotic cell (Liu et al., 1999; Rosenshine et al., 
1996).  After gentamicin treatment and washing to kill and remove bound bacteria, 
infection (i.e. “challenge”) of these monolayers with intimin-expressing bacteria permits 
sensitive assessment of bacterial binding mediated by Tir-intimin interaction (Liu et al., 
1999; Rosenshine et al., 1996).  Utilizing this assay, C. rodentium∆eae/pIntEHEC bound to 
pre-infected monolayers indistinguishably from that of wild type C. rodentium, and 
approximately 20-fold more efficiently than C. rodentium∆eae (Figure 4A). 
We next characterized the minimal region of EHEC intimin required for Tir-
mediated cell adherence when expressed in C. rodenitum.  The intimin related protein Y. 
pseudotuberculosis invasin, which binds to β1-chain integrins (Frankel et al., 1996a; 
Isberg and Leong, 1990), was previously used to deliver various portions of EHEC 
intimin to the surface of the bacteria in the form of invasin-intimin hybrid proteins (Liu et 
al., 1999).  C. rodentium∆eae expressing invasin was capable of high efficiency entry 
into cultured epithelial cells, strongly suggesting that invasin can be expressed in a 
functional form on the surface of C. rodentium (data not shown).  Thus, we determined 
the minimal region of EHEC intimin required for cell adherence by C. rodentium by 
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expression of invasin-intimin fusions in this bacterium.  C. rodentium∆eae producing 
Inv-Int395, a hybrid that contains the C-terminal 395 amino acids of intimin, bound to 
pre-infected monolayers at wild type levels, implying that this hybrid promotes Tir 
binding when expressed in C. rodentium∆eae, as it does when expressed in E. coli K12 
(Figure 4A; (Liu et al., 1999)).  In contrast, Inv-Int181, which was previously shown to 
retain some Tir-binding activity when expressed in E. coli K12 (Liu et al., 1999), and 
Inv-Int100, bound poorly to monolayers pre-infected with the EPEC∆eae mutant (Figure 
4A).  These data suggest that the minimal functional domain of EHEC intimin that can 
confer high-level Tir binding on C. rodentium is located in the C-terminal 395 amino 
acids. 
To determine if the functional Tir-binding domain defined by the more elaborate 
prime and challenge assay described above also functioned to promote cell attachment by 
C. rodentium during simple infection, we infected mouse embryonic fibroblasts (MEFs) 
with C. rodentiumΔeae expressing invasin or EHEC intimin derivatives and determined 
the number of bacteria bound to each of 25 randomly selected cells.  Cells infected with 
wild type C. rodentium harbored an average of more than nine bacteria per cell, and 
fewer than five of the 25 cells were entirely free of bacteria (Figure 4B).  Intimin was 
required for binding, because approximately 20 of the 25 cells infected with C. 
rodentiumΔeae were bacteria-free, and virtually no cells harbored more than five bacteria 
(Figure 4B).  EHEC intimin, when expressed in C. rodentiumΔeae, was able to restore 
binding capabilities of the mutant strain, with an average of approximately six bacteria 
per cell (Figure 4B).   
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Figure 4.  A hybrid containing the C-terminal 395 amino acids of EHEC intimin can 
complement a C. rodentium eae mutant for host cell attachment.  (A) HEp-2 cells pre-
infected with an EPEC∆eae strain were infected with wild type C. rodentium, C. 
rodentium∆eae, or C. rodentium∆eae strains expressing EHEC intimin, invasin, or the 
indicated invasin-EHEC intimin hybrids (Inv-Int395, Inv-Int181, and Inv-Int100), and 
stably bound bacteria were determined (Materials and Methods).  Data are shown as the 
mean ± SEM and represent two independent assays with at least three replicates per 
assay.  Asterisk indicates binding significantly (p<0.05) higher than C. rodentium∆eae of 
C. rodentium∆eae expressing pInv-Int181 or pInv-Int100, determined by two-tailed, 
unpaired t-test.  (B) Mouse embryonic fibroblasts were infected with the indicated C. 
rodentium strains and the number of bound bacteria per cell was counted for four sets of 
25 randomly selected cells.  Shown are the number of cells with the given number (0, 1-
5, 6-10, 11-15, 16-20, and >20) of bound bacteria.  The experiment was performed in 
triplicate.  Shown in box is the mean number of bacteria per cell ± SEM.  Asterisk 
indicates a significant difference (p<0.05) compared to C. rodentiumΔeae, determined by 
one-way ANOVA. 
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We similarly tested the ability of the invasin-intimin hybrids to bind to cells. 
Invasin, when expressed on the surface of C. rodentiumΔeae, dramatically enhanced the 
ability of the bacteria to associate with cells (p<0.05), with an average of approximately 
19 bacteria per cell, consistent with its ability to promote high-level host cell interaction 
(Figure 4B; (Isberg and Leong, 1990)).  C. rodentiumΔeae expressing Inv-Int395, which 
mediated attachment of C. rodentium in the prime and challenge assay (Figure 4A), 
bound to mammalian cells statistically indistinguishably from wild type C. rodentium, 
with an average of approximately eight bacteria bound to each cell (Figure 4B).  On 
average, fewer than five of the 25 cells were bacteria-free.  In contrast, C. rodentium 
expressing Inv-Int181 and Inv-Int100 bound to cells indistinguishably from C. 
rodentiumΔeae, with an average of less than two bacteria per cell and the majority of 
cells harboring fewer than five bacteria (Figure 4B).  These data indicate that EHEC 
intimin can complement a C. rodentiumΔeae mutant for cell attachment, and that the 
binding function of this protein is encompassed by the C-terminal 395 amino acids. 
 
EHEC intimin, but not a Tir-binding invasin-intimin hybrid, promotes Tir 
clustering and pedestal formation by C. rodentium. 
Given the ability of EHEC intimin and the hybrid Inv-Int395 to promote binding 
of C. rodentium to mammalian cells, we next tested their ability to promote Tir clustering 
and pedestal formation upon infection of mammalian cells.  As expected, cells infected 
with C. rodentiumΔeae demonstrated virtually no bound bacteria and after staining 
monolayers with anti-EHEC Tir, only one quarter of the rare bound bacteria were 
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associated with somewhat diffuse foci of Tir (Figure 5, column 2; and data not shown).  
In contrast, upon infection with wild type C. rodentium, 95% of bound bacteria were 
associated with intensely stained Tir foci, and 98% of bacteria generated actin pedestals 
(Figure 5, “Cr").  These defects in Tir clustering and pedestal formation were fully 
complemented by a plasmid expressing EHEC intimin, as well as by a plasmid 
expressing EPEC intimin, which was included as a positive control (Figure 5, 
“pIntEHEC“ and “pIntEPEC”, respectively).  Thus, EHEC intimin appears to provide full 
function for cell binding, Tir clustering, and pedestal formation when expressed in C. 
rodentium.  
To define the region of EHEC intimin critical for Tir clustering and pedestal 
formation, in parallel we infected monolayers with C. rodentiumΔeae expressing invasin-
intimin hybrids.  C. rodentiumΔeae expressing invasin or either of the two fusion 
proteins, Inv-Int181 or Inv-Int100, that were unable to promote Tir-mediated cellular 
attachment by C. rodentium, resulted in detectable Tir foci no more frequently than was 
found for C. rodentiumΔeae (Figure 5, “pInv”, “pInv-Int181”, or “pInv-Int100”).  In 
contrast, 59% of C. rodentiumΔeae expressing Inv-Int395, which promotes binding to C. 
rodentium to mammalian cells (Figure 4), were associated with Tir foci (Figure 5, 
“pInv-Int395”), a percentage that was both significantly higher than that of C. 
rodentiumΔeae and significantly lower than that of wild type C. rodentium or C. 
rodentiumΔeae expressing wild type EHEC intimin.  The partial complementation of Tir  
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Figure 5.  EHEC intimin, but not a Tir-binding invasin-intimin hybrid, promotes 
Tir clustering and pedestal formation by C. rodentium.  Monolayers were infected 
with the indicated C. rodentium (“Cr") strains and stained with DAPI to visualize 
bacteria (blue), anti-EHEC Tir antibody (green), and fluorescent phalloidin (red) to detect 
F-actin.  Twenty-five bound bacteria were scored for their association with Tir foci or 
pedestals.  †Note that when quantifying the percentage of cells infected with C. 
rodentiumΔeae that had Tir foci and/or actin pedestals associated with bound bacteria, 
many more cells needed to be counted given the inability/lack of this strain to adhere 
efficiently to cells.  Data represent quadruplicate samples.  Asterisk indicates that percent 
positive bacteria is significantly (p<0.05) greater than that for C. rodentiumΔeae. “#” 
indicates that percent positive bacteria is significantly (p<0.05) lower than that for C. 
rodentium/pIntEHEC. 
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clustering by pInv-Int395 was also reflected in the low (i.e. seven percent) frequency of 
pedestal formation (Figure 5, “pInv-Int395”).  Thus, although the expression of Inv-
Int395 in C. rodentium resulted in high-level Tir-mediated cell binding, it did not result in 
efficient Tir clustering or pedestal formation in cultured mammalian cells.  
 
A Tir-binding invasin-intimin fusion protein does not promote murine colonization 
by C. rodentium and results in minimal colonic hyperplasia. 
After characterizing the invasin-intimin hybrids in vitro, we next determined their 
ability to complement a C. rodentiumΔeae mutant for colonization and disease in vivo.  
As shown above (Figure 2A), after oral gavage of C57BL/6 mice with approximately 5 x 
109 C. rodentiumΔeae/pIntEHEC, C. rodentiumΔeae expressing EHEC intimin 
demonstrated wild type levels of colonization, colonic hyperplasia, goblet cell depletion, 
and abundant  inflammation (Figure 6A, B).  In contrast, in most instances C. 
rodentiumΔeae/pInv displayed colonization kinetics indistinguishable from C. 
rodentiumΔeae (Figure 6A) and did not trigger colitis (Figure 6B), showing that 
bacterial binding to β1-chain integrins, even by a high affinity ligand such as invasin 
(Tran Van Nhieu and Isberg, 1993) is not sufficient to promote C. rodentium 
colonization.  (Occasionally, C. rodentiumΔeae/pInv colonized mice somewhat better 
than C. rodentiumΔeae, but always at a level several orders of magnitude lower that wild 
type C. rodentium or C. rodentium expressing EHEC intimin and usually just above the 
limit of detection, i.e., 100 CFU/g feces; data not shown.) 
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As expected, C. rodentiumΔeae expressing Inv-Int181 or Inv-Int100, neither of 
which mediated mammalian cell attachment, Tir clustering, or pedestal formation in 
vitro, colonized mice no better than C. rodentiumΔeae and resulted in no detectable 
intestinal histopathology (Figure 6A, B).  Notably, C. rodentiumΔeae expressing Inv-
Int395, which promoted Tir-mediated attachment to cultured monolayers but did not 
cluster Tir efficiently or trigger pedestal formation on cultured cells, was as defective as 
C. rodentiumΔeae in colonization and triggered virtually no intestinal damage (Figure 
6A, B).  The inability of Inv-Int395 to demonstrate wild type intimin function during 
mammalian infection demonstrates that the ability of intimin to bind Tir, in the absence 
of efficiently clustering Tir and triggering pedestal formation, is insufficient to promote 
colonization and disease. 
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Figure 6.  A Tir-binding invasin-intimin fusion protein does not promote murine 
colonization by C. rodentium.  (A) Eight-week old C57BL/6 mice were inoculated with 
the indicated C. rodentium strains by oral gavage and colonization was determined by 
viable stool counts.  Shown are the averages CFU (± SEM) of groups of five mice.  Each 
strain was tested in at least three independent experiments.  The data displayed includes 
data from two different experiments, one in which C. rodentiumΔeae/pInv and C. 
rodentiumΔeae were analyzed and another in which the remaining strains were tested.  
The combined results are overlaid on the graph for ease of comparison.  (B) H&E stained 
large intestinal sections from mice infected with designated strain were analyzed at 100x 
magnification.  Scale bars measure 50 μm.  Arrow heads indicate foci of epithelial 
surface disruption.  Arrows indicate areas of goblet cells and asterisks indicate foci of 
active inflammation.      
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Intimin but not Tir is required for C. rodentium colonization of mice pre-treated 
with streptomycin. 
Streptomycin pre-treatment of mice permits EHEC, which is not normally an 
efficient mouse pathogen, to both colonize mice and cause toxigenic disease (Melton-
Celsa et al., 1996; Mohawk and O'Brien, 2011; Wadolkowski et al., 1990a; Wadolkowski 
et al., 1990b).  Pilot experiments indicated that brief streptomycin pre-treatment of 
outbred Swiss-Webster mice facilitated C. rodentium infection (D.S., Joseph Newman, 
and S.L., unpublished observations), so we pre-treated C57BL/6 mice with streptomycin 
for 48 hours prior to infection with C. rodentium strains that display different capacities 
to generate actin pedestals.  Wild type C. rodentium colonized these mice with high 
efficiency, reaching ~108 to 109/g feces by day three after inoculation and persisting at 
that level for ~15 days (Figure 7A, “Cr”).  Fecal colonization diminished after day 15 
post-infection, but unlike infection of untreated mice, easily detectable CFU were present 
until the experiment was terminated at 31 days post-infection.  Although C. 
rodentiumΔeae was present in the stool at high levels at three days post-infection, this 
strain was not capable of stable colonization (Figure 7A, “Cr Δeae”).  Fecal colonization 
of C. rodentiumΔeae at five days post-infection and throughout the remainder of the 
experiment was significantly lower than colonization by C. rodentium (Figure 7A, “Cr 
Δeae”, p<0.05).  The colonization defect was fully complemented by plasmid-borne 
EHEC or EPEC intimin for at least the first 15 days post-infection (Figure 7A, “Cr 
Δeae/pIntEHEC” or “Cr Δeae/pIntEPEC”, respectively).  Indeed, fecal colonization at 
seven to 18 was significantly higher (p<0.05) in mice infected with C. rodentium  
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Figure 7.   Intimin but not Tir is required for fecal colonization of streptomycin pre-
treated mice by C. rodentium.  (A, B) Eight-week old C57BL/6 mice were pre-treated 
with streptomycin in their drinking water for 48 hours prior to being inoculated with 
approximately 5 x 109 CFU of the indicated C. rodentium strains by oral gavage (see 
Materials and Methods), with the exception of C. rodentiumΔtir in panel A, in which 
approximately 106 CFU were inoculated.  Fecal colonization was determined by viable 
stool counts, and shown are the averages CFU (± SEM) of three to five mice per group.  
(Note that the slightly lower level of colonization by C. rodentiumΔtir in panel A at three 
days post-infection was likely due to the lower inoculum used.)  Each strain was tested in 
at least two independent experiments.  Statistical testing was done using a two-way 
ANOVA followed by Bonferroni’s post-tests. 
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expressing EHEC and EPEC intimin compared to mice infected with the C. rodentium 
eae mutant.  At later time points (after approximately 20 days post-infection), 
complementation was not complete, as bacteria expressing either EPEC or EHEC intimin 
were cleared somewhat more rapidly than wild type C. rodentium.  These data indicate 
that even when the flora is disrupted by antibiotic pre-treatment, intimin is required for 
maximal murine colonization.  In addition, the late time point differences 
notwithstanding, EHEC or EPEC intimin were able to provide wild type colonization 
function for the first two weeks of infection.    
To determine whether the requirement for intimin was a reflection of its ability to 
interact with Tir, we inoculated streptomycin pre-treated mice with a C. rodentiumΔtir 
mutant.  Notably, whereas Tir is essential for colonization by C. rodentium in 
conventional mice (Deng et al., 2003), we found that Tir was dispensable in streptomycin 
pre-treated mice.  In fact, fecal counts of C. rodentiumΔtir reached approximately 1010 
CFU/gram of feces by six days post-infection and remained highly elevated thereafter 
(Figure 7A, “Cr Δtir”).  Clearly, intimin provides a Tir-independent colonization 
function in this infection model. 
To test whether the potential integrin-binding activity of intimin might be the Tir-
independent activity that provides this function, we infected streptomycin pre-treated 
mice with C. rodentiumΔeae harboring pInv, which expresses the β1-chain integrin ligand 
invasin.  C. rodentiumΔeae/pInv, like C. rodentiumΔeae, was present at high levels 
transiently (at post-infection day three) in the stool of infected mice but was typically 
unable to sustain infection, suggesting that integrin binding of intimin did not contribute 
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to colonization function (Figure 7B, “Cr Δeae/pInv”).  (As was the case for infection of 
untreated C57BL/6 mice, occasionally the expression of invasin promoted a level 
colonization several orders of magnitude lower than C. rodentium that expressed 
endogenous or EHEC intimin; data not shown.)  
Finally, to determine what region of intimin was required to promote infection of 
antibiotic pre-treated mice, we infected mice with C. rodentiumΔeae/pInv-Int395 or C. 
rodentiumΔeae/pInv-Int100.  We found that expression of either Inv-Int395, which binds 
Tir, or Inv-Int100, which does not, was sufficient to promote stable high-level 
colonization (Figure 7B, “Cr Δeae/pInv-Int395” and “Cr Δeae/pInv-Int100”).  In 
some instances, the degree of colonization by C. rodentiumΔeae/pInv-Int100 was 
somewhat less than C. rodentiumΔeae/pInv-Int395 after ten days post-infection, but 
remained > ~106/gram feces throughout the 25 to 31 days of infection (Figure 7B and 
data not shown).  Thus, it appears that the C-terminal 100 residues of intimin contain the 
activity that promotes colonization of antibiotic pre-treated mice.  The finding that this 
portion of intimin is incapable of binding to Tir is consistent with the hypothesis that a 
Tir-independent function of intimin provides a critical colonization activity in animals 
with altered flora.    
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Discussion 
Intimin, encoded by eae, is an adhesin essential for colonization by AE pathogens 
(Dean-Nystrom et al., 1998; Donnenberg et al., 1993a; Ritchie et al., 2003; Schauer and 
Falkow, 1993b; Tzipori et al., 1995).  Allelic variation of intimin has been associated 
with differences in colonization of intestinal samples ex vivo (Fitzhenry et al., 2002; 
Mundy et al., 2007), and inoculation of gnotobiotic piglets with an EHEC strain 
harboring a plasmid encoding EPEC intimin resulted in colonization of the small 
intestine, a property not possessed by the same strain harboring a plasmid encoding 
EHEC intimin (Tzipori et al., 1995).  To avoid potential effects related solely to high 
copy number expression of intimin, in this study we precisely replaced the endogenous 
(chromosomal) eae coding sequence of EHEC with EPEC eae.  In fact, we found that the 
recombinant strain was incapable of efficiently colonizing the small intestine and infected 
the piglet indistinguishably from its isogenic wild type EHEC parent.  A previous study 
utilizing a newborn (not gnotobiotic) piglet model also failed to note differences in tissue 
tropism due to intimin allele, although that study was not designed to carefully assess 
tissue tropism (Donnenberg et al., 1993a).  Preliminary findings suggest that neither 
overexpression of EHEC nor EPEC intimin is associated with clear change in EHEC 
tissue tropism in gnotobiotic piglets, suggesting that simple overexpression does not 
account for the previously described tropism differences (M.J.B. and S.T., unpublished 
observations). 
To assess potential functional differences specific to intimin to particular alleles 
in a second animal model, we infected mice with C. rodentium strains expressing 
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endogenous intimin, or intimin of canonical EPEC or EHEC strains.  We found that 
EHEC intimin, like EPEC intimin, promoted efficient intestinal colonization and wild 
type disease.  Notably, previous studies indicated that C. rodentium expressing a chimeric 
intimin composed of the 554 N-terminal residues of EPEC intimin fused to the 380 C-
terminal residues of EHEC intimin colonized the murine intestine approximately a 
hundred-fold less efficiently than wild type C. rodentium and was entirely defective for 
inducing disease (Hartland et al., 2000; Mundy et al., 2007).  The N-terminal 554 
residues of EPEC and EHEC intimin are 97 percent identical, and although we cannot 
rule out the possibility that an important (perhaps Tir-binding) activity of EHEC intimin 
is diminished by the exchange of its N-terminus for that of EPEC intimin, an alternative 
hypothesis is that differences in the murine host strain contribute to the apparent 
discrepant results; previous studies demonstrating allele-specific differences utilized 
Swiss NIH or C3H/HeJ mice (Hartland et al., 2000; Mundy et al., 2007), whereas we 
utilized C57BL/6 mice in the current study.  Additionally, anecdotal evidence suggests 
that the degree of murine infection by C. rodentium is dependent on the commercial 
source of mice (M. McBee, personal communication), a factor that might influence the 
composition of the intestinal microbiome (Littman and Pamer, 2011).  Regardless, the 
demonstration here that EHEC intimin can confer apparently full biological function in 
this infection model provides a facile experimental system in which to assess either 
EHEC intimin function or therapeutic strategies targeting this important virulence factor.  
Intimin has the capacity to recognize mammalian proteins, such as β1-chain 
integrins or nucleolin, activities that have been postulated to facilitate colonization by 
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promoting initial bacterial attachment to mucosal surfaces (Frankel et al., 1996a; Sinclair 
and O'Brien, 2002).  Expression of invasin, a high affinity β1-chain integrin ligand, 
conferred on C. rodentium the ability to enter mammalian cells in vitro, indicating that 
the invasin integrin-binding domain was presented in a functional form on the bacterial 
surface.  Invasin did not, however, provide consistent intimin function in promoting 
murine colonization by C. rodentium, indicating that the β1-chain integrin binding 
activity is not the sole activity of intimin required for biological function.   
The above finding is predicted from the demonstration that an essential receptor 
for intimin is the type III effector Tir, which becomes localized in the plasma membrane 
after translocation (Kenny et al., 1997).  Tir binding by intimin is required for high-level 
attachment to cultured mammalian cells (Liu et al., 1999), and Tir-deficient mutants of 
AE pathogens, like intimin mutants, are incapable of intestinal colonization (Deng et al., 
2003; Marches et al., 2000; Ritchie et al., 2003).  We found that C. rodentium expressing 
EHEC intimin was capable of Tir-mediated binding to mammalian cells.  A C. rodentium 
strain expressing the intimin-invasin chimera Inv-Int395, which contains three intimin 
immunoglobulin-like domains and the C type lectin-like domain (Frankel et al., 1995; 
Luo et al., 2000), also efficiently bound to mammalian cells.  C. rodentium expressing 
Inv-Int181, which contains a region that is capable of binding Tir when expressed as a 
recombinant protein, did not bind primed cells or unmanipulated cells.  Previous analysis 
of recombinant intimin derivatives revealed that sequences N-terminal to the minimal 
181-residue Tir-recognition domain may influence binding (Liu et al., 1999).  
Interestingly however, a laboratory E. coli K12 strain expressing Inv-Int181, in contrast 
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to C. rodentium expressing this chimera, bound to mammalian cells that had been pre-
infected with EPEC (Liu et al., 1999).  LPS O antigen can sterically hinder the 
recognition of invasin in the outer membrane (Voorhis et al., 1991), and the strain-
specific difference in the activity of Inv-Int181 may reflect differences in O antigen 
length and/or density.    
Intimin-mediated clustering of Tir in the plasma membrane promotes the 
formation of an actin assembly complex beneath bound bacteria, leading to actin 
assembly (Campellone et al., 2004a; Touze et al., 2004).  Indeed, C. rodentium 
expressing EHEC intimin not only bound to monolayers that were primed with 
EPEC∆eae, but also triggered robust actin assembly.  In contrast, whereas C. rodentium 
expressing Inv-Int395 was capable of Tir-mediated binding to mammalian monolayers, 
this interaction did not trigger efficient pedestal formation.  Given the extensive sequence 
differences between invasin and intimin, any number of factors may account for the 
partial function of Inv-Int395 in pedestal formation.  However, multimeric interactions 
greatly facilitate the efficiency of actin assembly (Blasutig et al., 2008; Padrick et al., 
2008; Sallee et al., 2008), and it is possible that Tir binding by C. rodentium producing 
Inv-Int395 did not result in the high-density membrane clustering of Tir that triggers 
efficient actin assembly.  Consistent with this hypothesis, C. rodentium expressing Inv-
Int395 generated foci of Tir in infected cells at a significantly lower efficiency did C. 
rodentium expressing full-length C. rodentium, EPEC or EHEC intimin.  Indeed, whereas 
latex beads coated at high concentrations with C-terminal fragments of purified EHEC 
intimin stimulated robust actin assembly on monolayers pre-infected with EPEC∆eae, E. 
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coli K12 strains expressing invasin-intimin hybrids containing the equivalent regions of 
intimin did not (Liu et al., 1999).  
The finding that C. rodentium expressing either EHEC intimin or Inv-Int395 both 
bound to Tir but only the former triggered actin pedestal formation in vitro, provided an 
opportunity to determine if pedestal formation correlated with intestinal colonization.  
Indeed, whereas C. rodentium expressing EHEC intimin was capable of colonizing mice 
to levels indistinguishable from levels attained by wild type C. rodentium, C. rodentium 
expressing Inv-Int395 colonized mice at levels a million-fold lower, barely above 
background, and were cleared from the mice by day five post-infection.  C. 
rodentiumeae expressing Inv-Int395 also was not associated with any manifestations of 
disease.  A correlation between the ability to generate robust pedestal in vitro and 
efficient colonization of the mammalian host has previously been described.  First, an 
EHEC strain lacking a second translocated effector, EspFU (also known as TccP), 
remains capable of Tir translocation and intimin-mediated binding but is incapable of 
stimulating robust actin assembly (Campellone et al., 2004b; Garmendia et al., 2004), and 
is defective (albeit mildly) in late-stage colonization in infant rabbits (Ritchie et al., 
2008).  Second, a C. rodentium encoding a mutant Tir that binds intimin but is deficient 
in downstream actin signaling is out-competed late in infection by a wild type strain 
during co-infection experiments (Crepin et al., 2010).  Thus, mutants of any of the three 
bacterial factors directly involved in pedestal formation, intimin, Tir, and EspFU, that 
specifically diminish pedestal formation in vitro also diminish colonization in vivo.  A 
genetically engineered C. rodentium strain that generates pedestals using an additional 
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mechanism did not display a competitive advantage over a wild type strain (Girard et al., 
2009a), suggesting that even though inefficient pedestal formation is associated with 
diminished colonization, pedestal formation enhanced over wild type levels does not lead 
to enhanced colonization.  The means by which a threshold pedestal formation activity 
may be required for maximal intestinal colonization is currently unclear, but the 
observation that the EHEC∆espFU mutant formed smaller than wild type aggregates on 
the intestinal epithelium of piglets and showed a late colonization defect in infant rabbits 
(Ritchie et al., 2008) suggests that pedestals may stabilize bacterial interaction with the 
mucosal surface or otherwise promote expansion of the infectious niche at that site.   
Whereas Tir-mediated actin pedestal formation appears to contribute to 
colonization of gnotobiotic piglets and conventional mice, infection of streptomycin pre-
treated mice revealed a Tir-independent function of intimin.  Intimin function in this 
model was largely independent of intimin allele—C. rodentium expressing EPEC or 
EHEC intimin colonized these mice at high levels for at least two weeks, although they 
both showed somewhat diminished colonization relative to wild type C. rodentium 
beyond that time point.  Most notably, whereas C. rodentiumΔeae was incapable of 
stably colonizing antibiotic-treated mice, C. rodentiumΔtir colonized these mice at least 
as well as wild type C. rodentium.  The ability of intimin to bind host cells or components 
of host cells such as 1-chain integrins or nucleolin has been previously mapped to C-
terminal portions of intimin (Frankel et al., 1994; Frankel et al., 1996a; Sinclair and 
O'Brien, 2002, 2004).  We found that the colonization activity of intimin in this infection 
model was retained by intimin derivatives harboring C-terminal regions of intimin, even 
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if such derivatives (e.g. Inv-Int100, containing only the C-terminal 100 residues of 
intimin) were incapable of binding Tir.  Intimin also contributes to the disruption of 
epithelial barrier function in vitro in a Tir-independent manner (Dean and Kenny, 2004).  
Notably, the Tir-independent intimin activities in cell attachment or barrier disruption 
have been characterized entirely by in vitro assays, and the contribution of these activities 
to colonization and disease during mammalian infection has not been documented.  A 
comparison of these Tir-independent intimin in vitro activities to intimin function in 
promoting colonization of streptomycin pre-treated mice might provide insight into novel 
activities of intimin relevant to colonization of a mammalian host.   
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CHAPTER III. 
A NOVEL MURINE MODEL FOR SHIGA TOXIN-MEDIATED DISEASE BY  
ENTEROHEMORRHAGIC ESCHERICHIA COLI 
Abstract   
Upon attachment to intestinal epithelium, enterohemorrhagic E. coli (EHEC) generates 
‘attach and efface’ (AE) lesions, characterized by intimate attachment, microvillar 
effacement, and actin pedestal formation beneath bound bacteria.  AE lesion formation 
requires the type three-secreted effector Tir.  Production of the phage-encoded cytotoxin, 
Shiga toxin (Stx), by EHEC contributes to hemorrhagic colitis and the triad of hemolytic 
anemia, thrombocytopenia, and renal failure.  Conventional mice are not highly 
susceptible to infection with strains that produce Stx, and no mouse model clearly 
demonstrates AE lesions and intestinal damage after EHEC infection.  We lysogenized 
Citrobacter rodentium, a murine AE pathogen lacking Stx, with a λ phage that produces 
Stx2dact, an allele of Stx that is highly toxic to mice.  C. rodentium (λstx2dact) generated 
Stx2dact upon phage induction in vitro.  Mice infected with C. rodentium (λstx2dact) 
formed AE lesions on the intestinal epithelium and developed Stx2dact-dependent 
intestinal inflammatory damage.  In addition, renal proximal tubules were damaged, and 
mice suffered a lethal infection characterized by proteinuria, induction of serum and renal 
pro-inflammatory cytokines, and weight loss.  A C. rodentium (λstx2dact) tir mutant failed 
to colonize or cause disease.  Thus, C. rodentium (λstx2dact) provides a murine model for 
Stx-mediated intestinal and systemic disease by an AE pathogen.  
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Introduction 
Enterohemorrhagic E. coli (EHEC), particularly serotype O157:H7, is an 
important food-borne human pathogen responsible for both sporadic cases and epidemic 
outbreaks of diarrheal illness (Kaper et al., 2004; Pennington, 2010).  Human EHEC 
infection can cause severe local disease such as hemorrhagic colitis, characterized by 
damage to the intestinal epithelium, acute abdominal pain, and bloody diarrhea (Amirlak 
and Amirlak, 2006; Karch et al., 2005; Karmali et al., 2009; Tarr et al., 2005).  EHEC 
infection may also result in life-threatening systemic disease, most notably hemolytic 
uremic syndrome (HUS), characterized by the triad of hemolytic anemia, 
thrombocytopenia, and renal failure (Scheiring et al., 2010; Tarr et al., 2005).  In fact, 
HUS is the leading cause of renal failure in children (Mead and Griffin, 1998; Scheiring 
et al., 2008).   
A characteristic pathogenic feature of EHEC, one that it shares with 
enteropathogenic E. coli (EPEC), a cause of infantile diarrhea in the developing world, 
and Citrobacter rodentium, a natural murine pathogen, is the ability to generate attach 
and efface (AE) lesions (Kaper et al., 2004; Schauer and Falkow, 1993a).  These 
histopathological lesions are characterized by intimate adherence of the bacterium to the 
host cell, effacement of brush border microvilli, and the formation of filamentous actin-
rich pedestals beneath bound bacteria ((Moon et al., 1983); for review see (Kaper et al., 
2004).  The formation of AE lesions requires translocation of effector proteins into the 
mammalian cell via a type three secretion system (Kenny and Finlay, 1995; McDaniel et 
al., 1995).  A critical type three effector protein is Tir, which localizes in the host plasma 
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membrane and acts as a receptor for the bacterial outer membrane protein intimin, 
promoting intimate adherence and filamentous actin assembly beneath bound bacteria (de 
Grado et al., 1999; Donnenberg and Kaper, 1991; Hartland et al., 1999; Jerse et al., 1990; 
Kenny et al., 2002).  Both Tir and intimin are essential for colonization and virulence in 
several animal models of EHEC and Citrobacter infection (Deng et al., 2003; 
Donnenberg et al., 1993b; Marches et al., 2000; Ritchie et al., 2003; Schauer and Falkow, 
1993b; Tzipori et al., 1995).  
EHEC represent a subset of Shiga toxin-producing E. coli (STEC).  Shiga toxin 
(Stx) is a potent inhibitor of protein synthesis that is largely responsible for the extensive 
tissue damage and systemic disease generated by EHEC (O'Brien et al., 1992; Schuller et 
al., 2004; Tarr et al., 2005).  Stx is encoded by a lambdoid prophage and its production is 
often enhanced upon phage induction (Muhldorfer et al., 1996; Schmidt, 2001; Waldor 
and Friedman, 2005).  Stx traverses the intestinal epithelium and targets the endothelium, 
leading to vascular damage, particularly in tissues such as the kidney and central nervous 
system because these tissues express high levels of the Stx receptor, the glycolipid 
globotriaosylceramide or Gb3 (Obrig, 2010; Sandvig and van Deurs, 1996; Schuller, 
2011).  The action of Stx on endothelial cells leads to the induction of pro-inflammatory 
cytokines, thrombus formation in the vasculature, and renal damage (Nakao and Takeda, 
2000; O'Loughlin and Robins-Browne, 2001; Sandvig, 2001; Tesh et al., 1994; Thorpe et 
al., 2001).  Stx1 and Stx2 are the two major serotypes of Stx, and EHEC that express 
exclusively Stx2 are associated with a greater risk of HUS (Croxen and Finlay, 2010; 
Melton-Celsa et al., 2011; Ostroff et al., 1989).  There are several variants of Stx2, of 
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which Stx2c and Stx2dact are particularly important in human disease (Eklund et al., 
2002; Friedrich et al., 2002; Persson et al., 2007).  In particular, Stx2dact is 
proteolytically activated in the intestinal mucus, and is associated with STEC that cause a 
toxigenic illness in humans despite the fact that they lack the ability to generate AE 
lesions (Ito et al., 1990; Melton-Celsa et al., 2002).   
Injection of Stx into mice results in the induction of pro-inflammatory cytokines, 
vascular damage, hemolysis, and renal damage (Keepers et al., 2007; Keepers et al., 
2006; Psotka et al., 2009; Sauter et al., 2008), but in contrast to piglet and rabbit infection 
models (Garcia et al., 2006; Garcia et al., 2002; Panda et al., 2010; Tzipori et al., 1995), 
murine models fail to recapitulate the efficient intestinal colonization via AE lesion 
formation (reviewed in (Mohawk and O'Brien, 2011)).  For example, conventional mice 
suffer Stx-mediated mortality only after administration of large numbers of EHEC, 
numbers that diminish in the days following inoculation (Mohawk et al., 2010a; Mohawk 
et al., 2010b).  Disruption of the normal flora by antibiotic pre-treatment, or its complete 
elimination by rearing the animals in a germ-free environment, sensitizes mice to lethal 
infection after relatively low dose oral inoculation (Eaton et al., 2008; Lindgren et al., 
1993; Melton-Celsa et al., 1996).  However, only STEC that produce a particular 
Stx2dact consistently cause lethal infection of streptomycin pre-treated mice (Lindgren et 
al., 1993; Melton-Celsa et al., 1996).  Furthermore, EHEC or STEC infection of altered-
flora mice does not result in well documented AE lesions, nor have bacterial genes that 
promote AE lesion formation been demonstrated to be required for intestinal colonization 
or disease (Eaton et al., 2008; Lindgren et al., 1993; Melton-Celsa et al., 1996; 
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Wadolkowski et al., 1990a; Wadolkowski et al., 1990b).  Indeed, a laboratory E. coli K12 
strain that overproduces Stx2 but lacks Tir, intimin, and the type III secretion apparatus, 
is capable of lethal infection of streptomycin pre-treated mice (Wadolkowski et al., 
1990b).  Interestingly, in spite of the fact that intestinal damage and hemorrhagic colitis 
are prominent features of EHEC infection in humans, intestinal damage is not a 
prominent feature of current models involving infection of mice (Mohawk et al., 2010b; 
Mohawk and O'Brien, 2011). 
The AE pathogen Citrobacter rodentium has been used extensively as a murine 
model for EHEC and EPEC colonization (Barthold et al., 1978; Borenshtein et al., 2008; 
Deng et al., 2003; Luperchio and Schauer, 2001; Mundy et al., 2005), but does not 
express Stx.  To establish an infection model that reflects both the characteristic mode of 
intestinal colonization and Stx-mediated disease, we constructed a C. rodentium strain 
lysogenized by an Stx2dact-producing phage.  Administration of C. rodentium (λstx2dact) 
to mice by gavage recapitulated Tir-dependent AE lesion formation, as well as essential 
aspects of systemic Stx-mediated disease, including intestinal and renal damage, 
accompanied by the induction of pro-inflammatory cytokines.  Thus, C. rodentium 
(λstx2dact) provides a model for EHEC colonization and toxin-mediated disease in 
conventional mice.  
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Materials and Methods 
Plasmids, bacterial strains, and growth conditions.  Bacterial strains and plasmids 
used in this study are listed in Supplemental Tables 1 and 2.  All bacteria were cultured 
in Luria-Bertani broth (LB) (Miller) at 37oC, unless otherwise stated.  Antibiotics were 
used in the following concentrations kanamycin (25 μg/ml), zeocin (75 μg/ml), and 
chloramphenicol (10 μg/ml). 
 
Sequencing of Φ1720a-02 from Gobius EC1720.  Sequencing of the newly identified 
Φ1720a-02 from EC1720a, a strain originally isolated from retail ground beef (Gobius et 
al., 2003) was performed using the panhandle PCR technique as previously described 
(Jones and Winistorfer, 1993; Siebert et al., 1995), and Egan, PH.D. Thesis).  The adaptor 
sequences used were F-Adaptor 1 (see Supplemental Table 3) and R-Adaptor 2 (see 
Supplemental Table 3).  Primers F-AP1 and R-AP2 (see Supplemental Table 3) were 
used for the PCR reaction and sequencing of the PCR reaction, respectively.  Reactions 
for restriction digests and ligation of adaptors to genomic Φ1720a-02 DNA were as 
follows: 1 μg genomic Φ1720a-02 DNA, 10 pmol F-Adapter 1, 10 pmol R-Adapter 2, 10 
units blunt-end restriction enzyme (EcoRV, PvuII, RsaI, SspI, XmnI, DraI, HincII, HpaI, 
ScaI), 2.5 units T4 DNA ligase, 2 μl 20mM ATP, 4 μl of 10x One-Phor-All buffer PLUS 
(Amersham-Pharmacia, Piscataway, NJ, USA), and up to 20 μl water.  Reactions were 
then incubated at 20°C for 16 hours.  Next, enzymes were deactivated by heating at 68°C 
for 10 minutes and reactions were ethanol precipitated and resuspended in 50 μl sterile 
water.  The panhandle PCR reaction was then performed using 1 μl of the ethanol 
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precipitated template DNA, 2 μl Taq 10x reaction buffer containing 20 mM MgCl2, 1 μl 
10 mM dNTP mix, 10 pmol F-AP1 primer, 10 pmol gene specific primer, 1 unit Taq 
polymerase, and up to 20 μl water.  The PCR cycle parameters were as follows:  (1) 95°C 
for 1 minute, (2) 95°C for 30 sec, (3) 68°C for 7 minutes, and steps 2-3 were repeated 25 
times.  PCR reactions were then cleaned up using a QIAgen (Valencia, CA, USA) spin 
kit and sequenced at Tufts Core Sequencing Facility.  
 
To confirm the nucleotide and protein sequences of StxA and StxB from the newly 
identified Φ1720a-02 (λstx2dact), fragments of both genes, the predicted promoter region, 
and the region upstream of stxA were amplified by PCR and TA cloned into JM109 high 
efficiency competent cells (Promega, Madison, WI, USA).  The following primers (see 
Supplemental Table 3 for sequences) were used to clone each fragment: F-Oli218+R-
Oli219 (593 bp), F-Oli224+R-Oli210 (1.490 kb), R-Oli220+F-Oli221 (1.647 kb), F-
Oli222+R-Oli220 (~2 kb), R-Oli223+F-Oli222 (1.159 kb), F-Oli224+R-Oli223 (1.3 kb), 
F-Oli221+R-Oli210 (918 bp), F-Oli224+R-Oli219 (1.2 kb), R-Oli219+F-Oli226 (~2.1 
kb), and F-Oli228+R-Oli219 (~2 kb) (see Supplemental Table 3).  The clones were 
screened by colony PCR and restriction digestion.  Correct clones were sequenced at 
Tufts Core Sequencing Facility.  Fragments were aligned using BioEdit software and/or 
MacVector.  Nucleotide sequences of stxA and stxB were submitted to Genbank and were 
assigned the following accession numbers: JN194203 and JN194204.  
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Alignment of Φ 1720a-02 StxA2 and StxB2 from with other Stxs.  The predicted 
amino acid sequence of the A and B subunits of from the Φ1720a-02 from C. rodentium 
(λstx2dact) were aligned with the A and B subunits of Stx2 from EDL933 (Genbank 
accession number X078655), Stx2c from E32511 (Genbank accession number M59432), 
Stx2d from EH250 (Genbank accession number AF043627), Stx2dact (formerly called 
Stx2vhb) from B2F1 (Genbank accession number AF479829), and Stx2e from S1191 
(Genbank accession number M21534).  The sequences were aligned using the Align Plus 
5 program, version 5.03 (Scientific & Educational Software, Durham, NC, USA) 
following the global-ref alignment procedure (Myers and Miller, 1988) and the scoring 
matrix BLOSUM 62 (Henikoff and Henikoff, 1992). 
 
Antibiotic marking Φ1720a-02.  To create an antibiotic-marked Stx2-expressing 
Φ1720a-02 bacteriophage, a chloramphenicol resistance marker (cat, CmR) was inserted 
into the nonessential gene, Rz (Hernandez et al., 1985) using lambda red recombination.  
Briefly, a 707-bp fragment containing sequence upstream of the Rz gene was amplified 
from EC1720a genomic DNA using primers F-425 and R-426, flanked by Sph I and 
BamH I sites.  A 692-bp fragment containing sequence downstream of the Rz gene was 
amplified by PCR using primers F-259 and R-427 with BamH I and Sac I sites.  A 900 bp 
cat cassette was then amplified from pBR328 with flanking BamH I sites using primers 
F-265 and R-266.  A tertiary PCR reaction was done using the three PCR fragments with 
primers F-425 and R-427.  This tertiary PCR fragment was then inserted between the Sph 
I and Sac I sites of pUC to create pBJK5.  This plasmid was digested with Sph I and Sac I 
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to release a 2.3 kb fragment containing the cat cassette flanked by regions of the Rz gene.  
This fragment was electroporated into arabinose-induced EC1720a containing the lambda 
red recombinase plasmid pKD46.  The culture was recovered in 1 ml SOC for 1.5 hours 
at 37oC, and then plated on LB plates supplemented with chloramphenicol to select for 
recombinants.  Recombinants were screened by PCR using primer pairs F-425/R-427 and 
F-265/R-266. 
 
Creation of an stx-deletion within EC1720a∆Rz::cat.  Chimeric PCR was used to 
produce a fragment containing the KmR cassette within an in-frame deletion of stxAB.  
Three PCR reactions were done as follows:  1- template pUC18K with primers F-
2dH1/R-2dH2, 2-template EC1720a genomic DNA with primers F-498/R-2dH1AP, and 
3- template EC1720a genomic DNA with primers F-2dH2AP/R-499.  A tertiary PCR was 
then done using these three PCR reactions as templates and the resulting PCR product 
was then electroporated into EC1720a∆Rz::cat containing the lambda red recombinase 
plasmid, pKD46 and induced to recombine.  Recombinants were selected on LB plates 
supplemented with chloramphenicol and kanamycin and then screened by PCR using the 
following primer pairs: F-498/R-499, F-2dH1/R-2dH2, F-316/R-2dH2, F-316/R-398, and 
F-2dH1/R-398.  The loss of pKD46 from the resulting strain, EC1720a∆stx2dactAB::kan 
∆Rz::cat was confirmed by plating the strain on both kanamycin and ampicillin.   
 
Isolation of Φ1720a∆Rz::cat and Φ1720a∆stx2d::kan ∆Rz::cat.  Recombinant Stx 
bacteriophages Φ1720a∆Rz::cat and Φ1720a∆Rz::cat ∆stx2dactAB::kan were isolated from 
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the newly modified genetically manipulated EHEC strains JB-13-06 and JB-13-28 (see 
Supplemental Table 1), respectively, as previously described (Gobius et al., 2003; Teel 
et al., 2002).  Briefly, EHEC isolates were treated with mitomycin C (0.5 μg/ml) to 
induce the bacteriophage lytic cycle and production of phage.  The cells were treated with 
0.5 ml of chloroform per 3.0 ml of broth culture and were filtered through a 0.45 μm pore 
size filter to ensure a cell-free lysate.   
 
Construction of C. rodentium (λstx2dact) and C. rodentium (λstx2dact::kan
R).  The 
genetically engineered Stx2dact bacteriophages Φ1720a-02∆Rz::cat which has a 
chloramphenicol resistance cassette inserted into Rz, and Φ1720a-02∆Rz::cat 
∆stx2d::kan, which has a chloramphenicol resistance cassette inserted into Rz and a 
kanamycin resistance cassette inserted into Stx2dactAB, were isolated from genetically 
modified EHEC strains EC1720a∆Rz::cat and EC1720a∆Rz::cat ∆stx2d::kan, 
respectively.  C. rodentium DBS100 (Schauer and Falkow, 1993a) was provided with cell 
surface receptor for bacteriophage Stx2d by transformation of plasmid pTROY9 which 
contains the E. coli lamB gene and a tetracycline resistance marker (de Vries et al., 1984; 
Wehmeier et al., 1989).  The lambda phage receptor was put into DBS100, creating 
DBS100/pTROY9 and induced by growing overnight at 37ᵒC in lambda broth with 0.2% 
maltose and 10 mM MgSO4.  This strain was then lysogenized with the antibiotic-marked 
bacteriophages as described (McDonough and Butterton, 1999), resulting in DBS770 (C. 
rodentium (λstx2dact)) or DBS771 ((C. rodentium (λstx2dact::kan
R)). 
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Generation of C. rodentium (λstx2dact)tir.  The C. rodentium (λstx2dact) tir deletion 
mutant was made as previously described (Mallick et al., 2012) using a slightly modified 
version of the one-step PCR-based gene activation protocol (Datsenko and Wanner, 
2000).  
 
Construction of a plasmid expressing C. rodentium Tir.  Isolation of all plasmid DNA 
was done by the Miniprep procedure (QIAgen, Valencia, CA, USA).  Oligonucleotides 
were ordered from Invitrogen.  The C. rodentium complementation vector, pEM129 
(pTir), was created using a modified version of pMB46, pEM123, containing the 
additional unique restriction sites Mlu I and Sac II between Kpn I and Hind III.  C. 
rodentium tir – cesT was then amplified with using F-MluI-Cr-tirU and R-SacII-Cr-tirL 
and ligated into Mlu I and Sac II site of pEM123 to create pEM129.  Sequencing was 
performed at the DNA Sequencing Core Facility at Tufts Medical School.   
 
ELISA quantification of Stx.  Overnight bacterial cultures with antibiotic were diluted 
into a 5 ml culture with new medium and antibiotic.  The cultures were grown to OD600 = 
0.5-0.7.  Mitomycin C (5 μl of 0.5 ng/ml) was added to cultures and they were grown 
overnight with agitation.  Cultures were spun at 14,000 rpm for 5 minutes at room 
temperature.  Supernatants were collected for analysis.  To prepare pellets for ELISA, 
pellets were washed with 1M Tris pH8 on ice, frozen at -70ᵒC for 30 minutes, 
resuspended in 1 ml ice cold 1M Tris pH8, and sonicated (20 second bursts 3 times) and 
prepared for Stx2 ELISAs.  96-well plates (Corning Maxisorb) were coated with 4D1 
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Stx2 antibody (a gift from Cheleste Thorpe, M.D., Tufts University) 1:1000 in coating 
buffer, pH 9.6 overnight at 4ᵒC.  The plate was then blocked with 2% BSA in PBS or 
coating buffer for 1 hour at room temperature.  Plates were washed 5 times with 
PBS/Tween 20 (0.05%).  Samples of bacterial supernatants or lysed pellets were added to 
wells then incubated 1 hour at room temperature.  The primary antibody, rabbit anti-Stx2 
203αCT69 (a gift from Cheleste Thorpe, M.D., Tufts University), was added to the wells 
for 30 minutes followed by secondary antibody, anti-rabbit IgG Fc AP conjugate 
(Promega, Madison, WI, USA) for 30 minutes.  Freshly prepared para-nitro phenyl 
phosphate (Sigma, St Louis, MO, USA) was used as substrate.  ODs were read at 405 
nm.    
 
Mucus activation assays.  Activation assays were performed as previously described 
(Melton-Celsa et al., 1996; Melton-Celsa et al., 2002).  Briefly, culture supernatants were 
incubated with intestinal mucus from the small intestine of a mouse at a final 
concentration of 1 mg/ml for 2 hours at 37◦C.  As a control, a separate sample of each 
preparation was treated with HEPES buffer and incubated in the same manner.  
Following incubation with mucus or HEPES, protease inhibitor was added and samples 
were frozen at -20◦C until ready to assay.  The cytotoxicity of the samples was then 
determined on Vero cells (as previously described in (Melton-Celsa et al., 1996; Melton-
Celsa et al., 2002)).  The level of activation was determined by dividing the cytotoxicity 
of the mucus-treated sample by the cytotoxicity of the HEPES-treated sample.  Data 
shown are the averages (±SEM) of at least two activation assays. 
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Analysis of pedestal formation by C. rodentium on cultured cells.  Filamentous 
staining assays (FAS) using C. rodentium were done as previously described (Mallick et 
al., 2012).  Briefly, a single colony from each strain was grown in 1 ml media (+/- 
antibiotic) for 8 hours.  Cultures were diluted 1:500 into 5 ml DMEM supplemented with 
0.1M HEPES (pH 7.0) (+/- antibiotic) and incubated at 37ᵒC without agitation with 5% 
CO2 for 12-15 hours.  Cell monolayers were prepared by splitting 95-100% confluent 
MEFs into 24-well culture plates containing sterile glass coverslips followed by 
overnight growth at 37ᵒC with 5% CO2.  Prior to seeding onto culture plates, MEFs were 
maintained in MEF cell culture media (DMEM (hi glucose) + 10% fetal bovine serum 
(FBS) with penicillin, streptomycin, and glutamine) at 37°C, 5% CO2.  For infections, 
cell monolayers were washed twice with sterile PBS followed by addition of FAS media 
containing 25 μl of overnight cultured C. rodentium to each well.  Plates were spun at 
700 g for 10 minutes then incubated at 37ᵒC with 5% CO2 for 3 hours.  After 1.5 hours, 
plates were spun again at 700 g for an additional 10 minutes then to insure proper 
bacterial binding to cells.  After 3 hours, cells were washed twice with sterile PBS and 
0.5 ml pre-warmed FAS media was added to each well followed by an additional 3 hour 
incubation.  Cells were washed 5 times with sterile PBS, fixed with 4% PFA for 30 
minutes, washed, permeabilized with 0.1% Triton-X 100, and then stained with 
Phalloidin (Molecular Probes, Eugene, OR, USA) (1:100) and DAPI (1:500).  After 
washing cells an additional three times with PBS, the coverslips were mounted on slides 
using ProLong® Gold antifade reagent (Invitrogen, Eugene, OR, USA).   
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Mouse infections.  Mice were purchased from Jackson Laboratories (Bar Harbor, ME, 
USA) and housed in the UMMS animal facility and protocols were approved by the 
department of animal medicine.  Female, five to eight-week old C57BL/6J mice were 
gavaged with PBS or ~5 x 109 of overnight culture of C. rodentium in 100 μl PBS.  This 
dose is used to minimize the potential variability in colonization kinetics observed using 
lower inoculums (Mallick et al., 2012).  Inoculum concentrations were confirmed by 
serial dilution plating.  C. rodentium fecal shedding was determined by serial dilution 
plating of fecal slurries (10% w/v in PBS) on LB or Maconkey agar with selection for 
kanamycin, chloramphenicol, or kanamycin and chloramphenicol, as appropriate.  When 
using complemented strains containing antibiotics, feces were plated on plates containing 
both antibiotics.  Previously we have tested the rate of plasmid loss by plating on only 
one antibiotic and determined it was minimal.  Fecal water content was evaluated as 
previously described (Borenshtein et al., 2009).  Water content in stool was expressed as 
the percentage of wet-weight minus dry-weight divided by wet-weight.  Fecal occult 
blood was assessed by Sure-VueTM Fecal Occult Blood Test (Fisher Healthcare, Houston, 
TX, USA).  Fecal occult scores were as follows:  0=no occult blood, 0.5=trace amounts 
of fecal occult blood, 1=presence of fecal occult blood.  Body weights were monitored 
daily and mice were euthanized if they lost >20% of their body weight.  Some mice 
became moribund or died prior to the scheduled necropsy date, and these mice were 
necropsied early.  Mouse urinalysis was performed by collecting urine into a 1.5 ml 
conical tube.  The urine in the tube was thoroughly mixed and a 2 μl aliquot was pipetted 
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onto a Chemstrip 4MD urinalysis test strip (Roche Diagnostics, Laval, Quebec).  After 60 
seconds, the color change on the strip was compared to a supplied color scale.  The range 
of protein measured was 0 – 500 mg/dl, with the scale 0 indicating undetectable protein, 
0.5 indicating trace, 1.0 indicating ~30 mg/dl, 2.0 indicating ~100 mg/dl, and 3.0 
indicating ~500 mg/dl.  The range of hematuria measured was 0, trace, ~50 
erythrocytes/μl, and ~250 erythrocytes/ μl.  The amount of Kidney injury molecule-1 
(KIM-1) in mouse urine was measured using a KIM-1 ELISA kit (Adipo Bioscience, 
Santa Clara, CA, USA) according to manufacturer’s protocols.  All experimental groups 
contained at least five mice.  All animal experiments complied with the UMASS IACUC 
protocols.   
 
Tissue collection and histology.  At necropsy distal colon (~0.5 cm) and one kidney 
were snap frozen in liquid nitrogen and stored at -80ᵒC until RNA or protein isolation.  
Remaining colon, cecum, longitudinally divided kidneys, spleen, heart, lung, liver, and 
nasal turbinates were fixed in 10% buffered formalin, dehydrated and embedded in 
paraffin.  Five-micron tissue sections were cut and stained with hematoxylin and eosin 
(H&E) and/or period acid-Schiff (PAS).  Tissue sections were evaluated and scored 
blindly by a board-certified pathologist (V.V.).   
 
Tissue protein isolation and cytokine analysis.  Tissues were homogenized and protein 
was extracted using the Bio-Plex Cell Lysis Kit (Bio-Rad, Hercules, CA, USA) following 
manufacturer’s instructions.  Briefly, 200-500 μl lysis solution was added to sample.  
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Sample was ground on ice using disposable Kontes tubes and disposable pestle and 
frozen at -80ᵒC.  Sample was then thawed and sonicated (Duty cycle 40, output 6, pulse 
18x).  Sample was then centrifuged at 4,500 x g for 20 minutes at 4ᵒC.  Protein 
concentration of sample was then determined by BCA assay (Thermo Scientific, 
Rockford, IL, USA) and protein concentration was adjusted to 2 μg/ml with lysing 
solution.  Cytokine analysis was performed by UMASS mouse phenotyping core facility 
using the cytokine mouse 23-plex Bio-plex kit (Bio-Rad, Hercules, CA, USA) and 
Bioplex 200 Luminex machine. 
 
Serum BUN and cytokine analysis.  Blood was collected via cardiac puncture at 
necropsy and allowed to clot on ice for 30 minutes.  Blood was spun at 10,000 x g for 15 
minutes at 4ᵒC and serum was collected.  Serum was spun at 10,000 x g for an additional 
15 minutes at 4ᵒC and the remaining serum was collected and frozen at -80ᵒC until 
analysis.  Serum BUN and cytokine (mouse 23-plex Bio-plex kit [Bio-Rad, Hercules, 
CA, USA]) analysis was performed by UMASS mouse phenotyping core facility using a 
Cobas analyzer or Bioplex 200 Luminex, respectively. 
 
Transmission electron microscopy.  Mouse intestinal tissue samples were taken at 
various time points post infection and fixed in 2.5% gluteraldehyde in 0.05 M Sodium 
Phosphate buffer, pH 7.2.  Samples were processed and analyzed at the University of 
Massachusetts Medical School Electron Microscopy core facility according to standard 
procedures.  Briefly, fixed samples were moved into fresh 2.5% gluteraldehyde in 0.05 M 
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Sodium Phosphate buffer and left overnight at 4oC.  The samples were then rinsed twice 
in the same fixation buffer and post-fixed with 1% osmium tetroxide for 1 hour at room 
temperature.  Samples were then washed twice with DH2O for 20 minutes at 4
oC and then 
dehydrated through a graded ethanol series of 20% increments, before two changes in 
100% ethanol.  Subsequently, samples were infiltrated first with two changes of 100% 
Propylene Oxide and then with a 1:1 mix of propylene oxide:SPI-Pon 812 resin.  The 
following day three changes of fresh 100% SPI-Pon 812 resin were done before the 
samples were polymerized at 68oC in plastic capsules.  The samples were then reoriented 
and thin sections were placed on copper support grids and stained with Lead citrate and 
Uranyl acetate.  Sections were examined using the FEI Tecani 12 BT with 80Kv 
accelerating voltage, and images were captured using a Gatan TEM CCD camera. 
 
Statistical analysis.  Data were analyzed using GraphPad Prism software.  Comparison 
of multiple groups was performed using one-way analysis of variance (ANOVA) with 
Tukey’s multiple comparison post-tests or by using a two-way ANOVA with 
Bonferroni’s multiple comparison post-tests.  Statistical significance of differences 
between two groups was evaluated using two tailed unpaired t tests.  In all tests p values 
below 0.05 (*), 0.01 (**), and 0.001 (***) were considered statistically significant.  In all 
graphs error bars represent standard error of the mean (SEM), unless otherwise indicated. 
 
Nucleotide sequence and accession numbers 
stxA from Phage 1720a02:  BankIt1463613 Seq1 JN194203 
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stxB from Phage 1720a02:  BankIt1463613 Seq2 JN194204 
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Supplemental Table 1.  Strains used in this study.  
Strain Description and relevant phenotype Reference 
DBS100  Citrobacter rodentium wild type 
strain (prototype TMCH isolate, 
ATTC 51459, original biotype 4280) 
(Barthold et al., 1976; 
Schauer and Falkow, 
1993a) 
DBS132 DBS100/pTROY09,NalR (de Vries et al., 1984; 
Wehmeier et al., 1989)  
EC1720a EC1720a containing Φ1720a-01 and 
Φ1720a-02. 
(Gobius et al., 2003) 
JB-13-06 EC1720a containing Φ1720a-02 
ΔRz::cat, CmR 
This study 
JB-13-28 Φ1720a ΔRz::cat Δstx2dactAB::kan, 
CmR, KmR 
This study 
DBS770  DBS100 lysogenized with Φ1720a-
02 ΔRz::cat, CmR 
This study 
DBS771  DBS100 lysogenized with Φ 1720a-
02 ΔRz::cat Δstx2dactAB::kan, Cm
R, 
KmR  
This study 
EDL933 EHEC O157:H7 strain encoding stx1 
and stx2 
(Riley et al., 1983) 
TUV93-0 EDL933 cured of Stx1 and 2-
producing phages  
(Campellone et al., 2002) 
B2F1 
 
O91:H21 serotype containing 2 
copies of Stx2d 
(Teel et al., 2002) 
EH250 EHEC strain containing non-
activatable Stx2d toxin 
(Pierard et al., 1998) 
NalR, nalidixic acid resistant 
CmR, chloramphenicol resistant  
KmR, kanamycin resistant 
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Supplemental Table 2.  Plasmids used in this study. 
Plasmids Description Reference 
pTROY9 expresses LamB, NalR, TetR (de Vries et al., 1984; 
Wehmeier et al., 1989)  
pKD46 Expresses lambda Red 
recombinase; AmpR 
(Datsenko and Wanner, 
2000) 
pK184 Cloning vector, KmR (Jobling and Holmes, 1990) 
pMB46 pK184 containing EPEC tir 
promoter - EHEC tir - 
EHEC cesT, KmR in the 
KpnI and HindIII sites. 
This study 
pEM123 pMB46ΔEHEC tir - cesT 
with new restriction sites 
(MluI and SacII), KmR  
This study 
pEM129 (pTir) 
 
pEM123 containing C. 
rodentium tir – cesT, KmR   
This study 
pDONRzeo Contains zeocin gene Invitrogen 
pBJK5 pUC-based plasmid 
containing cat cassette 
flanked by 707 bp upstream 
and 692 bp downstream of 
Rz in EC1720a in the SphI 
and SacI site; CmR 
This study 
pBR328 Cloning vector; AmpR (Soberon et al., 1980) 
pUC18K Cloning vector; KmR (Menard et al., 1993) 
NalR, nalidixic acid resistant 
TetR, tetracycline resistant 
AmpR, ampicillin resistant 
KmR, kanamycin resistant 
CmR, chloramphenicol resistant
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Supplemental Table 3.  Oligonucleotide sequences used in this study. 
Primer Nucleotide sequence (from 5' to 3')a 
PanHandle PCR  
F-Adaptor1 CTA ATA CGA CTC ACT ATA GGG CTC GAG CGG CCG CCC 
GGG CAG GT 
R-Adaptor2 /5Phos/ACCTGCCCGG/3AmMC7/ 
F-AP1 primer GGA TCC TAA TAC GAC TCA CTA TAG GG 
R-AP2 primer AAT AGG GCT CGA GCG GC 
  
Sequencing of Φ1720a-02 (λstx2dact) 
R-Oli210 TGT ACC GTT CAT GCA TGG TG 
F-Oli218 ACT GTC TGA AAC TGC TCC TGT G 
R-Oli219 CAA ATC CTG AAC CTG ACG CAC AGG 
R-Oli220 TTC GGA TGG TTA AGG CGG CT 
F-Oli221 CGC TTC AGG CAG ATA CAG AG 
F-Oli222 ACG GAC AGA GAT ATC GAC CC 
R-Oli223 CTG TAA CTA CAT TGC TGC AC 
F-Oli224 ATG AAG TGT ATA TTA TTT AAA TGG GTA CTG TGC CTG 
F-Oli226 GGT GCT GAT TAC TTC AGC CAA 
F-Oli228 GAA TCC AGT ACA ACG CGC CAC A 
  
Antibiotic marking of Φ1720a-02 
F-425 AAAAAAGCATGCCTGCTGACATATCTGACGAAC 
R-426 AAAAAAGGATCCTTTGTAGGTGATGGCGTTATC 
R-427 AAAAAAGAGCTCATATCAATAACTTACACTGGT 
F-259 AAAAAAGGATCCGCGCAGCGCGATAAAAAAGCC 
F-265 AAAAAGGATCCTTCGAATAAATACCTGTGACGGAAGATCAC 
R-266 AAAAAGGATCCTTCGAATTTCTGCCATTCATCCGCTTATTA 
  
Stx-deletion within Φ1720a-02ΔRz::cat 
F-2dH1 CGT CAC TCA CTG GTT TCA TCA TAT CTG GCG TCC CGG 
GTG ACT AAC TAG GAG GAA TAA ATG 
F-498 GGC GCG TTT TGA CCA TTT CGT TTG ATT 
R-2dH2 TGA TTT GAT TGT TAC CGT CAT TCC TGT TAA TCC CCG 
GGT CAT TAT TCC CTC CAG GTA CTA 
R-2dH1AP CAT TTA TTC CTC CTA GTT AGT CAC CCG GGA CGC CAG 
ATA TGA TGA AAC CAG TGA GTG ACG 
F-2dH2AP TAG TAC CTG GAG GGA ATA ATG ACC CGG GGA TTA ACA 
GGA ATG ACG GTA ACA ATC AAA TCA 
R-499 CTG TGA CGC TGA TAT GCC CCG CCG CTC 
F-316 CTC AGG GGA CCA CAT CGG 
R-398 GCC GCC CTG ACC ACA TCG 
  
Generation of pTir  
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F-MluI-Cr-tirU CAT CAT ACG CGT ATG CCT ATT GGT AAT CTT GGT AAT 
AAT AAT ATA AGT AAC 
R-SacII-Cr-tirL CAT CAT CCG CGG GTT ATA GGC TCC ACC ACA ATG AGT 
TAG AAT GAG TAG TAA 
aF, forward (top strand) primer; R, reverse (bottom strand) primer. Restriction sites are 
underlined. 
bPrimers used to construct C. rodentiumΔtir.  Italicized regions indicate homology to 
zeocin cassette.  Numbers in primer name correspond to nucleotide positions primer is 
located within tir gene.  Int represents screening primers internal to the gene (tir or 
zeocin) and Ext represents screening primers that are external to the gene. 
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Results 
Cultured C. rodentium (λstx2dact), a C. rodentium strain lysogenized with a λ Stx 
phage, produces mucus-activatable Stx2dact at levels comparable to STEC. 
EC1720a, a STEC strain originally isolated from ground beef, has previously 
been shown to contain an Stx2dact-producing phage, Φ1720a-01 (Gobius et al., 2003).  
We identified and isolated an additional phage in this strain, Φ1720a-02.  The sequences 
of stxA and stxB of Φ1720a-02 were determined and the inferred protein sequences of the 
StxA and StxB subunits of Φ1720a-02 were aligned with other Stx2-producing 
bacteriophages isolated from E. coli strains (Supplementary Figure 1A and B).  The 
predicted amino acid sequences of stx2A and stx2B of Φ1720a-02 aligned well with non-
mucus activatable Stx2d (Pierard et al., 1998) (Supplementary Figure 1A and B) and 
contained the C-terminal glutamic acid necessary for activation of Stx2dact (Melton-
Celsa et al., 2002). 
In order to facilitate the generation of lysogens of Φ1720a-02, a chloramphenicol 
resistance cassette (cat, CmR) was inserted into the Rz locus of Φ1720a-02.  C. rodentium 
DBS100 (Schauer and Falkow, 1993a) (referred herein as “C. rodentium”) was 
lysogenized with Φ1720a-02 Rz::cat to create C. rodentium DBS100 (Φ1720a-02 
Rz::cat), which, for simplicity, we herein refer to as “C. rodentium (λstx2dact)”.  In 
addition, a C. rodentium lysogen of an Stx-deficient control phage, λstx2dact::kan
R was 
also generated (see Materials and Methods).  
To test if C. rodentium (λstx2dact) was able to produce Stx2 upon in vitro growth, 
the level of Stx2 was quantified by enzyme-linked immunosorbent assay (ELISA).   
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A 
                    10        20        30        40        50        60        70        80        90       100 
                     *         *         *         *         *         *         *         *         *         * 
Stx2        MKCILFKWVLCLLLGFSSVSYSREFTIDFSTQQSYVSSLNSIRTEISTPLEHISQGTTSVSVINHTPPGSYFAVDIRGLDVYQARFDHLRLIIEQNNLYV 
Stx2c       .................................................................................................... 
Stx2d       .....L..................................C........................................................... 
Stx2dact     .................................................................................................... 
Stx2e       .....L..I.............Q.....................A...........A..............IS.G........E..........R..... 
Φ1729a-02   .........................M..........................................................................        
            
                   110       120       130       140       150       160       170       180       190       200 
                     *         *         *         *         *         *         *         *         *         * 
Stx2        AGFVNTATNTFYRFSDFTHISVPGVTTVSMTTDSSYTTLQRVAALERSGMQISRHSLVSSYLALMEFSGNTMTRDASRAVLRFVTVTAEALRFRQIQREF 
Stx2c       .................................................................................................... 
Stx2d       .................A....................................................A............................. 
Stx2dact     .................................................................................................... 
Stx2e       ......T..........A...L.....I........................................................................ 
Φ1729a-02   .................................................................................................... 
                    
                   210       220       230       240       250       260       270       280       290       300 
                     *         *         *         *         *         *         *         *         *         * 
Stx2        RQALSETAPVYTMTPGDVDLTLNWGRISNVLPEYRGEDGVRVGRISFNNISAILGTVAVILNCHHQGARSVRAVNEESQPECQITGDRPVIKINNTLWES 
Stx2c       .................................................................................................... 
Stx2d       .L.............EE................F...G..................................S....I.............RL....... 
Stx2dact     .................................................................................................... 
Stx2e       .L.............E.....................A.............................................................. 
Φ1729a-02   ...............EE................F.................................................................. 
 
                   310 
                     * 
Stx2        NTAAAFLNRKSQFLYTTGK 
Stx2c       ................... 
Stx2d       .........RAHS.N.S.E 
Stx2dact     ............S.....E 
Stx2e       ............S.....E  
Φ1729a-02   .........RAHS.N.S.E 
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B 
                    10        20        30        40        50        60        70        80 
                     *         *         *         *         *         *         *         * 
Stx2        MKKMFMAVLFALASVNAMAADCAKGKIEFSKYNEDDTFTVKVDGKEYWTSRWNLQPLLQSAQLTGMTVTIKSSTCESGSGFAEVQFNND 
Stx2c       ............V.....................N.......A.............................................. 
Stx2d       ...I.V.A...FV.....................N.......A......N......................N..A...........-- 
Stx2dact     ............V.....................N.......A.............................................. 
Stx2e       .....I......V......................N......S.R....N....................I.N..S......Q.K..-- 
Φ1720a-02   ...I.V.A...FV.....................N.......A......N......................N..A...........— 
 
 
Supplementary Figure 1.  Amino acid alignment of Stx A and B subunits of ϕ1720a-02 from C. rodentium (λstx2dact) with 
other Stx A and B subunits from various STEC strains.  The A (A) or B (B) subunits of Φ1720a-02 (for simplicity termed 
“λstx2dact” in this study) were aligned with the corresponding subunits of Stx2 from EDL933 (Genbank accession number 
X078655), Stx2c from E32511 (Genbank accession number M59432), Stx2d from EH250 (Genbank accession number 
AF043627), Stx2dact (formerly called Stx2vhb) from B2F1 (Genbank accession number AF479829), and Stx2e from S1191 
(Genbank accession number M21534).  The sequences were aligned using the Align Plus 5 program, version 5.03 (Scientific & 
Educational Software, Durham, NC, USA) following the global-ref alignment procedure (Myers and Miller, 1988) and the 
scoring matrix BLOSUM 62 (Henikoff and Henikoff, 1992).  The underlined regions indicate the processed signal sequence, 
dots depict identical residues, green or red letters highlight conserved or non-conserved residues respectively, and a red dash 
indicates a gap in the alignment.   
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Spontaneous prophage induction is predicted to release toxin into culture supernatants, so 
supernatants and bacterial pellets were analyzed separately.  EDL933, an EHEC 
O157:H7 strain that harbors both stx1 and stx2 (Riley et al., 1983), produced high levels of 
Stx2 in both the supernatant and pellet (Figure 1, solid bars).  In contrast, TUV93-0, the 
stx1- and stx2-deficient derivative of EDL933 (Campellone et al., 2002) was completely 
unable to produce Stx2 (Figure 1).  EC1720a, which harbors Φ1720a-01 and Φ1720a-02, 
produced easily detectable levels of Stx2 in both supernatant and pellet, albeit several 
orders of magnitude lower than those found for EDL933, suggesting that baseline 
expression and/or prophage induction is lower in EC1720a compared to EDL933 (Figure 
1, solid bars).  Importantly, C. rodentium (λstx2dact) produced high levels of Stx2, the 
vast majority of which was present in the culture supernatant (Figure 1, solid bars).  C. 
rodentium (λstx2dact::kan
R) did not produce detectable toxin, a finding that indicates that, 
as predicted, Stx production by this strain required an intact stx2dact gene (Figure 1).   
Induction of the Stx-producing prophage often promotes high-level production of 
Stx by EHEC strains (Muhldorfer et al., 1996; Schmidt, 2001; Waldor and Friedman, 
2005), so each of the above bacterial strains were treated with mitomycin C to induce 
lysogenic phage.  Compared to uninduced samples, cultures of EDL933, EC1720a, and 
C. rodentium (λstx2dact) treated with mitomycin C produced several orders of magnitude  
more Stx2, particularly in the supernatant, consistent with lytic induction of the stx-
encoding prophage (Figure 1, open bars).  Strain TV93-0 and C. rodentium 
(λstx2dact::kan
R) did not produce any Stx upon mitomycin C treatment, a finding that 
indicates the predicted requirement of phage-encoded Stx for toxin production.  Notably,  
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Figure 1.  C. rodentium (λstx2dact) produces high levels of Shiga toxin upon prophage 
induction at levels comparable to EHEC isolates.  Stx2 in supernatants (“S”) or pellets 
(“P”) of untreated (filled bars) or mitomycin C-treated (open bars) cultures of the 
indicated strains was measured by capture ELISA and is expressed relative to bacterial 
number (see Materials and Methods).  Shown are the averages ± SEM of quadruplicate 
samples.  ND, not detected.  Data are representative of one of three independent 
experiments.   
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the levels of Stx produced by C. rodentium (λstx2dact) were comparable to or higher than 
the levels generated by the EHEC or STEC strains EC1720a and EDL933, suggesting 
that this strain might produce Stx-mediated disease upon animal infection.   
Because λstx2dact encodes an Stx allele that contains the C-terminal glutamic acid 
necessary for activation of Stx2dact (Melton-Celsa et al., 2002), we tested the capacity of 
the toxin produced by C. rodentium (λstx2dact) to be activated in the presence of intestinal 
mucus.  Strains B2F1, which encodes the mucus-activatable toxin Stx2dact, and EH250 
which encodes the non-activatable Stx2d were used in parallel assays as positive and 
negative controls, respectively (Melton-Celsa et al., 2002; Pierard et al., 1998; Teel et al., 
2002).  Culture supernatants from each strain were incubated with murine intestinal 
mucus or with buffer alone, and the Vero cell cytotoxicity of serially diluted samples was 
determined.  Toxin activity in culture supernatants from E. coli strain B2F1 increased 
~15-fold upon incubation with murine mucus (Table 1).  In contrast, there was minimal 
increase in the presence of the mucus in toxin activity of EH250, which does not contain 
mucus-activatable toxin (Table 1).  Toxin activity in the culture supernatant of C. 
rodentium (λstx2dact) increased approximately ~18-fold, comparable to the activity of E. 
coli B2F1, upon incubation with mucus indicating that the Stx produced by λstx2dact is 
indeed mucus-activatable (Table 1).   
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Table 1.  Stx2d from C. rodentium (λstx2dact) is mucus activatable. 
Strain Fold activation Range n 
Cr (λstx2dact) 17.9 (± 5.3)* 5.4-31 4 
B2F1 15.2 (± 2.9)* 11.7-21 3 
EH250 1.2 (± 0.1) 1.1-1.3 2 
Supernatant from C. rodentium (λstx2dact), B2F1 (as a positive control), and EH250 (as a 
negative control) were tested for Vero Cell cytotoxicity in the presence or absence of 
mouse intestinal mucus.  Shown here are the average fold-increases in cytotoxicity (± 
SEM) with the addition of mouse intestinal mucus compared to supernatants incubated 
with buffer alone.  n represents the number of replicates performed for each strain tested.  
Statistical significance was determined using a one-way ANOVA.  “*” (p<0.05) indicates 
a statistically significant difference compared to the increase in activation of EH250 in 
the presence of intestinal mucus.  
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C. rodentium (λstx2dact) causes lethal infection in mice.  
To determine whether C. rodentium (λstx2dact) would provide an Stx-mediated 
disease model, five-to-eight-week old C57BL/6 mice were infected with approximately 1 
x 109 CFU of this strain via oral gavage.  As controls, the Stx-deficient derivative C. 
rodentium (λstx2dact::kan
R) and the parental nonlysogen C. rodentium DBS100 were 
inoculated in parallel.  Fecal shedding of C. rodentium DBS100 and C. rodentium 
(λstx2dact::kan
R) reached approximately 109 CFU per gram of feces at day six post-
infection and remained relatively constant to the end of monitoring, ten days post-
infection (Figure 2A).  C. rodentium (λstx2dact) colonized the feces with similar kinetics, 
reaching a peak of ~1010 CFU per gram, which was not significantly higher than the two 
non-toxigenic strains (Figure 2A).  
To test whether mice infected with C. rodentium (λstx2dact) suffer Stx-mediated 
intestinal disease, we monitored fecal water content.  As expected, feces from uninfected 
mice contained 45-60% water throughout the course of infection (Figure 2B).  Feces 
from mice infected with C. rodentium DBS100 or C. rodentium (λstx2dact::kan
R) 
contained similar values of water content through approximately day four post-infection, 
but demonstrated elevated and progressively increasing levels of water after maximal 
bacterial burden was reached on day four post-infection, as previously observed 
(Borenshtein et al., 2009).  In contrast, water content of feces from mice infected with C. 
rodentium (λstx2dact) was significantly elevated (>70%) at four days post-infection 
(Figure 2B), indicating that the production of Stx was associated with an early increase 
in fecal water content.  By eight days post-infection, fecal water content declined to  
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Figure 2.  C. rodentium (λstx2dact) causes a lethal infection in mice.  (A) Colonization 
of five-week old C57BL/6 mice by C. rodentium (λstx2dact), C. rodentium 
(λstx2dact::kan
R), and C. rodentium (DBS100) was determined by viable stool counts.  
Shown are the averages CFU (± SEM) of five mice.  (B) Fecal water content of mock-
infected five-week old mice or mice infected with C. rodentium (λstx2dact), C. rodentium 
(λstx2dact::kan
R), or C. rodentium (DBS100).  Shown are the averages (±SEM) of groups 
of five mice.  Range of average fecal water content of uninfected mice is represented by 
vertical bar at zero days post-infection.  “*” (p<0.05) indicates a statistically significant 
difference from all other groups as determined by two-way ANOVA followed by 
Bonferroni post-tests.  (C) Body weight during infection of eight-week old mice, 
expressed as percent change from day zero body weight.  Shown are the averages 
(±SEM) of five mice per group.  ”**” (p<0.01) and “***” (p<0.001) indicate a 
statistically significant difference from all other groups as determined by two-way 
ANOVA followed by Bonferroni post-tests.  (D) Percent survival of groups of five eight-
week old mice that were mock-infected or infected with C. rodentium (λstx2dact), C. 
rodentium (λstx2dact::kan
R), or C. rodentium (i.e., DBS100).  Statistical significance was 
determined using a Chi squared test and in this panel, C. rodentium (λstx2dact) is 
significantly different from all other groups (p<0.05).  For all panels, results are 
representative of one of at least five independent experiments.  
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normal values, which could be due to the putative increasing dehydration and 
concomitant water reabsorption that may occur in these mice during later stages of 
infection (see Figure 2C).   
Weight loss is a notable feature in mice after Stx injection or infection in mice 
with an intact commensal flora with high doses of STEC (Keepers et al., 2006; Mohawk 
and O'Brien, 2011; Sauter et al., 2008).  We found that mock-infected mice, as well as 
mice infected with C. rodentium DBS100 or C. rodentium (λstx2dact::kan
R), maintained 
body weight, indicating that infection with C. rodentium strains that do not produce Stx 
were not associated with weight loss (Figure 2C).  In contrast, mice infected with C. 
rodentium (λstx2dact) lost >10% of their starting weight by six days post-infection and 
>20% by eight days post-infection.     
Finally, the severe weight loss in mice infected with C. rodentium (λstx2dact) 
corresponded temporally with mortality or severe disease warranting euthanasia (Figure 
2D).  Mock-infected mice, or mice infected with C. rodentium DBS100 or C. rodentium 
(λstx2dact::kan
R), suffered no mortality.  In contrast, mortality was observed in mice 
infected with C. rodentium (λstx2dact) starting at day four post-infection, and no mice 
survived past day nine.  Consistent with the previous correlation between weight loss and 
serious systemic disease (Keepers et al., 2006; Mohawk and O'Brien, 2011; Sauter et al., 
2008), nearly all (~95%) of mice that died or were euthanized had lost >20% body weight 
at the preceding weight assessment (data not shown).  
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Stx-mediated intestinal damage during murine infection with C. rodentium 
(λstx2dact).  
Although EHEC infection of humans is associated with hemorrhagic colitis, 
EHEC infection of streptomycin pre-treated or gnotobiotic mice does not typically result 
in obvious AE lesion formation or striking intestinal damage (Eaton et al., 2008; 
Lindgren et al., 1993), A.M. unpublished observations).  To assess the presence of 
hemorrhagic colitis in mice infected with C. rodentium (λstx2dact), we collected feces 
throughout infection and assessed for the presence of occult blood (see Materials and 
Methods).  Interestingly, we observed occult blood in mice infected with either C. 
rodentium (λstx2dact) or the non-toxigenic control strain C. rodentium (λstx2dact::kan
R) 
from approximately three-to-four days post-infection and throughout the remaining 
infection until the mice either succumbed to lethal disease (those infected with C. 
rodentium (λstx2dact)) or cleared infection (those infected with C. rodentium 
(λstx2dact::kan
R)) (Supplementary Figure 2).   
To assess the presence of AE lesions in mice infected with C. rodentium 
(λstx2dact), we examined colonic tissue by transmission electron microscopy (TEM) at six 
days post-infection.  Indeed, intimate bacterial attachment, microvillar effacement, and 
robust actin pedestals were produced on the intestinal epithelium of mice infected with C. 
rodentium (λstx2dact) in contrast to the normal intestinal architecture observed in mock-
infected mice (Figure 3A).  To investigate intestinal disease caused by infection with C. 
rodentium (λstx2dact), the large intestines of mice infected with C. rodentium (λstx2dact) for 
seven-to-ten days were examined histologically.  In accordance with previous studies, we  
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Supplementary Figure 2.  Infection by C. rodentium (λstx2dact) and C. rodentium 
(λstx2dact::kan
R) results in the presence of fecal occult blood.  Fecal samples were 
collected from mice daily throughout infection and assessed for the presence of occult 
blood.  Occult blood scores were assigned as follows:  0=no occult blood, 0.5=trace 
amounts of occult blood, and 1=presence of occult blood.  Data are representative of the 
average fecal occult blood scores (±SEM) of groups of ten mice infected with either C. 
rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R) or mock-infected.   
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Figure 3.  Stx-mediated intestinal damage during murine infection with C.  
rodentium (λstx2dact).  (A) Transmission electron microscopy of the proximal large 
intestine of C57BL/6 mice six days after mock-infection or infection by the indicated 
strain. White arrowheads indicate the presence of actin-rich pedestals.  Scale bars 
measure 0.5 μm.  (B) H&E-stained large intestinal sections of mock-infected mice or 
mice infected with designated strain are shown under 100x (top row) or 400x (bottom 
row) magnification.  Scale bars measure 50 μm.  Black box indicates area of complete 
crypt loss and abscess formation.  Black arrows depict goblet cells that are prominent in 
normal intestinal tissue and diminished in mice infected with C. rodentium (λstx2dact).  
Arrow head indicates infiltration of inflammatory cells into the mucscularis mucosa and 
muscularis propria layers.   
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observed that at seven-to-ten days post-infection, mice infected with C. rodentium 
DBS100 or C. rodentium (λstx2dact::kan
R) showed limited intestinal pathology, with only 
minimal hyperplasia and inflammatory infiltrates compared with mock-infected mice 
(data not shown and Figure 3B, middle and right panels).  C. rodentium infection 
results in colonic hyperplasia, but this manifestation typically is observed only after 
approximately 14 days of infection ((Luperchio and Schauer, 2001; McBee et al., 2008), 
and was not observed here).  In contrast, gross evaluation of intestines from mice infected 
for seven-to-ten days with C. rodentium (λstx2dact) showed severe destruction of the 
intestinal mucosa, colitis, and acute ischemic injury, with neutrophil infiltration into the 
muscularis layer and lamina propria, and intestinal abscesses (Figure 3B, left panels).  
Also present were areas of necrosis and degenerative changes in the epithelial cells, with 
crypt withering, and an overall loss of goblet cells (Figure 3B, left panels).  These data 
show that C. rodentium (λstx2dact) infection is associated with AE lesion formation and 
severe Stx-mediated intestinal damage.   
 
Stx-mediated systemic induction of pro-inflammatory cytokines during murine 
infection with C. rodentium (λstx2dact). 
Serum pro-inflammatory cytokines and chemokines are elevated in both humans 
suffering HUS and mice intoxicated with Stx (Keepers et al., 2007; Keepers et al., 2006; 
Proulx et al., 2001; Ray and Liu, 2001; Rovin and Phan, 1998; Sauter et al., 2008).  We 
measured 23 cytokines in the sera of mice infected with C. rodentium (λstx2dact) between 
seven and ten days post-infection (see Materials and Methods).  We found that  
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Figure 4.  Stx-mediated systemic induction of proinflammatory cytokines during 
murine infection with C. rodentium (λstx2dact).  The concentrations of TNF-α, IL-17, 
KC, RANTES, MCP-1, and MIP-1β in serum at seven-to-ten days post-infection in 
mock-infected mice or mice infected with the indicated strain was determined by 
Luminex (see Materials and Methods).  Data are pooled from two independent 
experiments, each using three- to eight-week old female mice and five to ten mice per 
group.  (Note: many of the mice infected with C. rodentium (λstx2dact) that had extremely 
elevated levels of serum cytokines were those on the verge of death (e.g. had >15% body 
weight loss, high-level colonization, ruffled fur, and needed to be sacrifice because of 
severe disease.)  Statistical significance was determined by one-way ANOVA and 
Tukey’s Multiple Comparison Tests.  “*” (p<0.05), “**” (p<0.01), and “***” (p<0.001) 
indicate statistically significant differences between the two groups.  Dotted line in the 
graphs represents the limit of detection.    
  
126 
 
cytokines commonly associated with disease in humans and animal models of HUS were 
reproducibly elevated relative to mock-infected mice.  Serum levels of the pro-
inflammatory cytokine TNF-α were elevated, as were the neutrophil chemoattractants IL-
17 and KC (Figure 4).  Additionally, macrophage/monocyte chemoattractants RANTES, 
MCP-1, and MIP-1β were elevated two- to five-fold in serum from C. rodentium 
(λstx2dact) infected mice relative to mock-infected mice (Figure 4).  In all instances, the 
cytokine or chemokine levels of mice infected with C. rodentium (λstx2dact) were 
significantly higher than those of mice infected with C. rodentium (λstx2dact::kan
R) 
(Figure 4), indicating that induction of the cytokines/chemokines was attributable to the 
production of Stx2dact rather than to simple colonization by C. rodentium. 
 
Stx-mediated renal damage during murine infection with C. rodentium (λstx2dact). 
Kidney damage is a hallmark of HUS and Stx causes renal pathology in mice after 
direct injection or upon absorption from intestinal STEC (Keepers et al., 2006; Lindgren 
et al., 1993; Mohawk and O'Brien, 2011; Sauter et al., 2008).  Renal cytokines and 
chemokines are elevated in murine models of Stx intoxication, therefore we measured 
cytokine and chemokine levels in the kidneys of mice infected with C. rodentium 
(λstx2dact) at seven-to-ten days post-infection.  Although the levels of the cytokines IL-6 
and G-CSF varied considerably from mouse to mouse, they were significantly increased 
in the kidneys of mice infected with C. rodentium (λstx2dact) compared to mock-infected 
controls, as were the chemokines RANTES and KC (Figure 5A).  In all cases, the 
increase in levels with respect to mock-infected mice was strictly associated with the 
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production of Stx2dact, because infection by C. rodentium (λstx2dact::kan
R) was not 
associated with any significant elevation of cytokine/chemokine levels (Figure 5A).  
Furthermore, the increase in renal IL-6 and RANTES was at least in part a reflection of 
increased transcription of the corresponding genes, because RT-PCR analysis of kidney 
mRNA revealed increased levels of IL-6 and RANTES mRNA relative to mock infected 
mice or mice infected with by C. rodentium (λstx2dact::kan
R) (data not shown).  
Stx intoxication of mice results in damage to the renal distal tubules (Keepers et 
al., 2006; Psotka et al., 2009; Sauter et al., 2008).  To evaluate renal pathology associated 
with the C. rodentium (λstx2dact) infection model, kidney sections were taken between 
seven and ten days post-infection from mice infected with C. rodentium (λstx2dact) and 
were stained with hematoxylin/eosin (H&E) and Periodic acid-Schiff (PAS) stain.  
Whereas the kidneys of mice infected with C. rodentium (λstx2dact::kan
R) or mock-
infected showed no signs of damage (Figure 5B, middle and lower panel), kidneys of 
mice infected with C. rodentium (λstx2dact) showed proximal tubule damage (Figure 5B, 
upper panel).  The epithelial lining of the tubules were attenuated or flattened, with 
prominent pyknotic nuclear material, loss of luminal brush border, and sloughing of dead 
cells in the tubular lumen (Figure 5B, upper panel, arrow heads).  Mitotic activity, 
indicating regenerative repopulation of the proximal tubules, was also observed in some 
mice (data not shown).  
To assess renal function in mice infected with C. rodentium (λstx2dact) in our 
model of HUS, we measured blood urea nitrogen (BUN).  To assess BUN during the   
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Figure 5.  Stx-mediated renal damage during murine infection with C. rodentium 
(λstx2dact).  (A)  Renal cytokines were measured in mock-infected eight-week old female 
mice or mice infected with the indicated strain.  Data are pooled from three independent 
experiments.  Statistical significance was determined by one-way ANOVA followed by 
Tukey’s Multiple Comparison Test; “*” (p<0.05) and “**” (p<0.01).  (B) 600x 
micrograph of H&E staining of kidney sections taken from mock-infected mice or mice 
infected with the indicated strain at seven-to-ten days post-infection.  Arrowheads 
indicate attenuation and sloughing of epithelial cells within the proximal tubules.  Scale 
bars measure 50 μm.  (C) Blood urea nitrogen (BUN) of eight-week old, female mice 
infected with indicated strain or mock-infected mice at day of necropsy, between seven 
and ten days post-infection.  Each data point represents BUN from a single mouse, and 
shown is the pool of four independent experiments using five eight-week old mice per 
group.  Statistical significance was determined using a one-way ANOVA followed by 
Tukey’s Multiple Comparison Test (**p<0.01).  (D) Urine protein content was measured 
daily in mock-infected eight-week old, female mice or mice infected with the indicated 
strain.  Data shown are average protein indices (see Materials and Methods) ± SEM of 
five mice per group.  Data shown represents one independent experiment that was 
repeated five times.  Statistical significance was determined using a two-way ANOVA 
and Bonferroni post-tests; “*” (p<0.05) and “**” (p<0.01) indicate a statistically 
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significant difference compared to C. rodentium (λstx2dact::kan
R).  Hematuria was 
measured (see Materials and Methods) in mock-infected mice or mice infected with C. 
rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R) and data are represented as the 
averages (±SEM) amounts of erythrocytes/μl urine in groups of ten mice.  Statistical 
significance was measured using a two-way ANOVA and Bonferroni’s post-tests.  “***” 
(p<0.001) indicates a statistically significant difference compared to the other groups.  
Urine Kim-1 concentrations were measured in mock-infected mice or mice infected with 
C. rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R) and data are represented as the 
averages (±SEM) pg/ml of Kim-1 urine in groups of three-to-six mice.  Statistical 
significance was measured using a two-way ANOVA and Bonferroni’s post-tests.  “**” 
(p<0.01) indicates a statistically significant difference compared to the other groups.            
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phase of terminal illness, we euthanized individual mice when they demonstrated signs of 
serious disease (see Materials and Methods), which occurred seven-to-ten days post-
infection.  In cases where mice were euthanized prior to ten days post-infection (due to 
severe disease), a mouse from the mock-infected group and C. rodentium (λstx2dact::kan
R) 
group were euthanized and analyzed in parallel.  The mean BUN of mice infected with C. 
rodentium (λstx2dact) was significantly (p<0.01) elevated relative to mock-infected mice, 
and was also elevated relative to mice infected with C. rodentium (λstx2dact::kan
R), 
although the latter comparison did not reach statistical significance (Figure 5C).  Renal 
tubular damage, with both leakage of protein and sloughing of cells into the lumen, may 
result in proteinuria, which we measured using a colorimetric assay (see Materials and 
Methods).  Whereas the urine of mock-infected mice or mice infected with C. rodentium 
(λstx2dact::kan
R) contained no or only trace levels of protein (protein index of 0-0.5 
indicating <50 mg/dl) and was not statistically different from protein content of urine 
from mock-infected mice, the urine of mice infected with C. rodentium (λstx2dact) 
contained significantly elevated protein indices as early as two days post-infection 
(Figure 5D).  Between four and seven days post-infection, average urine protein indices 
were as high 1 to 1.5 (corresponding to approximately 50-100 mg/dl), indicating that 
infection by C. rodentium (λstx2dact) results in functional renal compromise.  Additional 
renal compromise in mice infected with C. rodentium (λstx2dact) was evident from the 
presence of hematuria and increased levels of a renal tubule-specific biomarker, Kidney 
injury molecule-1 (Kim-1) specifically late in infection compared to mock-infected mice 
or mice infected with C. rodentium (λstx2dact::kan
R) (Figure 5D). 
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Given the presence of systemic disease, including specific intestinal and renal 
damage, we next evaluated histology of other tissues to investigate their involvement 
with disease upon infection by C. rodentium (λstx2dact).  Mice were either mock-infected 
or infected with C. rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R), and spleen, 
heart, lung, liver, and nasal turbinates were evaluated histologically.  The spleens of mice 
infected with C. rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R) both showed 
reactive germinal center formation and germinal center hyperplasia with large follicles 
(Supplemental Figure 3A).  More germinal center activity, depicted by evident cell 
turnover was observed in the spleens of mice infected with C. rodentium (λstx2dact), 
consistent with a shift to a state of reactive extramedullary hematopoiesis (EMH) 
(Supplemental Figure 3A).  A more robust germinal center hyperplasia was observed in 
mice infected with C. rodentium (λstx2dact::kan
R), which is consistent with evidence of 
gross splenomegaly (~30% increase in size compared to mice infected with C. rodentium 
(λstx2dact) (Supplemental Figure 3A).  Histological examination of both the lungs and 
the heart revealed no abnormal pathology in mice infected with either C. rodentium 
(λstx2dact) or C. rodentium (λstx2dact::kan
R) (Supplementary Figure 3B, C).  In contrast, 
the livers of mice infected with C. rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R) 
revealed foci of neutrophilic and lymphocytic inflammation as well as scattered 
hepatocellular death (Supplementary Figure 3D).  The liver injury was slightly worse in 
mice infected with C. rodentium (λstx2dact) compared to mice infected with C. rodentium 
(λstx2dact::kan
R) in the representative livers examined.  Lastly, nasal turbinates which  
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Supplementary Figure 3.  Infection by C. rodentium (λstx2dact) does not result in 
significant histological damage to the spleen, heart, lung, liver, or nasal turbinates.  
Tissue sections of the spleen (A), heart (B), lung (C), liver (D), and nasal turbinates (E) 
were taken from mock-infected mice or mice infected with C. rodentium (λstx2dact) or C. 
rodentium (λstx2dact::kan
R) at seven days post-infection, stained with H&E, and analyzed 
histologically by a board certified pathologist.  The magnification of spleen, lungs, heart, 
and liver samples is 200x and the magnification of the nasal turbinate samples is 40x.  
Scale bars measure 50 μm.  For spleen, heart, lung, and liver samples, data are 
representative of one mock-infected mouse, four mice infected with C. rodentium 
(λstx2dact) and two mice infected with C. rodentium (λstx2dact::kan
R).  For nasal turbinate 
samples, data are representative of five mice infected with C. rodentium (λstx2dact) and 
five mice infected with C. rodentium (λstx2dact::kan
R).   
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have been shown to express Gb3 receptors (Rutjes et al., 2002) were evaluated in mice 
infected with C. rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R).  There was no 
evidence of tissue damage to the nasal turbinates in mice infected with either C. 
rodentium (λstx2dact) or C. rodentium (λstx2dact::kan
R) (Supplementary Figure 3E).     
 
Tir is required for colonization and disease in the C. rodentium (λstx2dact) infection 
model. 
The ability to generate of AE lesions is a well-established virulence attribute of 
EHEC, but STEC strains that produce Stx2dact are capable of causing disease in humans 
(and mice) in the absence of AE lesion formation (Ito et al., 1990; Lindgren et al., 1993; 
Melton-Celsa et al., 1996).  To test whether murine infection with C. rodentium (λstx2dact) 
provided a disease model that was dependent on AE lesion formation, we determined if a 
C. rodentium (λstx2dact) defective for Tir production was also defective for colonization 
and disease.  Whereas C. rodentium (λstx2dact) and C. rodentium (λstx2dact::kan
R) were 
capable of generating actin pedestals indistinguishable from those formed by wild type C. 
rodentium DBS100 on monolayers of mouse embryonic fibroblasts, C. rodentium 
(λstx2dact)∆tir was impaired in cell binding and unable to form pedestals (data not shown).  
Pedestal formation was restored to this strain by pTir (pEM129), a Tir-expressing 
plasmid (data not shown; see Supplementary Table 2 and Materials and Methods).  To 
confirm that Tir was also required for AE lesion formation during infection, we compared 
the intestinal epithelia of mice infected with C. rodentium (λstx2dact)∆tir or the parental 
strain C. rodentium (λstx2dact) by transmission electron microscopy (TEM) six days post-
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infection.  Whereas infection by C. rodentium (λstx2dact) resulted in effacement of the 
intestinal brush-border microvilli and the formation of robust pedestals (Figure 3A, top 
left panel, arrowhead), C. rodentium (λstx2dact)∆tir left the epithelial cytoskeletal 
architecture indistinguishable from mock-infected controls (Figure 3A, lower left  
panel).  When tir was introduced in trans on pTir, the intestines of mice infected with C. 
rodentium (λstx2dact)Δtir/pTir showed many bound bacteria elevated on actin pedestals 
(Figure 3A, lower right panel, arrowhead) with concomitant destruction of microvilli, 
indicating that, as expected, Tir is required for AE lesion formation.   
The lack of C. rodentium (λstx2dact)∆tir detected by TEM reflected a significant 
colonization defect when assessed quantitatively, because mice infected with C. 
rodentium (λstx2dact)∆tir had vastly fewer fecal bacteria than mice infected with C.  
rodentium (λstx2dact) (Figure 6A).  At three days post-infection, fecal counts of mice 
infected with C. rodentium (λstx2dact)∆tir were approximately three orders of magnitude 
lower than mice infected with C. rodentium (λstx2dact), and this difference grew to 
approximately seven orders of magnitude four days later.  In contrast, C. rodentium 
(λstx2dact)∆tir/pTir was capable of efficiently colonizing mice, with peak bacterial 
burdens reaching almost 1010 CFU per gram of stool (Figure 6A).  Notably, the kinetics 
of colonization by C. rodentium (λstx2dact)∆tir/pTir were somewhat delayed relative to C. 
rodentium (λstx2dact), consistent with previous reports that plasmid complementation of a 
C. rodentium tir mutant is incomplete (Deng et al., 2003; Mundy et al., 2004).  
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Figure 6.  Tir is required for colonization and disease upon C. rodentium (λstx2dact) 
infection of mice.  (A) Colonization of eight-week old C57BL/6 mock-infected mice, or 
infected with the indicated strain, was determined by plating stool for viable counts.  
Shown are the averages CFU (± SEM) of five mice.  Data are representative of four 
independent experiments.  Statistical significance was determined using two-way 
ANOVA and Bonferroni post-tests indicates that C. rodentium (λstx2dact)∆tir colonized 
mice significantly (*p<0.05) less efficiently than C. rodentium (λstx2dact) and C. 
rodentium (λstx2dact)∆tir/pTir).  (B) Body weight during infection of eight-week old mice 
was determined and is expressed as percent change from day zero weight.  Shown are the 
averages (±SEM) of five mice per group.  Data are representative of four independent 
experiments.  (C) Percent survival of mock-infected eight-week old mice or mice 
infected with C. rodentium (λstx2dact), C. rodentium (λstx2dact)Δtir, or C. rodentium 
(λstx2dact)Δtir/pTir.  Groups of five mice were analyzed.  Data are representative of five 
independent experiments.  (D) H&E-stained large intestinal sections of mock-infected 
mice or mice infected with the indicated strain are shown under 100x (top row) or 400x 
(bottom row) magnification.  Scale bars measure 50 μm.  Asterisks (*) depict goblet cells 
that are prominent in normal intestinal tissue.  Arrowheads indicate infiltration of 
inflammatory cells into the mucscularis mucosa and muscularis propria layers.  (E) H&E-
stained 600x micrograph of kidney sections from mock-infected mice or mice infected 
with the indicated strain.  Arrowheads indicate attenuation and sloughing of epithelial 
cells within the proximal tubules.  Scale bars measure 50 μm.  
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The defect of C. rodentium (λstx2dact)∆tir in intestinal colonization was reflected 
in all aspects of Stx-mediated disease.  Histological analyses of the intestines of mice 
infected with C. rodentium (λstx2dact)∆tir were indistinguishable from those of mock-  
infected mice, in contrast to those of mice infected with C. rodentium (λstx2dact)∆tir/pTir, 
which showed areas of necrosis, inflammatory infiltrates, and the loss of goblet cells 
(Figure 6D).  Renal damage was associated only with infection by C. rodentium 
(λstx2dact)∆tir/pTir, not with the Tir-deficient mutant (Figure 6E).  These histological 
assessments of disease correlated with weight loss, because mice infected with C. 
rodentium (λstx2dact)∆tir maintained weight throughout infection (Figure 6B).  In 
contrast, mice infected with C. rodentium (λstx2dact)∆tir/pTir lost on average 18% body 
weight by 15 days post-infection.  The kinetics of weight loss by mice infected with the 
Tir-complemented strain, similar to the kinetics of colonization, were delayed several 
days relative to mice infected with C. rodentium (λstx2dact), but once weight began to 
decrease at approximately ten days post-infection, it declined steadily (Figure 6B).  
Finally, whereas infection by C. rodentium (λstx2dact)∆tir caused no mortality, infection 
by C. rodentium (λstx2dact)∆tir/pTir, like that of C. rodentium (λstx2dact), was uniformly 
fatal, with the predicted temporal delay (Figure 6C).  Thus, Tir is an essential virulence 
factor during lethal infection by C. rodentium (λstx2dact).   
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Discussion 
EHEC infection features high-level intestinal colonization accompanied by the 
formation of AE lesions and the production of Stx.  Some rabbit and piglet models mimic 
these two central aspects of EHEC infection (Garcia et al., 2006; Panda et al., 2010; 
Ritchie et al., 2003; Ritchie and Waldor, 2005; Tzipori et al., 1995), but no analogous 
model has yet been developed in conventional mice.  We show here that C. rodentium 
lysogenized with λstx2dact provides a model that features prototypic AE lesions during 
intestinal colonization, weight loss, and death, and recapitulates many manifestations of 
Stx-mediated disease observed in human EHEC infection and murine toxin injection 
models (Amirlak and Amirlak, 2006; Mohawk and O'Brien, 2011).  
Human HUS is associated with the induction of inflammatory cytokines (Caprioli 
et al., 2005b; Ray and Liu, 2001), and patients with a preponderance of pro-inflammatory 
cytokines often have more severe disease (Litalien et al., 1999).  Indeed, one model of 
Stx-mediated disease in mice requires the co-administration of LPS and Stx (Keepers et 
al., 2007).  Several means by which inflammatory cytokines may promote systemic 
disease have been proposed, including induction of the Gb3 glycolipid Stx receptor on 
host cells (Simon et al., 1998; van de Kar et al., 1992; van Setten et al., 1997), alteration 
of fibrinolysis and anticoagulation, or recruitment of inflammatory cells into damaged 
tissues (Ray and Liu, 2001).  In response to Stx, cultured monocytes secrete TNF- and 
IL-6 (Foster et al., 2000; van Setten et al., 1996; van Setten et al., 1997), and we found 
that these cytokines were elevated in the serum or kidneys of mice infected with C. 
rodentium (λstx2dact).  This response was dependent on Stx production, because neither 
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TNF- nor IL-6 was elevated in mice infected with C. rodentium (λstx2dact::kan
R).  MCP-
1 and KC were also elevated in C. rodentium (λstx2dact)-infected mice in an Stx-
dependent manner.  Notably, MCP-1 and IL-8, a functional human analog of KC, are 
found at elevated levels in the urine of children with HUS (van Setten et al., 1998).  
Interestingly, some mice infected with C. rodentium (λstx2dact) displayed much higher 
levels of all serum cytokines than others infected with the same strain.  Upon further 
analysis, we found that the mice on the verge of death (exhibiting >15% body weight 
loss, ruffled fur, high-level colonization, and were seizing) had consistently elevated 
serum cytokines throughout the panel of cytokines tested.  It is possible that the 
remainder of the mice infected with C. rodentium (λstx2dact) that had lower levels of 
serum cytokines would have had higher serum cytokine levels if testing were done at a 
later time point when these mice were moribund. 
Renal damage is central to human HUS (Scheiring et al., 2008), and the induction 
of kidney cytokines in the C. rodentium (λstx2dact) model was accompanied by renal 
compromise.  Glomerulonephritis is a prominent feature of human HUS, a manifestation 
that correlates with the relative abundance of Gb3 receptors on glomerular endothelium 
(Richardson et al., 1988).  In mice however, Gb3 is enriched in the renal tubules (Psotka 
et al., 2009), and the tubular damage we observed in infected mice likely reflects this 
localization.  Consistent with this hypothesis, tubular damage is also typically observed in 
EHEC-infected germ-free or streptomycin-treated mice (Eaton et al., 2008; Lindgren et 
al., 1993; Melton-Celsa et al., 1996; Psotka et al., 2009).  The histopathological findings 
were reflected in functional compromise, because mice infected with C. rodentium 
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(λstx2dact), but not C. rodentium (λstx2dact::kan
R), demonstrated elevated BUN and 
proteinuria, consistent with other murine models of HUS (Eaton et al., 2008; Keepers et 
al., 2006; Lindgren et al., 1993; Mohawk and O'Brien, 2011; Sauter et al., 2008). 
Elevated serum creatinine, another indicator of renal dysfunction, has been observed in 
some other murine models for Stx-mediated disease (Keepers et al., 2006; Lindgren et al., 
1993; Sauter et al., 2008).  In contrast, we found that, although serum creatinine was 
somewhat elevated in mice infected with C. rodentium (λstx2dact), the increase did not 
reach statistical significance (E.M. unpublished data), similar to the serum creatinine 
levels observed upon infection of BALB/c mice by EHEC (Mohawk et al., 2010b).  
Although our model resembles many aspects of murine Stx-mediated disease, 
several manifestations of human HUS are not recapitulated in the C. rodentium (λstx2dact) 
murine model.  For example, neurological damage is associated with HUS, and cerebral 
hemorrhage and edema have been reported in EHEC-infected, streptomycin pre-treated 
mice (Fujii et al., 1994; Kurioka et al., 1998).  Although mice infected with C. rodentium 
(λstx2dact) occasionally displayed tremors and seizures, we did not observe consistent 
pathological changes in the brain (E.M., M. McBee, and V.V., unpublished observations).  
In addition, contrary to what has been observed in human disease (Scheiring et al., 2010; 
Tarr et al., 2005) and Stx administration models (Karpman et al., 1997; Keepers et al., 
2006; Psotka et al., 2009; Roche et al., 2007; Sauter et al., 2008), mice infected with C. 
rodentium (λstx2dact) did not display renal platelet aggregation, red cell congestion, or 
fibrin deposition, and did not suffer thrombocytopenia or anemia.  Given that it has been 
hypothesized that erythrocytes are ruptured upon passage through damaged renal 
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glomeruli (Bull et al., 1967), it is tempting to speculate that the lack of 
glomerulonephritis in our model partially explains the lack of observable anemia.  We 
also found no hematological evidence of thrombotic disease, such as prolonged clotting 
time, fibrin D-dimer formation, or complement activation determined by measuring 
serum levels of Bb, C3, and sC5b-9 (E.M. unpublished observations).  
Given that a central goal of this study was to test whether C. rodentium (λstx2dact) 
could recapitulate EHEC toxin-mediated disease, an important finding was the 
requirement for Tir in promoting Stx-mediated disease in this model.  Colonization by a 
Tir-deficient derivative of C. rodentium (λstx2dact) was many orders of magnitude lower 
than colonization by the parental strain.  A Tir-encoding plasmid complemented the 
mutant for the ability to colonize mice and cause disease, although the kinetics of 
colonization, weight loss and death were somewhat slower than that by C. rodentium 
(λstx2dact).  The apparent partial complementation is consistent with previous studies 
indicating that plasmid-based expression in C. rodentium is often unable to completely 
restore wild type phenotypes (Deng et al., 2003; Mundy et al., 2004).  
Interestingly, in spite of the reports that the Stx receptor Gb3 is expressed on cells 
in the distal colon of the mouse (Imai et al., 2003; Schuller, 2011), the streptomycin pre-
treatment and gnotobiotic mouse models of EHEC infection models do not typically 
result in obvious intestinal damage ((Eaton et al., 2008; Lindgren et al., 1993), A.M 
unpublished observations).  Mild inflammatory cell infiltration, goblet cell depletion, and 
intestinal epithelial necrosis have been reported in a few studies (Isogai et al., 1998; 
Kurioka et al., 1998; Shimizu et al., 2003; Taguchi et al., 2002).  In contrast, we found 
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here dramatic intestinal damage in mice infected with C. rodentium (λstx2dact); indeed, 
these pathological changes were similar to those commonly observed in human infection 
by EHEC, which in some cases can mimic inflammatory bowel disease or ischemic 
colitis (Griffin et al., 1988; Moon, 1997; Sebbag et al., 1999; Siegler, 1994).  It is 
tempting to speculate that AE lesion formation, a prominent feature of this murine 
infection model, is critical to facilitating Stx-mediated intestinal epithelial damage.  The 
development of a murine model that encompasses both AE lesion formation and severe 
Stx-mediated tissue damage provides an opportunity to more fully explore the 
relationship between the dramatic alteration in host cytoskeletal structure and subsequent 
systemic disease. 
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CHAPTER IV. 
ACTIN PEDESTAL FORMATION BY AE PATHOGENS PROMOTES 
SYSTEMIC SHIGA TOXIN-MEDIATED DISEASE. 
Abstract 
Enterohemorrhagic E. coli (EHEC) colonizes the intestine and produces the phage-
encoded Shiga toxin (Stx), which is absorbed systemically and can cause life-threatening 
hemolytic uremic syndrome (HUS) consisting of the triad of hemolytic anemia, 
thrombocytopenia, and renal failure.  EHEC is an attaching and effacing (AE) pathogen 
that intimately adheres to epithelial cells and forms actin-rich “pedestals” beneath bound 
bacteria.  To generate AE lesions, EHEC translocates the type III effector, Tir, into 
mammalian cells, which functions as a receptor for the EHEC adhesin intimin.  Tir-
intimin binding triggers a signaling cascade leading to pedestal formation through the N-
WASP-Arp-2/3 pathway.  The ability to generate pedestals has been associated with 
moderately enhanced colonization, particularly late in infection; however, dramatic 
phenotypes associated with pedestal-defective mutants have yet to be identified.  Using 
our previously described murine model of Stx-mediated disease by C. rodentium 
(λstx2dact), we assessed the role of Tir-mediated actin assembly in colonization and 
disease.  First, conditional, intestinal, N-WASP-/- (iNWKO) mice were infected with C. 
rodentium (λstx2dact).  Interestingly, iNWKO mice were less colonized and exhibited less 
disease and mortality compared to littermate controls.  Next, wild type mice were 
infected with C. rodentium (λstx2dact) expressing a point mutant of Tir that promotes 
intimate bacterial attachment but not actin assembly.  C. rodentium expressing the mutant 
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Tir colonized mice almost as efficiently as C. rodentium expressing wild type Tir.  
Nevertheless, C. rodentium expressing wild type Tir caused lethal infection, while C. 
rodentium expressing the Tir point mutant was almost entirely incapable of lethality.  The 
expression of wild type Tir, but not the Tir mutant was associated with the ability to 
stably colonize the colonic mucosal surface.  These studies suggest that Tir-mediated 
actin pedestal formation may promote systemic Stx-mediated disease by stably localizing 
Stx-producing bacteria on the mucosal surface, thereby increasing delivery of the toxin 
across the mucosal barrier. 
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Introduction  
Enterohemorrhagic Escherichia coli (EHEC) particularly serotype O157:H7 is an 
important food-borne human pathogen responsible for both sporadic and epidemic 
outbreaks of diarrheal disease (Kaper et al., 2004; Pennington, 2010).  Human EHEC 
infection can result in local, intestinal disease such as diarrhea or hemorrhagic colitis, 
characterized by bloody diarrhea and severe abdominal pain or manifest in a life-
threatening, systemic disease known as hemolytic uremic syndrome (HUS) characterized 
by the triad of hemolytic anemia, thrombocytopenia, and renal failure (Karmali et al., 
2009; Tarr et al., 2005).  Notably, HUS is the leading cause of renal failure in children 
(Mead and Griffin, 1998; Scheiring et al., 2008).  
Systemic disease resulting from EHEC infection requires the phage-encoded 
cytotoxin Shiga toxin (Stx), and toxin expression is often enhanced upon phage induction 
(Muhldorfer et al., 1996; Schmidt, 2001; Waldor and Friedman, 2005).  Stx produced in 
the gut traverses the intestinal epithelium, enters the blood stream, and targets organs   
possessing the globotriasosylceramide Gb3 receptor, such as the vasculature, kidney, and 
central nervous system (CNS) (Obrig, 2010; Sandvig and van Deurs, 1996; Schuller, 
2011), where it inhibits protein synthesis.  Of the two major serotypes of Stx, Stx1 and 
Stx2, EHEC strains that express exclusively Stx2 are associated with a greater risk of 
HUS (Croxen and Finlay, 2010; Melton-Celsa et al., 2011; Ostroff et al., 1989).   
A characteristic colonization feature of EHEC that it shares with enteropathogenic 
E. coli, a cause of infantile diarrhea in the developing world, and Citrobacter rodentium, 
a murine pathogen that causes transmissible colonic hyperplasia, is the ability to form 
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attaching and effacing (AE) lesions on the intestinal epithelium (Kaper et al., 2004; 
Schauer and Falkow, 1993a).  These lesions are characterized by the degeneration of 
brush border microvilli, intimate attachment of bacteria to the host cell, and the formation 
of actin-rich pedestals beneath bound bacteria ((Moon et al., 1983), for review see (Kaper 
et al., 2004)).  Upon animal infection with EHEC or C. rodentium, mucosally adhered 
bacteria and AE lesions have been observed in the cecum, colon, and rectum (Dean-
Nystrom et al., 1999; Nagano et al., 2003; Nart et al., 2008; Schauer and Falkow, 1993a; 
Wales et al., 2001).  Interestingly, the cecum is the primary site of colonization of mice 
with C. rodentium (Wiles et al., 2004).   
The formation of AE lesions is dependent on a type III secretion system (T3SS) 
that translocates bacterial effectors directly into host cells (Garmendia et al., 2005; Kenny 
and Finlay, 1995; McDaniel et al., 1995).  An effector that is essential for pedestal 
formation is the translocated intimin receptor (Tir), which localizes in the host cell 
plasma membrane in a hair loop conformation with N- and C-terminal cytoplasmic 
domains and a central extracellular domain.  The extracellular domain binds to the outer 
membrane protein intimin (de Grado et al., 1999; Hartland et al., 1999; Kenny et al., 
1997), and membrane clustering of Tir by intimin induces a signaling cascade within the 
host cell resulting in the formation of filamentous (F)-actin-rich pedestals (reviewed in 
(Campellone, 2010; Caron et al., 2006; Hayward et al., 2006)). 
To generate actin pedestals, EPEC and C. rodentium utilize the Tir-Nck-N-WASP 
pathway (Campellone et al., 2002; Gruenheid et al., 2001; Kenny, 1999).  The Tir 
proteins of these two pathogens contain a critical tyrosine residue (TirY471 in C. 
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rodentium or its equivalent TirY474 in EPEC) that after translocation becomes 
phosphorylated by mammalian cell kinases (Phillips et al., 2004; Swimm et al., 2004a) to 
create a docking site for the SH-2 (src homology 2) domain of the host cell adaptor 
protein Nck (Campellone et al., 2002; Campellone et al., 2004a; Gruenheid et al., 2001).  
Nck then recruits all the components necessary for actin polymerization via the N-WASP 
and Arp-2/3 pathway ((Rivera et al., 2004; Rohatgi et al., 2001); for review see (Frankel 
and Phillips, 2008)).  Although canonical EHEC strains also produce Tir and intimin, 
EHEC Tir lacks a Nck binding sequence and instead produces an additional bacterial 
factor, EspFU (aka TccP) (Campellone et al., 2004b; Garmendia et al., 2004), absent in 
EPEC and C. rodentium, that vastly increases the efficiency of actin assembly via a Nck-
independent pathway (Brady et al., 2007; Campellone and Leong, 2005).  
While there is extensive evidence that intimin and Tir are required for 
colonization in a variety of animal models (Deng et al., 2003; Marches et al., 2000; 
Ritchie et al., 2003; Schauer and Falkow, 1993b; Tzipori et al., 1995), the importance of 
Tir-mediated actin rearrangement is less defined.  Some studies have indicated that the 
ability to generate actin pedestals is dispensable for colonization (Deng et al., 2003; 
Schuller et al., 2007; Vlisidou et al., 2006a), while other findings suggest that Tir-
mediated actin assembly enhances colonization (Crepin et al., 2010; Ritchie et al., 2008).  
For example, murine infection with a C. rodentium tir mutant harboring a plasmid 
containing a Tir deficient in pedestal formation in vitro (pTirY471F) was not significantly 
down for colonization compared to infection by a pedestal-proficient strain (C. 
rodentiumΔtir/pTirWT) (Deng et al., 2003).  Similarly, intestinal colonization in calves 
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and lambs was unaltered upon infection with an EHEC espFU mutant (Vlisidou et al., 
2006a), nor was colonization of intestinal explants altered by infection with EPEC, Tir 
phosphorylation-deficient mutants (Schuller et al., 2007).  In contrast, an EHEC strain 
deficient for pedestal formation displayed a mild colonization defect late in infection of 
infant rabbits and generated smaller than wild type bacterial aggregates on the intestinal 
mucosa of infected piglets (Ritchie et al., 2008).  In addition, a C. rodentium pedestal-
deficient mutant was outcompeted by wild type C. rodentium in a dual infection (Crepin 
et al., 2010).   
The above experiments were not performed in experimental systems that 
prominently manifest Stx-mediated systemic disease, a central aspect of EHEC infection.  
To assess the consequence of pedestal formation in an animal model that features Stx-
mediated intestinal and renal damage, we utilized C. rodentium lysogenized with an Stx-
producing phage.  Infection of mice with C. rodentium (stx2dact) recapitulates many 
aspects of EHEC toxin-mediated disease, including high-level colonization, intestinal 
damage, and renal compromise (Chapter III).  We found that pedestal formation 
promotes colonization of the colonic but not the cecal mucosa, and that dramatically 
enhanced colonic colonization was required to cause severe systemic disease.  
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Materials and Methods  
Plasmids, bacterial strains, and growth conditions.  All bacteria were cultured in 
Luria-Bertani broth (LB) (Miller) at 37oC, unless indicated otherwise.  Antibiotics were 
used in the following concentrations kanamycin (25 μg/ml), zeocin (75 μg/ml), 
chloramphenicol (10 μg/ml), and tetracycline (5 μg/ml).  For recombination using pKD46 
in C. rodentium (λstx2dact) strains, 750 μg/ml of ampicillin was used to select for 
transformants because of the presence of a chromosomal β-lactamase in C. rodentium 
(λstx2dact).  The bacterial strains and plasmids used in this study are listed in Tables 1 and 
2. 
 
Plasmid isolation, primers, and sequencing.  Isolation of all plasmid DNA was done 
using the QIAprep Spin Miniprep Kit (QIAgen, Valencia, CA, USA).  All primers were 
purchased from Invitrogen (Grand Island, NY, USA) and are listed in Table 3.  
Sequencing was performed at Tufts University Core Sequencing Facility (Boston, MA, 
USA).  Sequences were analyzed using BioEdit and MacVector software.   
 
Construction of a plasmid expressing C. rodentium TirY471F.  The pTirY471F plasmid 
was constructed using SLIM as previously described (Chiu et al., 2004) using the 
following primers: R-Oli178, F-Oli179, R-Oli180, and F-Oli181.  Plasmid sequence was 
confirmed by sequencing and pedestal formation was tested in a FAS assay.   
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Generation of an anti-Citrobacter antibody.  To generate the C. rodentium Tir 
expressing plasmid pCrTirExp, primers F-190 and R-191 were used to amplify C. 
rodentium tir with Nde I and Sal I flanking restriction sites (1.644 kb) from pEM129 
“pTirWT”.  This PCR fragment was cloned into the Nde I and Sal I sites of pET21b ligated 
and transformed into CaCl2 competent DH5α E. coli.  Transformants were selected on 
plates containing ampicillin.  Candidate clones were then verified by restriction digestion, 
PCR with primers R-iTirL and F-iTirU (480 bp), and sequencing.  Sequences were 
analyzed using BioEdit software (Ibis Therapeutics, Carlsbad, CA, USA).  pCrTirExp 
was then transformed into BL21 DE3. 
 
For expression and protein purification of C. rodentium Tir, BL21 DE3+pCrTirExp was 
cultured in 2xYT media at 37°C to an OD600 of 0.6- 0.7 then induced with 1 mM IPTG 
for three hours at 37°C.  The culture was spun at 4,420 x g, 20 minutes at 4C and the 
supernatant was discarded.  The pellet was resuspended in 2.5 ml lysis buffer per gram 
wet weight.  4 mg lysozyme was added and the sample was sonicated ([Branson Sonifier 
450, Branson Ultrasonics Corporation, Danbury, CT, USA] Duty cycle 70, output 3, 10 
second bursts X 6 cycles).  The lysate was then centrifuged at 16,100 x g, 20 minutes at 
4°C.  The supernatant was run on a QIAgen Ni-NTA Agarose column (QIAgen, 
Valencia, CA, USA) and resulting C. rodentium Tir was eluted and quantified using Bio-
Rad Protein Assay kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA).  
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For C. rodentium antibody production, all inoculations were completed subcutaneously 
with 30 ng of purified C. rodentium Tir in 50 μl with 50 μl of adjuvant for a total 
inoculation volume of 100 μl.  Eight-week old, female BALB/c mice (Jackson 
Laboratories, Bar Harbor, ME, USA) were inoculated with C. rodentium Tir 
supplemented with Imject Freund’s Complete Adjuvant (Thermo Scientific, Rockford, 
IL, USA).  At days 14 and 28 mice were boosted with C. rodentium Tir supplemented 
with Imject Freund’s Incomplete Adjuvant (Thermo Scientific, Rockford, IL, USA).  
Mice were sacrificed on day 38 and blood was harvested via cardiac bleed.  Blood was 
allowed to clot at room temperature for 30 minutes, and then was spun twice at 8,600 x g, 
15 minutes at 4°C, aliquoted and stored at -80°C. 
 
Tir immunoblotting.  C. rodentium strains were cultured in DMEM + 0.1 M HEPES at 
37°C, 5% CO2 for 4.5 hours.  After centrifuging at 22,000 x g for 10 minutes at room 
temperature, media was decanted and trichloroacetic acid was added in a 1:1 volume and 
incubated overnight at -20°C.  After incubation, sample was centrifuged at 22,000 x g for 
10 minutes at 4°C.  Supernatant was decanted and pellet was resuspended in acetone and 
centrifuged at 20,800 x g at 4°C for 10 minutes.  The acetone was decanted and the pellet 
was allowed to air dry for 10 minutes and was then resuspended in glass-distilled water.  
Loading of sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE) was standardized to 
either final protein concentration quantified by Nanodrop (Thermo Fisher Scientific Inc., 
Wilmington, DE, USA) or final OD600.  
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Infection analysis of C. rodentium (λstx2dact) and mutants on cultured cells.  The 
filamentous actin staining assay was done as previously described (Mallick et al., 2012).  
Briefly, a single colony from each strain was grown in 1 ml media (+/- antibiotic) for 
eight hours.  Cultures were diluted 1:500 into 5 ml DMEM supplemented with 0.1M 
HEPES (pH 7.0) (+/- antibiotic) and incubated at 37ᵒC without agitation with 5% CO2 for 
12-15 hours.  Cell monolayers were prepared by splitting 95-100% confluent mouse 
embryonic fibroblasts (MEFs) into 24-well culture plates containing sterile glass 
coverslips followed by overnight growth at 37ᵒC with 5% CO2.  For infections, cell 
monolayers were washed twice with sterile PBS followed by addition of FAS media 
containing 25 μl of overnight cultured C. rodentium to each well.  Plates were spun at 
700g for 10 minutes then incubated at 37ᵒC with 5% CO2 for 3 hours.  After 1.5 hours, 
plates were spun again at 700 g for an additional 10 minutes then to insure proper 
bacterial binding to cells.  After 3 hours, cells were washed twice with sterile PBS and 
0.5 ml pre-warmed FAS media was added to each well and plates were incubated for 3 
hours.  Cells were washed 5 times with sterile PBS, fixed with 4% PFA for 30 minutes, 
washed, permeabilized with 0.1% Triton-X 100, and then stained with Phalloidin 
(Molecular Probes, Eugene, OR, USA) (1:100) and DAPI (1:500).  After washing cells 
an additional three times with PBS, the coverslips were mounted on slides using 
ProLong® Gold antifade reagent (Invitrogen, Eugene, OR, USA).   
 
Mouse infections.  Mice were purchased from Jackson Laboratories (Bar Harbor, ME, 
USA) and housed in the UMMS animal facility.  Protocols were approved by the 
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department of animal medicine and complied with the UMMS IACUC protocols.  Female 
five-to-eight week old C57BL/6J mice were gavaged with PBS or ~5 x 109 of overnight 
culture of C. rodentium in 100 μl PBS.  Inoculum concentrations were confirmed by 
serial dilution plating.  C. rodentium fecal shedding was determined by serial dilution 
plating of fecal slurries (10% w/v in PBS) on LB or Maconkey agar with selection for 
kanamycin, chloramphenicol, or kanamycin and chloramphenicol, as appropriate.  When 
using complemented strains containing antibiotics, feces were plated on plates containing 
both antibiotics.  Previously we have tested the rate of plasmid loss by plating on only 
one antibiotic and determined it was minimal.  Body weights were monitored daily and 
mice were euthanized if they lost >20% of their body weight.  Some mice became 
moribund or died prior to the scheduled necropsy date, and these mice were necropsied 
early.  Mouse urinalysis was performed by collecting urine into a 1.5 ml conical tube.  
The urine in the tube was thoroughly mixed and a 2 μl aliquot was pipetted onto a 
Chemstrip 4MD urinalysis test strip (Roche Diagnostics, Laval, Quebec).  After 60 
seconds, the color change on the strip was compared to a supplied color scale.  The range 
of protein measured was 0 – 500 mg/dl, with the scale 0 indicating undetectable protein, 
0.5 indicating trace, 1.0 indicating ~30 mg/dl, 2 indicating ~100 mg/dl, and 3.0 indicating 
~500 mg/dl.  All experimental groups contained at least five mice unless otherwise 
stated.   
 
Tissue Collection and Histology.  At necropsy, the distal colon and cecum were taken 
along with longitudinally divided kidneys and were fixed in 10% buffered formalin, 
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dehydrated and embedded in paraffin.  Five-micron intestinal and kidney sections were 
cut and stained with hematoxylin and eosin (H&E).  Tissue sections were evaluated by a 
board-certified pathologist (V.V.) with a subspecialty expertise in renal pathology.  
Assessment of intestinal mucosal hyperplasia was targeted to areas of comparable 
muscularis propria thickness in order to reduce error from differences in planes of 
section.  For immunofluorescence staining, histological sections of the intestine were 
stained with an anti-Citrobacter antibody (a gift from the lab of David Schauer, MIT) 
used at 1:1600, DAPI, and phalloidin (1:100) (Invitrogen, Grand Island, NY, USA) by 
the DERC Histology Core Facility at UMMS. 
 
Determination of CFU associated with different intestinal segments.  Mice were 
gavaged with approximately 5 x 109 bacteria and fecal colonization and body weight was 
monitored throughout infection.  At day of necropsy, the large intestine (cecum through 
rectum) was removed and after removal of fecal contents, the large intestine was flushed 
with 1 ml sterile PBS and to remove any loosely bound bacteria.  The contents of the 
flush (“output” or “luminal contents”) were then collected and serial dilutions of the flush 
(“output” or “luminal contents”) were plated on the LB with the appropriate antibiotic.  
The intestine was then divided into two parts: cecum and colon, homogenized, and serial 
dilutions of the tissue homogenate were plated on the appropriate antibiotic to determine 
the amount of bacteria per mg of tissue. 
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Generation and characterization of conditional, intestinal, N-WASP-/- mice.   It has 
previously been shown that germline deletion of N-WASP results in early embryonic 
lethality in association with severe neural tube defects and cardiac abnormalities 
(Lommel et al., 2001; Snapper et al., 2001).  Therefore, a conditional, intestinal, N-
WASP knockout mouse (iNWKO) was generated using the Cre-Lox system, where Cre 
expression was driven by a villin-specific promoter.  Breeders to generate conditional, 
intestinal N-WASP knockout mice were obtained from Scott Snapper (Children’s 
Hospital, Boston, MA) and bred at UMMS.  The breeding scheme was as follows: a 
female mouse homozygous for LoxP-flanked N-WASP alleles and Cre- (L2L/L2L, Cre-) 
was bred with a male heterozygous for LoxP-flanked N-WASP alleles and Cre+ (L2L/+, 
Cre+).  iNWKO knockout offspring were the pups that were homozygous for LoxP-
flanked N-WASP and Cre+ (L2L/L2L, Cre+).  This breeding resulted in approximately 
15% of the desired genotype.  Genotyping was performed by Transnetyx (Cordovia, TN, 
USA) using a specific genotyping assay designed for the iNWKO mouse.  Western blot 
analysis was performed on the colon, ileum, jejunum, and duodenum of correctly 
genotyped mice using an anti-N-WASP antibody.  Body weight of iNWKO and 
littermate controls was measured daily after birth.  The colons of iNWKO mice were 
analyzed grossly, by H&E, and by Transmission Electron Microscopy (TEM).  The 
colonic mucosa and distribution of colonic goblet cells of iNWKO mice appeared grossly 
normal.  The ileum of the iNWKO mice exhibited uncondensed nuclei compared to 
littermate controls.  Additionally, iNWKO mice displayed normal ultrastructural 
intestinal architecture, with prominent microvilli, however the microvilli were shorter in 
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length than those of the littermate controls.  To assess intestinal permeability in iNWKO 
mice, mice were given 100 μl of 10 mg/ml solution of FITC-dextran (Sigma, St. Louis, 
MI, USA) and four hours later were sacrificed.  Blood was collected via cardiac bleed, 
allowed to clot, and then centrifuged for 30 minutes.  The serum was separated and 
fluorescence intensity was measured in undiluted serum using SpectraMax Gemini XS at 
an excitation wavelength of 483 and emission wavelength of 517.  All infection 
experiments using the iNWKO mouse were completed as described above (Mouse 
Infections, Tissue Collection and Histology, and Determination of CFU associated with 
different intestinal segments) and included age and sex matched littermate controls.    
 
Transmission Electron Microscopy.  Mouse intestinal tissue samples were taken at 
various time points post infection and fixed in 2.5% gluteraldehyde in 0.05 M Sodium 
Phosphate buffer, pH 7.2.  Samples were processed and analyzed at the UMMS Electron 
Microscopy core facility according to standard procedures.  Briefly, fixed samples were 
moved into fresh 2.5% gluteraldehyde in 0.05 M sodium phosphate buffer and left 
overnight at 4oC.  The samples were then rinsed twice in the same fixation buffer and 
post-fixed with 1% osmium tetroxide for 1 hour at room temperature.  Samples were then 
washed twice with DH2O for 20 minutes at 4
oC and then dehydrated through a graded 
ethanol series of 20% increments, before two changes in 100% ethanol.  Samples were 
then infiltrated first with two changes of 100% propylene oxide and then with a 1:1 mix 
of propylene oxide:SPI-Pon 812 resin.  The following day three changes of fresh 100% 
SPI-Pon 812 resin were done before the samples were polymerized at 68oC in plastic 
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capsules.  The samples were then reoriented and thin sections were placed on copper 
support grids and stained with lead citrate and uranyl acetate.  Sections were examined 
using the FEI Tecani 12 BT with 80Kv accelerating voltage, and images were captured 
using a Gatan TEM CCD camera. 
 
Statistical analysis.  Data were analyzed using GraphPad Prism software.  Comparison 
of multiple groups was performed using one-way analysis of variance (ANOVA) with 
Tukey’s multiple comparison post-tests or using a two-way ANOVA with Bonferroni’s 
post-tests.  Statistical significance of differences between two groups was evaluated using 
two tailed unpaired t tests.  In all tests p values below 0.05 (*), 0.01 (**), and 0.001 (***) 
were considered statistically significant.  In all graphs error bars represent standard error 
of the mean (SEM), unless indicated otherwise.  Logistic analysis was performed by 
Stephen Baker at the UMMS. 
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Table 1.  Strains used in this study. 
Strain Description and relevant phenotype Reference 
DBS100  Citrobacter rodentium wild type 
strain (prototype TMCH isolate, 
ATTC 51459, original biotype 4280) 
(Barthold et al., 1976; 
Schauer and Falkow, 
1993a) 
DBS770  DBS100 lysogenized with Φ1720a-
02 ΔRz::cat, CmR 
Chapter III 
DBS771  DBS100 lysogenized with Φ 1720a-
02 ΔRz::cat Δstx2dactAB::kan, Cm
R, 
KmR  
Chapter III 
DH5α BL21DE3 Protein expression E. coli strain Invitrogen 
CmR, chloramphenicol resistant  
KmR, kanamycin resistant 
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Table 2.  Plasmids used in this study. 
Plasmids Description Reference 
pK184 Cloning vector, KmR (Jobling and Holmes, 1990) 
pEM129 (pTirWT) 
 
pEM123 containing C. 
rodentium tir – cesT, KmR   
Chapter III 
pTirY471F pK184 based plasmid 
containing Y471F C. 
rodentium Tir point mutant; 
KmR 
This study 
pCrTirExp pET21b containing C. 
rodentium tir, AmpR 
This study 
PET21b Expression vector with T7 
promoter, AmpR 
EMD Biosciences, San 
Diego, CA 
AmpR, ampicillin resistant 
KmR, kanamycin resistant 
CmR, chloramphenicol resistant 
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Table 3.  Oligonucleotide sequences used in this study. 
Primera Nucleotide sequence (from 5' to 3')b 
R-Oli178 cga ctt cat caa aaa tag gct ctt ctg gag cga gaa gcg atg gat t 
F-Oli179 aga gcc tat ttt tga tga agt cgc tcc gga tcc taa cta tag cgt t 
R-Oli180 tct gga gcg aga agc gat gga tt 
F-Oli181 ctc cgg atc cta act ata gcg tt 
F-190 cat cat cat cat atg atg cct att ggt aat ctt ggt 
R-191 cat cat cat gtc gac gac gaa acg ttc aac t 
R-iTirL cca att cct gct gac gtt tag 
F-iTirU ata cac gtt ctg ttg gtg tcg 
aF indicates forward (top-strand) primer and R indicates reverse (bottom-strand) primer. 
bRestriction sites are underlined 
 
  
161 
 
Results  
Characterization of a conditional, intestinal, N-WASP-/- mouse. 
iNWKO mice were generated as described in Materials and Methods.  To 
confirm the absence of N-WASP, western blot analysis was performed.  As expected, 
littermate control mice (designated “LMC” in figures) produced high levels of N-WASP 
in the colon, ileum, jejunum, and duodenum, while N-WASP was absent in iNWKO mice 
(Figure 1A).  iNWKO mice were viable but gained weight less rapidly than their 
littermate controls (Figure 1B, C).  As depicted in Figure 1B, wild type mice (LoxP-
NW-/-, Vil-Cre-) and littermate control mice homozygous for LoxP-flanked N-WASP 
alleles and negative for Cre (LoxP-NW+/+, Vil-Cre-) appeared larger than iNWKO mice 
(LoxP-NW+/+, Vil-Cre +).  Notably, between eight and 15 weeks of age, iNWKO mice 
gained significantly less (p<0.05) weight than their littermate controls (Figure 1C).  
Histologically, the colons of iNWKO were grossly normal, but ultrastructural analysis 
revealed that their intestinal microvilli and apical junction complexes (AJC) were 
significantly shorter compared to littermate controls (Figure 1D, E).  Because of this 
abnormal ultrastructure, we assessed barrier function by measuring intestinal 
permeability (see Materials and Methods).  Interestingly, iNWKO mice had increased 
gut permeability compared to controls, suggesting that elimination of intestinal N-WASP 
decreases barrier function (Figure 1F).  
 
  
162 
 
 
Figure 1.  Characterization of a conditional, intestinal, N-WASP knockout mouse.  
(A) Western blotting showing complete deletion of N-WASP in iNWKO mice.  (B)  
Overall appearance of wild type (LoxP-NW-/-, Vil-Cre-) or littermate controls (NW+/+, 
Vil-Cre-), and iNWKO (NW+/+, Vil-Cre+) mice.  iNWKO mice (middle animal) are 
smaller than wild type mice and their littermate controls (left and right animals).  (C) 
Change in body weight of iNWKO and littermate controls over time.  Littermate controls 
are depicted by black circles and iNWKO mice are depicted by black triangles.  Asterisk 
(*) indicates that iNWKO is statistically different from littermate controls (p<0.05).  (D) 
Transmission electron microscopy of the intestines of iNWKO mice and littermate 
control mice.  (E) Microvillus length and apical junction complex depth were measured 
in iNWKO mice and littermate controls.  Shown are the average lengths (± SEM).  (F) 
Intestinal permeability of iNWKO mice compared to littermate controls measured as 
mean fluorescence.  Data are representative of one experiment using two-three mice per 
group. 
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N-WASP promotes high-level colonization and systemic disease during C. rodentium 
(λstx2dact) infection.  
In order to determine whether the N-WASP pathway of actin pedestal formation 
was required for colonization, iNWKO and littermate control mice were infected with 
approximately 1x109 CFU C. rodentium (λstx2dact) by oral gavage and intestinal 
colonization was monitored by viable stool counts throughout infection.  Peak 
colonization in littermate controls occurred between 11 and 14 days post-infection and 
reached approximately 109 CFU/g stool.  Colonization slowly diminished thereafter, and 
by 30 days post-infection, bacteria were no longer detected in the stool (Figure 2), 
presumably reflecting clearance by an adaptive immune response (Ghaem-Maghami et 
al., 2001; Simmons et al., 2003; Vallance et al., 2002).  In comparison to littermate 
controls, colonization of iNWKO mice by C. rodentium (λstx2dact) was diminished ten- to 
1000-fold, depending on the particular experiment, a difference that was statistically 
significant in two of four independently performed experiments (Figure 2).  By 30 days 
post-infection, no bacteria were detected in the stool of iNWKO mice, presumably 
reflecting clearance by an adaptive immune response (Ghaem-Maghami et al., 2001; 
Simmons et al., 2003; Vallance et al., 2002).  Tissue colonization was also measured in 
iNWKO and littermate control mice and, similar to fecal colonization, at 11 days post-
infection colonization of the cecum and colon was significantly (1000-fold, p<0.05) 
attenuated in iNWKO mice compared to littermate controls (data not shown).  
Weight loss is a common finding in murine models of HUS including infection of 
C57BL/6 mice with C. rodentium (λstx2dact) (Chapter III), infection of conventional  
164 
 
 
Figure 2.  N-WASP promotes high-level colonization during C. rodentium (λstx2dact) 
infection.  (A) Colonization of iNWKO (green) or littermate controls (black) mice 
infected with C. rodentium (λstx2dact) was determined by viable counts in stool samples.  
Shown are the average CFU (± SEM) of three iNWKO and two littermate controls.  Data 
are representative of one of four single experiments using two-to-seven mice per group.  
Statistically significant differences between the two groups were determined by two-way 
ANOVA and Bonferroni’s post-tests and in the experiment shown, no statistically 
significant differences were identified.   
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mice by EHEC, and injection of mice with Stx (mouse models of HUS are reviewed in 
(Mohawk and O'Brien, 2011)).  Therefore, body weight loss was monitored throughout 
infection of iNWKO mice and littermate controls by C. rodentium (λstx2dact).  Body 
weight remained constant (similar to day zero body weight) in littermate controls through 
nine days post-infection, however, by day ten post-infection, mice began losing weight 
(Figure 3A).  Notably, the moderate weight loss displayed by the littermate controls 
during this time correlated not only with peak colonization, but also with mortality (in 
40% of littermate control mice) (Figure 3B).  The mice that survived infection re-gained 
lost weight as the infection started to be cleared at approximately 25 days post-infection 
(Figure 3A).  In contrast, body weight of iNWKO mice remained constant throughout 
the course of infection (~30 days) and none of the iNWKO mice succumbed to lethal 
disease.  These data indicate that N-WASP is required for weight loss and mortality upon 
murine infection by C. rodentium (λstx2dact). 
Given that intestinal damage is often observed in patients with HUS and in 
murine infection by C. rodentium (λstx2dact) (Chapter III), intestinal sections of iNWKO 
mice and littermate control mice infected with C. rodentium (λstx2dact) were examined 
histologically.  The intestines of littermate control mice displayed severe damage to the 
mucosal surface of the intestine (Figure 4, left hand panel, asterisks), infiltration of 
inflammatory cells (Figure 4, left hand panel, arrowheads), crypt withering, and 
depletion of goblet cells, all of which are evidence of acute injury.  In contrast, the 
intestines of iNWKO mice appeared histologically normal with an intact mucosal surface 
and abundance of goblet cells (Figure 4, right hand panel, arrows).  These data suggest  
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Figure 3.  N-WASP is required for weight loss and mortality during C. rodentium 
(λstx2dact) infection.  (A) Percent body weight during infection of iNWKO (green) or 
littermate controls (black) mice infected with C. rodentium (λstx2dact) was determined.  
Shown are the averages (±SEM) of six iNWKO and seven littermate control mice per 
group.  Data are one representative of four independent experiments using two-to-seven 
mice per group.  Statistically significant differences between the two groups were 
determined by two-way ANOVA and Bonferroni’s post-tests and in the experiment 
shown, no statistically significant differences were identified.  (B) Percent survival of 
iNWKO (green) or littermate control (black) mice infected with C. rodentium (λstx2dact).  
Statistical significance was determined using a Chi squared test and in the data presented 
there is not a statistically significant difference between the two groups.  Data are one 
representative of four independent experiments using two-to-seven mice per group.  Note 
that while the mortality rate for littermate controls was typically 40-50%, in one of the 
four experiments performed, none of the littermate controls suffered a lethal infection.     
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Figure 4.  N-WASP promotes intestinal damage upon infection with C. rodentium 
(λstx2dact).  H&E stained intestinal sections of iNWKO and littermate control mice 
infected with C. rodentium (λstx2dact) at 11 days post-infection are shown at 100x.  
Asterisks indicate areas where the integrity of the mucosal surface of the intestine has 
been destroyed.  Arrow heads represent areas of inflammation and arrows represent areas 
of goblet cells.  Scale bars measure 50 μm. 
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that intestinal N-WASP, and presumably the presence of a functional pathway to 
polymerize actin, is required for Stx-mediated intestinal damage. 
HUS is known to manifest in renal disease during human EHEC infection as well 
as in murine models of HUS (Keepers et al., 2006; Lindgren et al., 1993; Mohawk and 
O'Brien, 2011; Sauter et al., 2008; Tarr et al., 2005) (Chapter III).  Therefore, we 
assessed renal impairment by measuring protein content in urine of iNWKO mice or 
littermate controls infected with C. rodentium (λstx2dact) (see Materials and Methods).  
Whereas the urine of iNWKO mice infected with C. rodentium (λstx2dact) contained no 
protein or only trace levels, i.e. a protein index of 0-0.5 indicating <50 mg/dl, the urine of 
littermate control mice infected with C. rodentium (λstx2dact) contained significantly 
elevated protein indices as early as one day post-infection (Figure 5A).  Between one and 
12 days post-infection, average urine protein indices were as high as 1 to 1.5, 
corresponding to approximately 50-100 mg/dl, indicating that infection by C. rodentium 
(λstx2dact) results in renal compromise only in mice that express intestinal N-WASP.  The 
compromise in renal function corresponded to severe damage to the proximal tubules, 
with cells sloughing into the lumen (Figure 5B, left hand panel, arrows) and flattening 
of proximal tubule cells (Figure 5B, left hand panel, arrowheads).  Mitotic activity was 
observed in some proximal tubule cells, presumably reflecting regeneration of damaged 
cells (V.V. and E.M. unpublished observations).  In contrast, the kidneys of iNWKO 
mice, which did not suffer proteinuria upon infection with C. rodentium (λstx2dact), were 
structurally normal, and showed no evidence of renal damage (Figure 5B, right hand  
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Figure 5.  N-WASP promotes renal damage upon infection with C. rodentium 
(λstx2dact).  (A) Urine protein content was monitored daily in iNWKO (green) or 
littermate control (black) mice infected with C. rodentium (λstx2dact) and is represented as 
average protein index (see Materials and Methods) (±SEM).  Statistical significance 
was determined using a two-way ANOVA and Bonferroni post-tests; “*” (p<0.05), “**” 
(p<0.01), “***” (p<0.001) indicate a statistically significant difference between the two 
groups.  Data are representative of one of three experiments using four-to-seven mice per 
group.  (B) H&E-stained 400x micrograph of kidney sections from iNWKO or littermate 
control mice infected with C. rodentium (λstx2dact) at 11 days post-infection.  Arrowheads 
indicate flattening of the lining of the tubules and arrows indicate sloughed tubules and 
necrotic tissue.  Scale bars measure 50 μm. 
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panel).  These data suggest that the presence of intestinal N-WASP is required for renal 
tubule damage upon infection by C. rodentium (λstx2dact). 
 
Tir-mediated actin pedestal formation is required for high-level fecal colonization 
by C. rodentium (λstx2dact). 
To further assess the requirement for Tir-mediated actin pedestal formation in 
colonization and Stx-mediated disease, we next infected wild type mice with a bacterial 
strain that is specifically defective in generating actin pedestals.  We previously 
established that murine infection with C. rodentium (λstx2dact) results in Tir-dependent 
colonization and Stx-mediated disease and that the defect in colonization and disease 
displayed by the tir mutant could be rescued in trans by a plasmid expressing wild type 
Tir (“pTirWT”) (Chapter III).  Therefore, to abolish the ability of C. rodentium to 
generate actin pedestals, we generated a plasmid, pTirY471F, that expressed the Tir 
phenylalanine substitution mutant TirY471F, which is incapable of recruiting Nck and 
generating robust pedestals on cultured cells (Deng et al., 2003) (see Materials and 
Methods).  
  To ensure the Tir plasmids expressed similar levels of protein, a western blot was 
performed on bacterial lysates and TCA (trichloroacetic acid) precipitated bacterial 
proteins secreted into the culture media (Supplementary Figure 1A and B, 
respectively).  C. rodentium (λstx2dact) bacterial lysates produced a strong protein band 
that migrated at ~70 kD that reacted specifically with the anti-C. rodentium Tir antibody, 
while the same band was missing from the tir mutant.  Plasmid expression of either  
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Supplementary Figure 1.  Wild type Tir and Tir point mutants are expressed at 
similar levels.  Western blot of Tir from isogenic strains of C. rodentium (λstx2dact) and 
representative C. rodentium (λstx2dact)Δtir, C. rodentium (λstx2dact)Δtir/pTirWT, and C. 
rodentium (λstx2dact)Δtir/pTirY471F mutants.  Note that although the predicted molecular 
weight of C. rodentium Tir is 56.2 kD, Deng and co-workers have previously shown that 
C. rodentium Tir migrates on SDS-PAGE at approximately 68 kDa (Deng et al., 2003) 
due to proposed post-translational modifications (DeVinney et al., 1999a; Kenny et al., 
1997).  (A) Bacterial lysates of isogenic strains of C. rodentium (λstx2dact) and 
representative C. rodentium (λstx2dact)Δtir, C. rodentium (λstx2dact)Δtir/pTirWT, and C. 
rodentium (λstx2dact)Δtir/pTirY471F mutants. SDS-PAGE loading was standardized to 
culture OD600 reading.  Asterisk “*” designates Tir degradation bands.  Membranes were 
blotted with anti-C. rodentium Tir antibody.  (B) TCA precipitated culture supernatant 
from isogenic strains of C. rodentium (λstx2dact) and representative C. rodentium 
(λstx2dact)Δtir, C. rodentium (λstx2dact)Δtir/pTirWT, and C. rodentium 
(λstx2dact)Δtir/pTirY471F.  SDS-PAGE loading was standardized to protein concentration.  
Membranes were blotted with anti-C. rodentium Tir antibody.  Asterisk (“*”) indicates an 
unknown band that cross-reacted with the anti- C. rodentium Tir antibody.   
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pTirWT or pTirY471F, was able to restore (or even increase to greater than endogenous 
levels) Tir expression the tir mutant in bacterial lysates (Supplementary Figure 1A).  
Similar to C. rodentium (λstx2dact), C. rodentium (λstx2dact)Δtir expressing either pTirWT or 
pTirY471F also generated several Tir-degradation bands <70 kD that reacted with the anti-
C. rodentium Tir antibody.  These results indicate that Tir is being expressed to similar 
levels in bacterial lysates of each of our strains. 
To ensure Tir expressed from a plasmid was being secreted from the bacteria, and 
that type III secretion was functional in each of our strains, we measured the amount of 
Tir produced in bacterial culture supernatants of each of our strains.  As shown in 
Supplementary Figure 1B, a ~70 kD band was present in culture supernatant from C. 
rodentium (λstx2dact) that was absent in the tir mutant.  Expression of pTirWT or pTirY471F  
generated a more intense band at 70 kD than seen in C. rodentium (λstx2dact), indicating 
that plasmid-based Tir is overexpressed in culture supernatants (Supplementary Figure 
1B).  These data demonstrate that Tir is indeed being expressed from the plasmid 
constructs and that the amount of Tir being produced is often greater than that produced 
from wild type C. rodentium (λstx2dact). 
Next, we tested the ability of pTirWT and pTirY471F to generate actin pedestals on 
mouse embryonic fibroblasts (MEFs) in a filamentous actin staining assay (FAS).  As 
previously described, C. rodentium (λstx2dact) generated robust actin pedestals beneath 
bound bacteria (Chapter III, Supplementary Figure 2, row 1), while the tir mutant 
bound very poorly to cells and failed to generate any actin pedestals (Supplementary 
Figure 2, row 2) similar to the tir mutant complemented with the empty vector (pVector)  
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Supplementary Figure 2.  TirY471F does not promote C. rodentium (λstx2dact) 
pedestal formation on cultured cells.  Mouse embryonic fibroblasts (MEFs) were 
infected with isogenic strains of C. rodentium in a FAS assay.  Bacteria and MEF cell 
nuclei were stained with DAPI (blue) and F-actin was stained with phalloidin (red).   
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(Supplementary Figure 2, row 5).  In contrast, expression of pTirWT in C. rodentium 
(λstx2dact)Δtir restored bacterial binding and pedestal formation on cultured cells 
(Supplementary Figure 2, row 3).  Conversely, although the C. rodentium 
(λstx2dact)Δtir/pTirY471F was able to bind to cells, none of these bacteria were associated 
with actin pedestals (Supplementary Figure 2, row 4), verifying that the TirY471F 
mutant could promote bacterial binding to mammalian cells but was deficient in pedestal 
formation.   
We subsequently utilized murine infection to assess the function of TirY471 when 
expressed in C. rodentium either expressing or not expressing Stx using the toxigenic, 
cell-binding, pedestal-deficient mutant (C. rodentium (λstx2dact)Δtir/pTirY471F) and the 
non-toxigenic cell-binding, pedestal-deficient mutant (C. rodentiumΔtir/pTirY471F) to 
colonize C57BL/6 mice.  Mice were infected with approximately 5x109 CFU of the 
designated C. rodentium strain and fecal colonization was monitored every two-to-three 
days post-infection.  We confirmed that infection with C. rodentium (λstx2dact) resulted in 
high-level colonization that peaked approximately seven days post-infection (Chapter 
III; Figure 6).  In contrast, C. rodentium (λstx2dact)Δtir was unable to detectably (>100 
CFU/gram feces) colonize mice.  Complementation of C. rodentium (λstx2dact)Δtir with 
pTirWT restored colonization to near wild type levels (Figure 6 and Chapter III).  
Infection with C. rodentium (λstx2dact)Δtir/pTirY471F resulted in a moderate (10- to 100-
fold) defect in colonization, particularly late (>seven days) in infection, a defect that was 
statistically different from colonization by C. rodentium (λstx2dact)Δtir/pTirWT in five out 
of the seven independently performed experiments (Figure 6 and data not shown).   
175 
 
 
Figure 6.  Tir-mediated actin pedestal formation is required for maximal intestinal 
colonization by C. rodentium (λstx2dact).  Colonization of eight-week old C57BL/6 mice 
infected with C. rodentium (λstx2dact), C. rodentium (λstx2dact)∆tir, C. rodentium 
(λstx2dact)∆tir/pTirWT, and C. rodentium (λstx2dact)∆tir/pTirY471F was determined by viable 
counts in stool samples.  Shown are the average CFU (± SEM) of five mice.  Statistical 
significance was determined using two-way ANOVA and Bonferroni post-tests.  “*” 
(p<0.05) indicates that C. rodentium (λstx2dact)∆tir/pTirWT is significantly different from 
C. rodentium (λstx2dact)∆tir/pTirY471F.  Data are representative of one of five single 
experiments.  The results for C. rodentium (λstx2dact), C. rodentium (λstx2dact)∆tir, and C. 
rodentium (λstx2dact)∆tir/pTirWT have been previously described and are included here for 
ease of comparison (see Chapter III).   
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The colonization defect was independent of Stx production because C. 
rodentiumΔtir/pTirY471F, which does not produce Stx, also typically colonized mice late 
in infection significantly less efficiently than the pedestal-proficient strains C. rodentium 
and C. rodentiumΔtir/pTirWT (Supplementary Figure 3).  These results suggest that Tir-
mediated actin pedestal formation promotes late colonization by C. rodentium 
independently of Stx production. 
 
Tir-mediated actin assembly and Stx-mediated disease by C. rodentium (λstx2dact).  
Given that EHEC-induced HUS results in intestinal and renal damage, we next 
assessed intestinal and renal pathology in mice infected with either C. rodentium 
(λstx2dact)Δtir, C. rodentium (λstx2dact)Δtir/pTirWT, or C. rodentium (λstx2dact)Δtir/pTirY471F  
between ten and 13 days post-infection.  Similar to our previous study (Chapter III), 
mice infected with the tir mutant had virtually no intestinal damage and an abundance of 
goblet cells (Figure 7, left column, arrows).  In contrast, the intestines of mice infected 
with C. rodentium (λstx2dact)Δtir/pTirWT showed severe destruction of the intestinal 
mucosa, colitis, and acute ischemic injury with infiltration of inflammatory cells into the 
muscularis layer and lamina propria (Figure 7, middle column, arrowheads).  Also 
present were areas of necrosis and degenerative changes in the epithelial cells with crypt 
withering (Figure 7, middle column).  Interestingly, despite the fact that C. rodentium 
(λstx2dact)Δtir/pTirY471F was able to colonize mice, infection was not associated with 
colonic damage (Figure 7, right column).   
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Supplementary Figure 3.  Pedestal formation promotes colonization by C. rodentium 
that does not produce Shiga toxin.  Fecal CFUs of mice infected with C. rodentium, C. 
rodentium∆tir, C. rodentium∆tir/pTirWT, and C. rodentium∆tir/pTirY471F were determined 
at indicated times post-infection.  Shown are the average CFU (± SEM) from groups of 
five eight-week old mice.  Statistical significance was determined using two-way 
ANOVA and Bonferroni post-tests.  “***” indicates a statistically significant difference 
from C. rodentium or C. rodentium∆tir/pTirWT.  Data shown are representative of one of 
three independent experiments.  
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Figure 7.  Tir-mediated actin assembly by C. rodentium (λstx2dact) promotes intestinal 
damage.  H&E stained intestinal sections of mice infected with C. rodentium 
(λstx2dact)∆tir, C. rodentium (λstx2dact)∆tir/pTirWT, and C. rodentium 
(λstx2dact)∆tir/pTirY471F at ten-to-13 days post-infection are shown at 100x (top) and 200x 
(bottom).  Arrowheads indicate areas of inflammation/inflammatory infiltrates and 
arrows indicate areas of goblet cells.  Scale bars measure 50 μm.   
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The majority of mouse Gb3 receptors are present on the renal tubules (Psotka et 
al., 2009), therefore, much of renal destruction that resulting from infection with C. 
rodentium (λstx2dact) occurs here.  As previously shown (Chapter III), infection by C. 
rodentium (λstx2dact)Δtir/pTirWT resulted in extensive damage to the proximal tubules 
depicted by an attenuated or flattened epithelial lining, pyknotic nuclear material, and 
sloughing of dead cells in the tubular lumen (Figure 8A, middle panel, arrowheads).  
Mitotic activity, indicating regenerative repopulation of the proximal tubules, was also 
observed in some mice (data not shown).  Similar to infection with C. rodentium 
(λstx2dact)Δtir, infection with C. rodentium (λstx2dact)Δtir/pTirY471F did not result in 
damage to the proximal renal tubules (Chapter III; Figure 8A, right panel).  
Additionally, we observed significant increases (p<0.001) in proteinuria at five, six, and 
ten days post-infection in mice infected with C. rodentium (λstx2dact)Δtir/pTirWT, 
compared to zero-to-trace levels of protein in mice infected with C. rodentium 
(λstx2dact)Δtir/pTirY471F (Figure 8B).  These findings provide evidence that actin pedestal 
formation, not simply Tir binding, is required for intestinal and renal tubule damage upon 
infection with C. rodentium (λstx2dact). 
  Weight loss and death are consistent findings in murine models of Stx 
intoxication (Keepers et al., 2006; Mohawk and O'Brien, 2011; Sauter et al., 2008) and 
we have previously shown that Tir is required for weight loss and death upon murine 
infection by C. rodentium (λstx2dact) (Chapter III).  Therefore, we determined the 
requirement of TirY471 in systemic disease caused by C. rodentium (λstx2dact).  Similar to 
our previous study (Chapter III), mice infected with either C. rodentium (λstx2dact) or C.  
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Figure 8.  Tir-mediated actin assembly by C. rodentium (λstx2dact) promotes renal 
damage.  (A) H&E-stained 600x micrograph of kidney sections from mice infected with 
C. rodentium (λstx2dact)∆tir and C. rodentium (λstx2dact)∆tir/pTirWT, and C. rodentium 
(λstx2dact)∆tir/pTirY471F at ten days post-infection.  Sloughing and attenuation of epithelial 
cells within the proximal tubules is indicated by arrow head.  Scale bars measure 50 μm.  
(B) Urine protein content was monitored daily in mice infected with C. rodentium 
(λstx2dact)∆tir/pTirWT (purple) and C. rodentium (λstx2dact)∆tir/pTirY471F (blue) and is 
represented as average proteinuria index (see Materials and Methods) (±SEM). 
Statistical significance was determined using a two-way ANOVA and Bonferroni post-
tests; “***” (p<0.001) indicates a statistically significant difference between the two 
groups.  Data are representative of one of two independent experiments using five-to-ten 
mice per group. 
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Figure 9.  Tir-mediated actin assembly is required for weight loss and death by C. 
rodentium (λstx2dact).  (A) Body weight during infection of mock-infected eight-week-old 
C57BL/6 mice or mice infected with C. rodentium (λstx2dact), C. rodentium 
(λstx2dact)Δtir/pTirWT, or C. rodentium (λstx2dact)Δtir/pTirY471F  was determined and is 
expressed as percent change from day zero weight.  Shown are the averages (±SEM) of 
five mice per group.  Data are representative of one of six independent experiments.  
Statistical significance was determined using a two-way ANOVA and Bonferroni’s Post 
Tests.  (B) Percent survival of mock-infected eight-week old mice or mice infected with 
C. rodentium (λstx2dact), C. rodentium (λstx2dact)Δtir/pTirWT, or C. rodentium 
(λstx2dact)Δtir/pTirY471F.  Groups of six mice were analyzed.  Data shown are 
representative of one of five independent experiments using six to eight mice per group.  
Statistical significance was determined using a Log-rank (Mantel-Cox) Test. 
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rodentium (λstx2dact)Δtir/pTirWT lost a significant amount [(mice infected with C. 
rodentium (λstx2dact) lost significantly (p<0.05) more weight than mice infected with 
other strains at six to ten days post infection; mice infected with C. rodentium 
(λstx2dact)Δtir/pTirWT lost significantly more body weight than mice infected with C. 
rodentium (λstx2dact)Δtir/pTirY471F at 13 and 14 days post-infection (p<0.05) and (p<0.01), 
respectively)] of body weight after approximately six and 11 days post-infection, 
respectively (Figure 9A) and succumbed to lethal infection (infection by C. rodentium 
(λstx2dact)Δtir/pTirWT resulted in significantly more death (p<0.05) than infection by C. 
rodentium (λstx2dact)Δtir/pTirY471F) (Figure 9B).  In contrast, mock-infected mice and 
mice infected with the tir mutant maintained day zero body weight or gained weight 
throughout the course of infection (Figure 9A) and survived (Figure 9B).  Interestingly, 
mice infected with C. rodentium (λstx2dact)Δtir/pTirY471F also maintained body weight 
throughout infection and survived, implying that weight loss and death caused by C. 
rodentium (λstx2dact) is dependent on the ability of the bacterium to generate actin 
pedestals.   
 
Actin pedestal formation promotes lethal infection independent of level of fecal 
colonization. 
We next assessed whether high-level colonization correlated with mortality by 
analyzing peak fecal colonization levels of mice infected with each of our strains in a 
total of seven independent experiments and whether the mouse survived or succumbed to 
lethal infection.  Peak colonization of mice infected with C. rodentium (λstx2dact) was 
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approximately 6.3x109 CFU/gram stool and infection always resulted in 100% mortality 
(Figure 10, green).  The majority of mice infected with C. rodentium 
(λstx2dact)Δtir/pTirWT (62%) succumbed to lethal infection and peak colonization of these 
mice was  1.5x109 CFU/gram stool (Figure 10, red).  In contrast, the peak colonization 
level of mice that survived infection by C. rodentium (λstx2dact)Δtir/pTirWT (38%) was 
much lower (5.0x107 CFU/gram stool) (Figure 10, red).  The majority of mice infected 
with C. rodentium (λstx2dact)Δtir/pTirY471F (95%) had lower peak colonization levels than 
mice infected with C. rodentium (λstx2dact)Δtir/pTirWT (7.9x10
7 CFU/gram stool), and 
survived infection (Figure 10, black).  Interestingly, only one mouse (1/20) infected with 
C. rodentium (λstx2dact)Δtir/pTirY471F succumbed to lethal infection and was very highly 
colonized (2.5x109 CFU/gram feces) (Figure 10, black).  These data demonstrate that 
high-level colonization (≥2.5x109 CFU/gram feces) regardless of the ability to generate 
actin pedestals, results in mortality.  Indeed, logistic analysis of these data revealed that 
the relative risk factor for death increased approximately 11 times for every one-log unit 
of increase in fecal colonization (with a 95% confidence interval of 4.383-25.656), 
regardless of the strain of bacteria the mice were infected with.    
We next determined whether infection with a strain able to generate actin 
pedestals resulted in more lethality at lower levels of colonization by comparing similar 
peak colonization levels of mice infected with C. rodentium (λstx2dact)Δtir/pTirWT and C. 
rodentium (λstx2dact)Δtir/pTirY471F in conjunction with the outcome of infection.  We 
stratified peak colonization levels into five intervals (<7.7 Log CFU/gram feces, 8.3-9.1 
Log CFU/gram feces, 9.1-9.7 Log CFU/gram feces, and 9.7-10.7 Log CFU/gram feces)  
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Figure 10.  Actin assembly by C. rodentium (λstx2dact) promotes lethal infection 
independent of level of fecal colonization.  Fecal CFUs of mice infected with C. 
rodentium (λstx2dact) (green), C. rodentium (λstx2dact)∆tir/pTirWT (red), and C. rodentium 
(λstx2dact)∆tir/pTirY471F (black) were determined daily, and shown are the peak fecal CFU 
in each mouse.  Black horizontal lines and the number next to the line represent the mean 
peak CFU for the designated group of mice.  Error bars represent ± SEM.  Data are 
representative of a compilation of seven independent experiments using groups of five 
eight-week old mice per group.  Each dot represents one mouse.  A total of 51, 40, and 20 
mice were infected with C. rodentium (λstx2dact), C. rodentium (λstx2dact)∆tir/pTirWT, and 
C. rodentium (λstx2dact)∆tir/pTirY471F, respectively.  Whether the mouse survived or 
succumbed to lethal infection is depicted by “survival” at the top of the graph and by “+” 
or “-“ on the x axis.  N.A., not applicable.   
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Table 4.  Actin pedestal formation promotes lethal infection independent of level of 
fecal colonization. 
Range of 
fecal counts 
(log) 
Cr (λstx2dact)Δtir/pTir Cr (λstx2dact)Δtir/pTirY471F 
Average log 
fecal 
colonization 
% Lethality 
(#dead/total) 
Average log 
fecal 
colonization 
% Lethality 
(#dead/total) 
9.7-10.7 9.8 80% (4/5) na na 
9.1-9.7 9.3 91% (10/11) 9.4 100% (1/1) 
8.3-9.1 8.8 53%* (8/15) 8.8 0% (0/5) 
7.7-8.3 8.0 60%* (3/5) 8.0 0% (0/8) 
Below 7.7 4.8 0% (0/4) 7.4 0% (0/6) 
Average fecal counts were determined in each colonization interval for mice infected 
with the designated strain and are represented as Log(10) CFU/g feces.  Data are 
compiled from seven independent experiments using groups of five eight-week old mice 
per group.  Number in parentheses represents the number of mice that succumbed to 
lethal infection over the total number of mice colonized by the indicated strain at the 
indicated level.  Asterisk (*) represents a statistically significant difference compared to 
mice infected with Cr (λstx2dact)Δtir/pTirY471F (p<0.05).  na, not applicable.  Note:  
stratification of fecal colonization levels were grouped such that there was an 
approximately even distribution of mice within each interval and the average fecal 
colonization level of each interval was the same for mice infected with Cr 
(λstx2dact)Δtir/pTir and  Cr (λstx2dact)Δtir/pTirY471F. 
 
186 
 
and determined the average peak colonization and percent lethality in each interval 
(Table 4).  Both C. rodentium (λstx2dact)Δtir/pTirWT and C. rodentium 
(λstx2dact)Δtir/pTirY471F were capable of colonizing mice to 1.9x10
8 to 1.2x109 CFU/gram  
stool, however, significantly more mice infected with C. rodentium (λstx2dact)Δtir/pTirWT 
succumbed to lethal infection (53% and 0%, respectively; p<0.05) (Figure 10, Table 4).  
Similarly, infection by C. rodentium (λstx2dact)Δtir/pTirWT resulted in significantly 
(p<0.05) more death (60%)  at even lower levels of peak colonization (5.0x107 to 1.9x108 
CFU/gram stool) compared to no death in mice infected with C. rodentium 
(λstx2dact)Δtir/pTirY471F colonized to the same amount (Figure 10, Table 4).   
In addition to the stratification analysis, a logistic regression analysis was also 
performed on these data.  We determined that even when the levels of fecal colonization 
are normalized, mice infected with C. rodentium (λstx2dact)Δtir/pTirWT have a 16-times 
greater relative risk (with a 95% confidence interval of 1.712-147.345) of succumbing to 
lethal infection compared to mice infected with the pedestal-deficient C. rodentium 
(λstx2dact)Δtir/pTirY471F strain.  Taken together, these data indicate that Tir-mediated actin 
pedestal formation facilitates in Stx-mediated killing at any level of colonization. 
 
Tir-mediated actin pedestal formation facilitates efficient colonization of the colonic 
mucosa by C. rodentium (λstx2dact).     
Fecal counts of mice infected with C. rodentium (λstx2dact)Δtir/pTirY471F were 
somewhat diminished relative to C. rodentium (λstx2dact)Δtir/pTirWT late in infection, so 
we determined bacterial counts that were closely associated with different segments of 
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the intestine.  Mice infected with C. rodentium (λstx2dact)Δtir/pTirWT or C. rodentium 
(λstx2dact)Δtir/pTirY471F were sacrificed at six days post-infection, the cecum and the colon 
were isolated and fecal contents were removed.  In addition, the lumen was flushed with 
PBS.  The number of C. rodentium associated with the feces, the luminal washings, or 
cecal or colonic homogenates were determined by plating for viable counts (see 
Materials and Methods).  Cecal and colonic colonization were then compared to fecal 
and luminal colonization.  (Note: fecal and luminal colonization are often highly related 
and therefore, are usually equivalent).  As expected, fecal colonization was similar (and 
not statistically different) between mice infected with the tir mutant expressing pTirWT 
and mice infected with the tir mutant expressing pTirY471F, with mean fecal counts of 
3.1x108 and 3.1x107 CFU/gram, respectively (Figure 11A, far left panel), similar to 
what was observed previously (Figure 6).  Likewise, there was no difference in luminal 
colonization between mice infected with C. rodentium (λstx2dact)Δtir/pTirWT or C. 
rodentium (λstx2dact)Δtir/pTirY471F (Figure 11A, middle left panel, “luminal 
washings”), suggesting that the ability to generate actin pedestals does not influence the 
ability of the bacterium to colonize the lumen of the intestine.  We next quantified 
bacterial colonization of the cecum, which is the first site of colonization in C. rodentium 
infection (Wiles et al., 2004), in the pedestal-proficient and pedestal-deficient mutant.  
Cecal colonization of mice infected with C. rodentium (λstx2dact)Δtir/pTirWT was 
comparable to mice infected with C. rodentium (λstx2dact)Δtir/pTirY471F (Figure 11A, 
middle right panel).  Surprisingly, however, the colons of mice infected with C. 
rodentium (λstx2dact)Δtir/pTirWT were significantly (p<0.01) more colonized than those of  
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Figure 11.  Tir-mediated actin assembly by C. rodentium (λstx2dact) promotes 
colonization of the mucosal surface.  (A)  Fecal colonization of eight-week old 
C57BL/6 mice infected with C. rodentium (λstx2dact)∆tir/pTirWT and C. rodentium 
(λstx2dact)∆tir/pTirY471F was determined by viable stool counts at six days post-infection 
(left panel).  Luminal colonization at six days post-infection was determined by plating 
serial dilutions of luminal contents and determining CFU/ml flush (see Materials and 
Methods) (middle left panel). Intestinal colonization [cecum (middle right panel) and 
colonic (right panel)] was determined by harvesting intestines at six days post-infection, 
homogenizing, and plating for CFU (See Materials and Methods).  Data are a 
compilation of two experiments using three mice per group.  Each data point represents a 
different mouse and horizontal line indicates the mean.  Error bars indicate ± SEM.  
Statistical significance was determined using an unpaired t-test.  “**” (p<0.01) indicates 
a statistically significant difference between the two groups.  (B) Cecal (left) and colonic 
(right) sections of mice infected with C. rodentium (λstx2dact)∆tir/pTirWT or C. rodentium 
(λstx2dact)∆tir/pTirY471F at ten days post-infection were either stained with DAPI (blue) 
and anti-Citrobacter antibody to visualize bacteria adhered to the intestinal surface 
(green) or processed for TEM (Note: colonic tissue was taken at six days post-infection 
and processed for TEM).  Fecal counts of mice infected with each strain were equivalent.  
For the immunofluorescence and cecal TEM experiment, at ten days post-infection mice 
infected with C. rodentium (λstx2dact)∆tir/pTirWT and C. rodentium (λstx2dact)∆tir/pTirY471F 
were colonized in the stool to 4.8x107 CFU/g and 3.6x107 CFU/g for, respectively.  In the 
colonic TEM experiment at five days post-infection, fecal colonization levels were 
1.1x107 CFU/g, 1.6x107 CFU/g for C. rodentium (λstx2dact)∆tir/pTirWT and C. rodentium 
(λstx2dact)∆tir/pTirY471F, respectively.  White scale bars in TEM images measure 0.5 μm, 
magnification 20,500x.  
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mice infected with C. rodentium (λstx2dact)Δtir/pTirY471F (~10
5 CFU/mg colon and 103 
CFU/mg colon, respectively).  These data provide evidence that the ability to generate 
actin pedestals aids in colonization of the colon (Figure 11A, far right panel). 
We next utilized immunofluorescence staining to assess mucosal colonization of 
the cecum and colon in greater detail.  At ten days post-infection intestinal sections of 
mice infected with C. rodentium (λstx2dact)Δtir/pTirWT or C. rodentium 
(λstx2dact)Δtir/pTirY471F with similar levels of fecal colonization (4.8x10
7 and 3.6x107 
CFU/gram stool, respectively) were stained with anti-Citrobacter antibody and DAPI and  
evaluated microscopically.  The cecum of mice infected with C. rodentium 
(λstx2dact)Δtir/pTirWT contained bacteria adhered to the mucosal surface that penetrated 
into the intestinal crypts (Figure 11B, left panel, top row).  Similarly, bacteria were 
closely adhered to the surface of cecal enterocytes mice infected with C. rodentium 
(λstx2dact)Δtir/pTirY471F (Figure 11B, left panel, bottom row).  These data indicate that 
actin pedestal formation is dispensable for colonization of the cecal mucosa. 
In the colon, bacteria were closely adhered to the mucosal surface and penetrated 
deep into the intestinal crypts of mice infected with C. rodentium (λstx2dact)Δtir/pTirWT 
(Figure 11B, right panel, top row).  In contrast, despite high-level fecal colonization 
comparable to fecal colonization levels in mice infected with C. rodentium 
(λstx2dact)Δtir/pTirWT, few bacteria were closely associated with the colonic surface on 
mice infected with C. rodentium (λstx2dact)Δtir/pTirY471F,  and the majority of the bacteria 
were located within the intestinal lumen (Figure 11B, right panel, bottom row).  
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To determine if the mucosal colonization observed for C. rodentium (λstx2dact) 
derivatives expressing wild type Tir reflected bona fide AE lesion formation, cecal and 
colonic tissue were collected (see Materials and Methods) at six (colonic) and ten 
(cecal) days post-infection to assess surface colonization by transmission electron 
microscopy.  The cecum of mice infected with C. rodentium (λstx2dact)Δtir/pTir formed 
distinct AE lesions on the intestinal surface (Figure 11B, left panel, top row).  Infection 
by C. rodentium (λstx2dact)Δtir/pTirY471F resulted in close attachment of bacteria to the 
mucosal surface, as seen by immunofluorescence, however, no distinct AE lesions were 
identified (Figure 11B, left panel, bottom row).  Actin pedestals were also present on 
the colons of mice infected C. rodentium (λstx2dact)Δtir/pTirWT (Figure 11B, right panel, 
top row).  Interestingly, and contrary to what was previously seen by Deng and co-
workers (Deng et al., 2003), the majority of the colons of mice infected with C. 
rodentium (λstx2dact)Δtir/pTirY471F were devoid of bacteria (Figure 11B, right panel, 
bottom row).  Extensive examination of samples revealed rare bacteria associated with 
the intestinal colonic surface and evidence of actin accumulation beneath these few 
bound bacteria was lacking (data not shown).  These results suggest that pedestal 
formation is required for mucosal colonization of colonic but not cecal epithelium.  
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Discussion 
While the requirement for Tir in colonization is well documented (Deng et al., 
2003; Marches et al., 2000; Ritchie et al., 2003; Schauer and Falkow, 1993b; Tzipori et 
al., 1995), the ability of Tir-mediated actin pedestal formation has been associated with 
either no or only a modest colonization defect in several animal models (Crepin et al., 
2010; Deng et al., 2003; Vlisidou et al., 2006a).  We addressed the role of Tir-promoted 
actin assembly in a murine model for Stx-mediated disease (Chapter III).  C. rodentium 
(λstx2dact) was incapable of maximal colonization of mice deficient in intestinal N-WASP, 
a host nucleation promoting factor that is required for pedestal formation by C. 
rodentium.  N-WASP has been previously shown to be required for efficient type III 
secretion (Vingadassalom et al., 2010), raising the possibility that the colonization defect 
observed may in part be due to diminished type III secretion, a process required for 
efficient colonization (Deng et al., 2004; Ritchie and Waldor, 2005).   
Thus, we also evaluated colonization by C. rodentium (λstx2dact) expressing the 
mutant TirY471, which lacks the ability to recruit the host adaptor Nck that promotes 
robust actin assembly (Campellone et al., 2002; Gruenheid et al., 2001).  This mutant was 
incapable of actin pedestal formation in vitro, consistent with previous results 
(Campellone et al., 2002; Deng et al., 2003; Gruenheid et al., 2001).  In contrast to 
several previous findings in which AE strains incapable of pedestal formation in vitro 
nevertheless appeared to efficiently generate AE lesions during infection of animals 
(Crepin et al., 2010; Deng et al., 2003; Vlisidou et al., 2006a) or intestinal explants 
(Schuller et al., 2007), we found that C. rodentium (λstx2dact) expressing TirY471 was 
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only very rarely intimately associated with intestinal epithelium (Figure 11B and data not 
shown).  Numerous differences in methodology, such as the choice of host animal, 
infecting bacterium or intestinal segment(s) examined (see below) may account for the 
discrepant findings. 
We found that the actin pedestal formation by C. rodentium (λstx2dact) was not 
required for colonization of the cecal mucosa.  Localization of C. rodentium on the 
epithelial surface by immunofluorescence microscopy and quantitation of viable bacteria 
in cecal homogenates revealed no differences between C. rodentium (λstx2dact) expressing 
TirY471F or wild type Tir.  TEM analysis showed that C. rodentium expressing 
TirY471F was closely associated with the cecal epithelium, although bacteria did not 
form canonical AE lesions, suggesting that, as is the case in the colon, Nck-mediated 
actin assembly is required for pedestal formation in this intestinal segment.  Apparently, 
translocation of Tir to the plasma membrane of cecal epithelial cells, followed by intimin-
mediated attachment, is sufficient to promote bacterial infection of the cecal mucosa even 
without subsequent robust actin assembly.   
In contrast, colonization of the colonic epithelium was largely dependent on the 
ability of Tir to trigger robust pedestal formation.  Although C. rodentium (λstx2dact) 
expressing TirY471F was found in high numbers in feces and luminal washings, analysis 
of bacterial-mucosal interaction by TEM and immunofluorescence microscopy, and 
assessment of living bacteria plating for viable counts, indicated that the mutant was 
severely defective in colonization of the colonic mucosa (Figure 11).  Analysis of 
infection by non-toxigenic C. rodentium strains suggested that the colonization defect 
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associated with TirY471F is independent of Stx (Supplementary Figure 3).  In addition, 
a non-toxigenic derivative of an EHEC mutant lacking EspFU, a type III translocated 
effector that generates pedestals in concert with EHEC Tir, similarly displayed a defect in 
mucosal colonization (Ritchie et al., 2008), suggesting that a defect in pedestal formation, 
regardless of its underlying etiology or the presence or absence of Stx, compromises 
epithelial colonization.   
The critical colonic colonization function provided by pedestal formation is not 
known.  Pedestal formation, by promoting (indirect) attachment of the bacterium to the 
host cytoskeleton, may stabilize bacteria at the cell surface.  Indeed, the ability to 
generate actin assembly is associated with enhanced intimin binding by Tir localized in 
the plasma membrane of cultured mammalian cells (M. Brady, S. Battle, P. Kailasan, and 
G. Hecht, personal communication).  Alternatively, both EHEC and EPEC have been 
demonstrated to be propelled on the surface of cultured mammalian cells in an actin-
dependent manner (Sanger et al., 1996; Shaner et al., 2005).  One can speculate that, 
similar to actin-based cell-to-cell spread by Vaccinia virus (Goldberg, 2001), pedestal 
formation may promote movement of AE pathogens on the intestinal epithelium, perhaps 
resulting in lateral spread and the formation of bacterial aggregates that occupy relatively 
large patches of intestinal mucosa (Ritchie et al., 2008).  
Regardless of the mechanism of pedestal-mediated enhancement of epithelial 
colonization, apparently this function is required in the colon more so than in the cecum.  
The differential requirement for pedestal formation may be related to the observation that 
blind pouches or cul de sacs, of which the cecum is an example, are more efficiently 
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colonized by AE pathogens on the basis of their anatomy (Sherman and Boedeker, 1987).  
In addition, the cecum is the initial site of C. rodentium colonization in mice (Wiles et al., 
2004) and EHEC colonization in lambs, calves, and chickens (Beery et al., 1985; Dean-
Nystrom et al., 1999; Wales et al., 2001; Wiles et al., 2004), indicating that it may 
provide AE pathogens with an environment in which to establish an initial intestinal 
infection.  Apparently, this environment is “hospitable” enough to support mucosal 
colonization in the absence of robust pedestal formation.  Nevertheless, the observation 
that a C. rodentium TirY471A/Y451A double mutant, which is defective in both the 
TirY451-mediated, Nck-independent actin assembly pathway and the TirY471-mediated, 
Nck-dependent pathway, is severely defective during murine co-infection studies with 
wild type C. rodentium, whereas either single tyrosine substitution alone is not, suggests 
that efficient colonization of even the cecum may require some level of Tir-mediated 
actin assembly.  
A striking feature was that although we found that colonic colonization by C. 
rodentium (λstx2dact) expressing TirY471F was diminished dramatically (i.e. 
approximately 50-fold) when assessed by viable counts, colonization of the feces or of 
luminal washings revealed no or only a moderate (approximately five-fold) colonization 
defect.  Similarly, during infant rabbit infection, the fecal colonization defect of an 
EspFU- (and pedestal-) deficient EHEC strain was muted compared to its defect in tissue 
colonization (Ritchie et al., 2008).  We speculate that the efficient colonization of the 
cecum by C. rodentium (λstx2dact) expressing TirY471F provides an abundant source of 
these bacteria in the feces, but that, lacking the ability to form pedestals, these bacteria 
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are unable to stably localize to the colonic epithelium.  Interestingly, fecal counts are 
routinely used to follow colonization by AE pathogens (Crepin et al., 2010; Deng et al., 
2003; Girard et al., 2009a; Marches et al., 2005; Mundy et al., 2004; Ritchie and Waldor, 
2005; Vlisidou et al., 2006a), and the failure of this method to accurately reflect more 
severe segment-specific mucosal colonization defects may contribute to the inability of 
many studies to detect epithelial colonization defects of pedestal-defective AE pathogens.  
The ability to generate actin pedestals had a dramatic effect on toxin-mediated 
disease.  Mice lacking intestinal N-WASP uniformly survived infection by C. rodentium 
(λstx2dact), whereas littermate controls lost weight and exhibited 50% lethality.  Consistent 
with the hypothesis that the protection afforded by N-WASP-deficiency was due to the 
role of N-WASP in pedestal formation, C57BL/6 mice infected with C. rodentium 
(λstx2dact) expressing TirY471F routinely survived, whereas 62% of mice infected with C. 
rodentium (λstx2dact) expressing wild type suffered lethal infection.  Lethal disease was 
likely a function of Stx production, because wild type-infected mice exhibited 
manifestations of toxemia, including weight loss, proteinuria, renal damage, and 
intestinal damage.  Although C. rodentium (λstx2dact) expressing TirY471F did not, on 
average, colonize to the same degree as wild type C. rodentium (λstx2dact), mice infected 
with wild type C. rodentium (λstx2dact) were still dramatically more likely to suffer lethal 
consequences of infection even after normalizing for fecal colonization (Table 4, Figure 
10).  
The association of actin pedestal formation with lethal toxigenic disease may be 
multifactorial.  First, it is tempting to speculate that the production of Stx by bacteria in 
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intimate proximity to the mucosal surface facilitates toxin uptake across the epithelium 
and into the bloodstream, where it may readily access endothelium, its major target.  In 
addition, the barrier function of epithelium may be compromised by pedestal formation, 
which alters the apical actin network that promotes tight junction integrity, or by an 
inflammatory response to the simple proximity of bacteria (and their proinflammatory 
components) to the epithelial surface.  Interestingly, infection by the recently emerged E. 
coli O1O4:H4, a Stx-producing strain that is related to the highly adherent 
enteroaggregative E. coli (EAEC) (Rasko et al., 2011), is associated with a high rate of 
rapidly progressing Stx-mediated disease and HUS, giving rise to speculation that the 
combination of tight bacterial adherence and Stx production is particularly effective at 
triggering severe disease (Bielaszewska et al., 2011).  Thus, the analysis of how Tir-
mediated pedestal formation, a virulence attribute that facilitates tissue-specific mucosal 
colonization, promotes lethality during infection by C. rodentium (λstx2dact) may provide 
general insight into the pathogenesis of toxigenic mucosal pathogens.  
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CHAPTER V. 
DISCUSSION 
The striking AE lesion was first described in the early 1980’s (Riley et al., 1983) 
and much has been learned about the mechanism of AE lesion formation.  However, 
nearly all the work has been done using biochemical or cell culture approaches.  To 
examine the biological significance of properties of EHEC or purified EHEC proteins 
characterized in vitro one must be able to assay their function during infection of 
mammalian hosts.  Several animal models exist to study the pathogenesis of EHEC (for 
review, see (Mohawk and O'Brien, 2011; Wales et al., 2005)), yet no single model 
recapitulates all aspects of colonization and Stx-mediated disease.   
The bacterial adhesin intimin has been shown to promote tight attachment and 
pedestal formation via Tir binding ((Hartland et al., 1999; Kenny et al., 1997), for review, 
see (Campellone, 2010; Caron et al., 2006; Hayward et al., 2006)), and to promote 
colonization (Marches et al., 2000; Schauer and Falkow, 1993b; Tzipori et al., 1995).  
Some alleles of intimin, including EHEC intimin, cannot be easily tested for function 
because of the lack of a murine model.  In addition, Tir-independent functions of intimin 
have been demonstrated in vitro, but the in vivo significance of these functions remains 
unknown.  Finally, Tir has been shown to be critical for actin assembly (for review, see 
(Campellone, 2010; Caron et al., 2006)), and despite the fact that the mechanisms of 
pedestal formation have been well characterized, the significance of pedestal formation 
has not been clearly defined.   
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In this thesis we first addressed the allele- and Tir-dependent and independent 
roles of intimin during infection using two animal infection models.  Next, we developed 
a novel murine model of EHEC Stx-mediated disease.  Finally, using this model, we 
addressed the role of Tir-mediated actin pedestal formation in colonization and Stx-
mediated disease. 
 
Allele- and Tir-independent functions of intimin  
Efficient attachment to mammalian cells is an essential step in bacterial 
pathogenesis.  Indeed, the AE pathogens EHEC, EPEC, and C. rodentium employ a 
multitude of ways to attach to host cells.  Initial attachment is mediated by fimbriae, pili, 
curli, surface proteins, outer-membrane proteins, and flagella (for review, see (Bardiau et 
al., 2010; Nougayrede et al., 2003; Torres et al., 2005)).  The most well characterized 
bacterial adhesin for AE pathogens, however, is intimin, which binds to the bacterial type 
III secreted effector Tir, initiating intimate attachment.   
In addition to binding Tir, intimin may also provide Tir-independent functions.  
For example, intimin has been shown to bind mammalian proteins in vitro including β1-
chain integrins and nucleolin (Frankel et al., 1996a; Sinclair and O'Brien, 2002).  In 
addition, intimin contributes to disruption of epithelial barrier function in vitro in a Tir-
independent manner (Dean and Kenny, 2004).  Despite these in vitro findings, little is 
known about the Tir-independent functions of intimin in vivo.   
Based on differences in the C-terminus of intimin, several alleles of intimin exist, 
and these allelic differences have been associated with variations in tissue tropism and 
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host species range (Fitzhenry et al., 2002; Girard et al., 2005; Mundy et al., 2007; Phillips 
and Frankel, 2000).  For instance, whereas wild type EHEC colonizes the large intestine 
of gnotobiotic piglets, an EHEC strain harboring a plasmid expressing EPEC intimin 
gained the ability to colonize the small intestine (Tzipori et al., 1995).  Additionally, 
while C. rodentium expressing EPEC intimin is able to efficiently colonize Swiss NIH 
and C3H/HeJ mice (Frankel et al., 1996b; Hartland et al., 2000; Schauer and Falkow, 
1993b), C. rodentium expressing a derivative of EPEC intimin containing the adhesive 
domain of EHEC intimin provided poor colonization function in these animals (Hartland 
et al., 2000; Mundy et al., 2007).  In Chapter II, we addressed the following questions 
(1) do allelic differences in intimin contribute to tissue tropism and host species range? 
and (2) do allele- and Tir-independent functions of intimin exist in vivo? 
To gain insight into the critical allele- and Tir-independent functions in vivo, we 
used gnotobiotic piglet and murine infection models.  For the gnotobiotic piglet model, 
we replaced the EHEC chromosomal eae gene with EPEC eae and found that the two 
alleles were functionally homologous in infection (Chapter II), in disagreement with 
previous results (Tzpiori et al., 1995).  The fact that Tzipori and co-workers used plasmid 
complementation, while we used chromosomal replacement may explain the discrepant 
results.  Next, we tested whether full-length EHEC intimin could complement a C. 
rodentium eae mutant for colonization and disease in C57BL/6 mice.  In contrast to 
previous studies (Hartland et al., 2000; Mundy et al., 2007), we established that C. 
rodentium expressing EHEC intimin was fully functional for colonization as well as 
induction of colonic hyperplasia (Chapter II).  The inconsistent findings may be due to 
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the use of an EHEC-EPEC hybrid plasmid in previous work that exchanged the N-
terminus of EHEC intimin for that of EPEC intimin which may have diminished an 
important (possibly Tir-binding) activity of EHEC intimin.  Alternatively, the 
inconsistency may be explained by differences in murine host strain.  Indeed, strain-strain 
variability in susceptibility to C. rodentium has been documented (Vallance et al., 2003), 
and we have observed variations in the kinetics of colonization and disease when using 
animals purchased from different vendors or with different genetic backgrounds (E.M. 
and M. McBee unpublished observations).   
We next tested whether Tir-intimin binding (in the absence of actin pedestal 
formation) was sufficient for murine colonization of C. rodentium and determined that 
the Tir binding domain of EHEC intimin (expressed from pInv-Int395) could not restore 
colonization by C. rodentiumΔeae (Chapter II).  These results indicate that the ability to 
trigger actin assembly, not simply to bind Tir, is required for intimin-mediated intestinal 
colonization.  One caveat, however, is that, due to lack of a suitable assay, we do not 
know how well the fusion containing the Tir-binding domain (Inv-Int395) expressed in 
C. rodentium is able to bind to Tir.  Nonetheless, it has been established that Inv-Int395 
expressed in E. coli K12 binds Tir with less efficiency than full length intimin (Liu et al., 
1999).  Similarly, our data suggests that Inv-Int395, when expressed in C. rodentium, also 
displays a binding defect because pedestal formation by this strain was not as robust as C. 
rodentium expressing full length intimin (Chapter II).  This finding may be due to 
inefficient Tir clustering by Inv-Int395.   
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To assess the Tir-independent functions of intimin in vivo, we developed an 
experimental system using streptomycin pre-treated mice.  In contrast to previous studies 
using conventional mice (Deng et al., 2003), we found that streptomycin pre-treated mice 
infected with a C. rodentium tir mutant became colonized to high levels and remained 
colonized throughout the course of ~30 days (Chapter II).  Additionally, we observed 
that intimin was required for this Tir-independent function.  We mapped the region of 
intimin responsible for this activity and found that the C-terminal 100 amino acids of 
EHEC intimin were sufficient for colonization.  Biochemical approaches could be used to 
determine the host cell receptor these 100 amino acids of intimin are binding to.  For 
instance, the C-terminal 100 amino acids of intimin could be purified and used in pull-
down experiments with uninfected cell membrane fractions to identify potential binding 
partners.  Similarly, one could use the yeast two-hybrid system or BiacoreTM to identify 
potential host cell receptors for this region of intimin. 
The above results are consistent with the hypothesis that in addition to Tir, intimin 
binds a host cell receptor.  Two potential candidates are β1-chain integrins and nucleolin, 
both of which have been shown to bind intimin in vitro but have not been identified as 
receptors in vivo (Frankel et al., 1996a; Sinclair and O'Brien, 2002).  Nucleolin knockout 
mice are currently being generated (at KOMP repository) and may prove to be useful 
reagent for future studies.  Similarly, the newly developed conditional, β1-chain integrin-
deficient mice (which have β1-chain integrins knocked out in collagen 1-producing cells) 
(Riopel et al., 2011) have been generated, and a strategy to specifically eliminate β1-chain 
integrins in the intestine could be of use for future experiments.  Streptomycin pre-
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treatment of mice reveals a Tir-independent function of intimin in vivo, and may be used 
in mice deficient in β1-chain integrins or nucleolin to determine if either of these two 
molecules functions as a host cell receptor for intimin.  
 
Elucidating the role of actin pedestal formation in colonization and Stx-mediated 
disease   
EHEC, EPEC, and C. rodentium all generate distinctive AE lesions on the 
intestinal epithelium consisting of the intimate attachment of bacteria, effacement of 
brush border microvilli, and the formation of actin-rich pedestals beneath bound bacteria.  
Actin pedestal formation is dependent on the adhesin intimin and the type III secreted 
effector Tir, and the mechanisms of pedestal formation by these three AE pathogens have 
been studied in great detail (for review, see (Caron et al., 2006)).  While several previous 
studies have been unable to detect a requirement for actin polymerization during 
colonization (Schuller et al., 2007; Vlisidou et al., 2006;Deng et al., 2003), three groups 
have shown that actin assembly enhances colonization (Bai et al., 2008; Crepin et al., 
2010; Ritchie et al., 2008).  Unfortunately, the phenotypes linking actin pedestal 
formation and colonization have been modest and the mechanism by which this occurs is 
unknown.  To generate a small animal model to study Stx-mediated disease that requires 
colonization and the presence of normal flora, we developed a model where wild type 
C57BL/6 mice were infected with C. rodentium (λstx2dact) (Chapter III).  Infection 
resulted in high-level colonization, significant weight loss, renal damage, intestinal 
damage, and mortality, consistent with many features of human HUS caused by EHEC 
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infection.  Interestingly, in our model, colonization and disease were dependent on Tir, in 
contrast to other models of Stx-mediated disease utilizing streptomycin-treated or 
gnotobiotic mice (Eaton et al., 2008; Lindgren et al., 1993; Melton-Celsa et al., 1996; 
Wadolkowski et al., 1990a; Wadolkowski et al., 1990b).  Therefore, we were able to use 
this model to assess whether Tir-mediated actin pedestal formation promotes colonization 
and/or Stx-mediated disease. 
We began by using EHEC effectors (Tir and EspFU) expressed from a single 
plasmid or dual plasmids to complement a C. rodentium (λstx2dact)Δtir mutant (see 
Appendix C).  We hypothesized that C. rodentium (λstx2dact) expressing EHEC Tir but 
not EspFU would be able to bind cells but not generate actin pedestals, while C. 
rodentium (λstx2dact) expressing both EHEC Tir and EspFU would be able to generate 
actin pedestals via the Nck-independent pathway (Brady et al., 2007; Campellone and 
Leong, 2005).  Our hypothesis held true in cell culture (both when EHEC Tir and EspFU 
were expressed from dual plasmids and when expressed from a single plasmid; data not 
shown), consistent with results showing that EspFU is able to cooperate with C. 
rodentium to generate actin pedestals in a Nck-independent pathway (Girard et al., 
2009a). 
Given that these C. rodentium strains carrying EHEC alleles in trans behaved 
appropriately in vitro, we assessed the function of actin pedestal formation in 
colonization and Stx-mediated disease in vivo by comparing infection with pedestal-
proficient (C. rodentium (λstx2dact) expressing EHEC Tir and EspFU) and pedestal-
deficient bacteria (C. rodentium (λstx2dact) expressing EHEC Tir).  Mice infected with C. 
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rodentium (λstx2dact) expressing EHEC Tir became colonized to an intermediate level, 
(i.e. peak levels of ~104-107 CFU/g between six and eight days post-infection) (Appendix 
C), several logs lower than peak colonization by wild type C. rodentium (λstx2dact) (see 
Chapter III).  Consistent with the intermediate colonization phenotype, very little weight 
loss and mortality was observed in these mice.  Colonization by C. rodentium (λstx2dact) 
expressing EspFU in addition to EHEC Tir expressed from two individual plasmids 
resulted in similar levels of peak colonization (~104-107 CFU/g feces) as C. rodentium 
expressing EHEC Tir alone (Appendix C).  Interestingly, in one out of three 
experiments, C. rodentium (λstx2dact) expressing EspFU and EHEC Tir from two plasmids 
resulted in more severe disease than C. rodentium (λstx2dact) expressing EHEC Tir alone, 
with approximately 60% vs. 0% mortality.  These data suggest that actin pedestal 
formation does not augment colonization but possibly enhances Stx-mediated disease and 
mortality.  Unfortunately, this phenotype was not consistently reproducible, perhaps due 
to the inadequacies of plasmid complementation (e.g. plasmid loss or variable 
expression).   
We then hypothesized that a single plasmid containing both EHEC Tir and EspFU 
may eliminate some of the confounding issues of plasmid complementation and yield a 
consistent phenotype.  Despite our efforts, murine infection by C. rodentium (λstx2dact) 
expressing a single plasmid containing both EHEC Tir and EspFU resulted in no 
difference in colonization, weight loss, or death compared to mice infected with C. 
rodentium (λstx2dact) expressing EHEC Tir (Appendix C).  These data suggest that while 
EHEC effectors have the ability to function in C. rodentium, expression of these effectors 
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from a plasmid results in variability in their effectiveness.  Future experiments may 
include incorporation of EHEC effectors onto the chromosome of C. rodentium.  
Nonetheless, this initial data provides very weak evidence that actin pedestal formation 
contributes to Stx-mediated disease. 
Using alternative experimental systems: (1) iNWKO mice and (2) infection by C. 
rodentium (λstx2dact) expressing a pedestal-deficient mutant (Chapter IV), we determined 
that Tir-mediated actin pedestal formation was required for maximal colonization, similar 
to previous findings (Bai et al., 2008; Crepin et al., 2010; Ritchie et al., 2008).  We also 
demonstrated that FAS activity in vitro correlated with FAS activity in vivo—a question 
that has remained ambiguous for many years (Crepin et al., 2010; Deng et al., 2003; 
Girard et al., 2008; Schuller et al., 2007; Vlisidou et al., 2006a).  In addition, we found 
that the ability to generate actin pedestals promoted Stx-mediated disease including 
weight loss, renal damage, intestinal damage, and death (Chapter IV).  Finally, we 
provided strong evidence that actin pedestal formation facilitates colonization of the 
colonic, but not cecal, mucosa (Chapter IV). 
 It has been established that C. rodentium undergoes weak actin polymerization via 
a Nck-independent pathway in the absence of TirY471 phosphorylation, utilizing 
TirY451 (Brady et al., 2007; Campellone and Leong, 2005).  To assess the contribution 
of this alternative pathway to colonization and Stx-mediated disease in our model, we 
constructed Tir complementation vectors expressing the single TirY451A mutant or the 
double TirY471F/Y451A mutant.  Murine infection by C. rodentium (λstx2dact) 
expressing TirY471F/Y451A was identical to infection with C. rodentium (λstx2dact) 
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expressing TirY471F, resulting in a mild colonization defect in stool late in infection, less 
disease, and less mortality compared to infection with C. rodentium (λstx2dact) expressing 
TirWT or TirY451A (see Appendix C).  Our observations are consistent with a previous 
study using a non-toxigenic C. rodentium strain expressing a TirY451A point mutation 
on the chromosome revealing that TirY451 is dispensable for colonization (Crepin et al., 
2010).  Contrary to our previously described results, however, this same group observed 
no defect in colonization by C. rodentium expressing TirY471F/Y451A or TirY471F on 
the chromosome in single infection experiments (Crepin et al., 2010).  In dual infection 
experiments, on the other hand, the double TirY471F/Y451A mutant was outcompeted 
by wild type C. rodentium (Crepin et al., 2010).   
 One aspect of colonization that was not addressed in our studies was the 
contribution of TirY451A to mucosal colonization of the cecum.  We speculate that the 
low-level actin polymerization via the Nck-independent pathway may be sufficient to 
colonize the cecal mucosa (which would presumably allow for some luminal colonization 
and the presence of bacteria in the stool) in the absence of TirY471-mediated actin 
assembly.  To test this, one could infect mice with C. rodentium (λstx2dact) expressing 
TirY471F/Y451A and assay for mucosal colonization by immunofluorescence and TEM.  
If TirY451 was contributing to cecal colonization, we would expect to see a lack of 
mucosal colonization upon infection with the TirY471A point mutant.  However, since 
we have not observed a defect in fecal colonization during infection with the double 
TirY471F/Y451A mutant (see Appendix C), it is likely that it colonizes the cecum.  C. 
rodentium (λstx2dact)Δtir should be included in the experiment and we would predict that 
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it would be unable to colonize the cecal mucosa, given that infection results in fecal 
colonization at or below the limit of detection. 
Because plasmid complementation by TirWT only partially restored colonization 
and disease in C. rodentium (λstx2dact)Δtir (see Chapter III), we cannot ignore the fact 
that subtle phenotypes observed by complementing C. rodentium (λstx2dact)Δtir with Tir 
point mutants on a plasmid might be very difficult to discern, especially with the 
TirY451A mutant.  Generation of chromosomal point mutants as done by Crepin and co-
workers (Crepin et al., 2010) could resolve this.  One might predict that C. rodentium 
(λstx2dact) expressing TirY451A from the chromosome may display a phenotype that 
would have been missed using the plasmid complementation system.   
Expression of the TirY471F, TirY451A, and TirY471F/Y451A point mutants 
from the chromosome of C. rodentium (λstx2dact) may also provide an experimental 
system to test the role of multiple actin polymerization pathways on colonization and Stx-
mediated disease, a question that remains ambiguous due to conflicting results.  Notably, 
one study suggested that additional actin polymerization pathways to EHEC enhances 
colonization in human intestinal in vitro organ cultures (Bai et al., 2008), while another 
study using C. rodentium expressing EspFU on the chromosome revealed that the 
enhanced actin polymerization capabilities offered no competitive advantage to the 
bacteria during murine infection (Girard et al., 2009).  One way to explain this 
discrepancy is that one group used in vitro organ cultures as their experimental system, 
while the other group used an animal infection model.  
 
208 
 
Insights into the mechanism(s) of how actin pedestal formation facilitates 
colonization and Stx-mediated disease 
Even though defects in colonization and disease resulted from abolition of actin 
pedestal formation, the question of whether these phenotypes are really due to the 
inability to generate actin pedestals per se remains.  Other alternatives to the actin 
pedestals themselves affecting colonization and disease include the fact that simple 
disruption of the host cytoskeleton may result in higher level colonization and/or disease 
or that simply higher levels of bacteria produce more toxin and therefore, cause lethal 
disease.  To address this, we attempted to restore colonization and disease in mice 
infected with C. rodentium (λstx2dact) expressing TirY417F by adding EspFU to the strain 
(either on its own plasmid or on the same plasmid as TirY471F, see Appendix C).  The 
expression of EspFU in the mutant expressing TirY471F restored its ability to generate 
actin pedestals in vitro but resulted in no evident increase in murine colonization, weight 
loss, or death (see Appendix C).  There was a slight increase, however, in colonic 
colonization upon addition of EspFU, suggesting that actin pedestal formation facilitates 
the association of bacteria with the colonic mucosa and presumably, subsequent lethal 
disease.  Chromosomal expression of EspFU in C. rodentium (λstx2dact) expressing 
TirY417F may more fully recapitulate infection by pedestal-proficient bacteria.     
Our effector knockout studies (see Appendix A) provide additional support for 
the hypothesis that toxigenic bacteria cause lethal disease via pedestal formation, rather 
than by simply causing alterations in the host cell cytoskeleton.  No defects in 
colonization or disease resulted from infection with C. rodentium (λstx2dact)ΔespH, C. 
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rodentium (λstx2dact)ΔespG, C. rodentium (λstx2dact)ΔespF, or C. rodentium 
(λstx2dact)ΔespK even though these effectors are known to disrupt the actin cytoskeleton 
(see Appendix A).  Taken together, our findings support that pedestal formation itself, or 
some specific actin rearrangement that is closely associated with pedestal formation, is 
responsible for increased colonization of the colonic mucosa and lethal disease upon 
infection by C. rodentium (λstx2dact). 
Evidence from our lab suggests that actin assembly promotes bacterial binding in 
vitro, and paired with the findings in this thesis, strong bacterial binding via pedestal 
formation may promote lethal Stx-mediated disease.  Previous studies examined the Tir-
intimin adhesion pathway in absence of potentially redundant pathways by infecting 
mammalian cells with EPEC or EHEC intimin mutants that deliver Tir but cannot stably 
attach to host cells and challenged the “pre-infected” monolayers with a lab strain of E. 
coli that expresses intimin but cannot otherwise attach to mammalian cells.  These studies 
revealed that intimin-mediated bacterial attachment was decreased by point mutations 
(i.e. EHEC TirY458A) in the cytoplasmic domain of Tir that diminish actin pedestal 
formation, and by chemical inhibitors of actin assembly (M. Brady Thesis).   
An additional study measured the ability of EHEC and EPEC mutants to bind to 
intimin coated plates and revealed that EHEC TUV bound significantly better than an 
EHEC pedestal-deficient mutant (ΔespFU ) (P.K. unpublished data).  Similarly, the 
TirY454F/TirY474F double mutant of EPEC bound to intimin at significantly lower 
levels compared to wild type EPEC.  On the other hand, EPEC containing either the 
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chromosomal point mutant TirY454F or TirY474F bound less than wild type EPEC but 
the differences were not statistically significant (P.K. unpublished data). 
Several hypotheses can explain how actin polymerization enhances bacterial 
binding.  One possible mechanism could be that actin polymerization may enhance type 
III secretion.  However, preliminary data makes this hypothesis unlikely as EHEC 
expressing TirY458A is translocated with wild type efficiency into mammalian cells (M. 
Brady Thesis).  A more likely hypothesis is that actin assembly increases the affinity or 
avidity of Tir and intimin and therefore augments bacterial binding to the mucosal 
surface.  For example, it is possible that initiation of actin assembly induces a 
conformational change in the intimin binding region of Tir resulting in a higher affinity 
for intimin.  Alternatively, actin assembly may increase the avidity of intimin-Tir 
interactions by assisting the movement of Tir from the cytoplasm to the membrane.  To 
test this, one could measure surface expression of Tir by FLOW cytometry using anti-Tir.  
It is also possible that actin polymerization blocks endocytosis of Tir and therefore allows 
for more Tir to be retained in the host cell membrane.  Preliminary data from our lab is 
consistent with this model, as EHEC Tir mutants deficient in actin polymerization 
generate fewer Tir foci than wild type EHEC (M. Brady Thesis).  Similarly, Tir foci are 
diminished upon treatment with the actin polymerization inhibitor, cytochalasin D (M. 
Brady Thesis). 
One can imagine that actin polymerization may “anchor” a rather weak binding 
interaction by physically linking the extracellular pathogen with the cytoskeletal network 
of the host cell.  Consistent with this model is the fact that pedestal-deficient bacteria are 
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rarely found in close association with the colonic mucosa as opposed to pedestal-
proficient bacteria.  We hypothesize that the mechanical force of washing the intestines 
prior to analysis breaks the bonds between the weakly adherent bacteria and the colonic 
surface, allowing only bacteria bound by actin pedestals to remain.  To test this 
hypothesis in vitro, one could utilize optical/laser tweezers to quantitate the degree of 
binding and see if bacteria bound to cells via actin pedestals bind more tightly to cells 
than bacteria unable to generate actin pedestals. 
Actin pedestal formation may also increase bacterial motility on the epithelial 
surface, leading to expansion of the infectious niche on the mucosal surface.  Indeed, this 
phenomenon of hijacking host cell actin machinery as a means of bacterial motility to 
spread from host cell to host cell has been observed for several intracellular bacterial and 
viral pathogens (e.g. Shigella, Listeria, Rickettsia, and Vaccinia) (Goldberg, 2001).  
Furthermore, it has been established that extracellular EPEC and EHEC move along the 
surface of cultured epithelial cells in an actin polymerization-dependent fashion, 
suggesting that pedestal formation is important for bacterial movement (Sanger et al., 
1996; Shaner et al., 2005).  Finally, two studies revealed that bacterial aggregates on the 
intestinal epithelium were much smaller upon infection pedestal-deficient mutants in 
infection of gnotobiotic piglets (Ritchie et al., 2008) and human intestinal explants 
(Schuller et al., 2007), suggesting that this actin-based motility allows for aggregation of 
bacteria and expansion beyond the initial infectious niche.  It is also possible that actin 
polymerization-based surface motility may help the bacteria to move into and occupy the 
intestinal crypts.    
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A corollary of the observation that pedestal formation is associated with mucosal 
colonization is that bacteria localized on the mucosal surface promote systemic disease.  
A simple hypothesis is that Stx production in direct apposition to the epithelium has the 
most serious consequence.  Data from Chapter IV supports this hypothesis because even 
when bacteria maintain the ability to colonize the feces, lumen, and cecum, but are 
unable to colonize the colonic mucosal surface, they are unable to cause lethal disease, as 
seen with mice infected with C. rodentium (λstx2dact)Δtir expressing TirY471F.  
Additionally, streptomycin pre-treated mice infected with non-pedestal-producing C. 
rodentium (λstx2dact)Δtir became colonized to high levels (i.e. >10
9 CFU/g through the 
duration of the ~30 day experiment), and did not experience weight loss or lethal disease 
(data not shown).  We hypothesize that infection by C. rodentium (λstx2dact)Δtir in 
streptomycin pre-treated mice results in lethal disease because the bacteria were unable to 
efficiently colonize the colonic mucosa, similar to non-streptomycin pre-treated mice 
infected with C. rodentium (λstx2dact) expressing TirY471F (Chapter IV).  We predict 
that in both instances, bacteria are able to colonize the cecum, but cannot produce Stx in 
sufficient quantity or in close enough proximity to the colonic mucosa to deliver lethal 
quantities of toxin into the bloodstream.  To test this hypothesis, we could infect 
streptomycin pre-treated mice with C. rodentium (λstx2dact)Δtir and evaluate cecal and 
colonic adherence by immunofluorescence and TEM.  In addition, we could also measure 
Stx in the blood of mice infected with toxigenic pedestal-proficient and pedestal-deficient 
bacteria or in streptomycin pre-treated mice infected with C. rodentium (λstx2dact)Δtir.  
An alternative approach would be to treat mice infected with a pedestal-deficient strain 
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with a toxin-inducing agent (e.g. mitomycin C or Cipro) and assess whether toxin 
induction and presumably increased toxin concentration now is able to result in lethal 
disease.  Lastly, we could reassess both cecal and colonic TEM sections of mice infected 
with pedestal-proficient and pedestal-deficient strains by immuno-EM using an anti-Stx 
antibody and determine if more Stx is present under bacteria attached via actin pedestals 
as opposed to simply “sitting” on the mucosal surface. 
Further data supporting the hypothesis that localization of mucosal-associated 
bacteria is responsible for lethal disease comes from our results of C. rodentium (λstx2dact) 
infection in immunodeficient mice.  We determined that MyD88 was necessary to protect 
mice against pedestal-deficient bacteria (Appendix B).  One might predict that in the 
absence of MyD88, more bacteria (regardless of their ability to generate actin pedestals) 
would be located at the mucosal surface of the intestine due to poor recognition of 
PAMPs (pattern associated molecular patterns).  These putative PAMPs presumably are 
not restricted to LPS because TLR4 is not required for protecting against pedestal-
deficient bacteria (Appendix B). 
Another reason why localization may promote lethality is that normal flora [the 
apparent implication is that normal flora is located more closely to the mucosa] and/or 
close contact with host cells may promote phage induction, resulting in more toxin 
production, and more disease.  Interestingly, there is evidence that stx2 expression is 
highly dependent on the lytic cycle and is induced by DNA-damaging agents (Wagner et 
al., 2001b).  Furthermore, while in vitro and in vivo studies reveal that administration of 
probiotic bacteria (i.e. Lactobacillus and Bifidobacterium) inhibits Stx1 and Stx2 
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production (Asahara et al., 2004; Carey et al., 2008), other studies have discovered that 
the presence of commensal E. coli susceptible to Stx2 phage infection leads to increased 
Stx2 production (Gamage et al., 2003).  Finally, exposure to human neutrophils and 
macrophages has also has been shown to lead to increases in stx2 expression and toxin 
production (Poirier et al., 2008; Shimizu et al., 2011; Wagner et al., 2001a).   
We tested the hypothesis of whether toxin production is increased by bacteria that 
are in close proximity to mammalian cells by growing C. rodentium (λstx2dact) in the 
presence or absence of MEFs in a 96-well plate.  The bacteria were grown for three hours 
(in an empty well or in a well with a confluent layer of MEF’s), after which, the media 
was changed and mitomycin C was added to induce phage induction.  After an additional 
three hour incubation, the wells were washed and culture supernatant was assayed for 
Stx2 production via ELISA (see Chapter III Materials and Methods).  The amount of 
bacteria in each well was enumerated by plating serial dilutions, and toxin production 
was normalized to total bacteria in the well.  We found that toxin production was 
increased when bacteria were in the presence of mammalian cells (E.M. unpublished 
observations).  Given this finding, another interesting experiment would be to determine 
if pedestal-proficient bacteria generate greater quantities of toxin in the presence of 
mammalian cells compared to pedestal-deficient bacteria.  Preliminary data from our lab, 
however, suggests that both C. rodentium (λstx2dact)Δtir/pTirWT and C. rodentium 
(λstx2dact)Δtir/pTirY471F produce similar amounts of Stx in the presence of mammalian 
cells (E.M. unpublished data).    
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An additional mechanism for how actin pedestal formation facilitates lethal 
disease may be that actin polymerization results in better toxin translocation across 
epithelium.  There is evidence that Stx1 uptake and transcytosis is actin dependent 
(Malyukova et al., 2008; Mettlen et al., 2006) and it has also been shown that Stx1 can be 
taken up by the cell via macropinocytosis, a fluid-phase uptake pathway that uses actin 
turnover (Malyukova et al., 2009).  Furthermore, it has been established that neutrophil 
migration enhances toxin translocation across polarized epithelial cell monolayers 
(Hurley et al., 2001).  Therefore, to test whether inhibition of neutrophil migration has 
any effect on toxigenic disease in vivo, we infected 12-LOX-/- mice, which are deficient in 
the pathway to generate the neutrophil chemoattractant hepoxilin A3 (McCormick, 2007) 
with C. rodentium (λstx2dact) (see Appendix B).  We found that infection by C. rodentium 
(λstx2dact) in these mice was no different than infection of wild type mice in regards to 
colonization, weight loss, mortality, and renal and intestinal pathology (Appendix B and 
data not shown).  However, this does not rule out the hypothesis that neutrophil migration 
enhances toxin translocation completely, because the absence of 12-LOX may have little 
impact on neutrophil migration across the intestinal epithelium, which was not tested in 
these experiments.   
The hypothesis that close bacterial association with the mucosal surface facilitates 
toxin translocation is consistent with the pathogenesis of the recently described EHEC-
EAEC hybrid bacterium responsible for the outbreak of HUS in Germany in the spring of 
2011.  This strain, E. coli O14:H4, contains Stx2 from EHEC, is eae negative, and 
possesses the adhesive properties of EAEC, most notably the ability to adhere to 
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epithelial cells in a stacked-brick conformation.  Researchers hypothesize that the 
augmented adherence of this strain, coupled with the presence of the Stx2 toxin, 
facilitated toxin translocation and systemic absorption of toxin, explaining the high 
progression to HUS (Bielaszewska et al., 2011).     
To further test the hypothesis that actin pedestal formation facilitates toxin 
translocation, one could measure amount of Stx in serum of C57BL/6 mice infected with 
pedestal-proficient and pedestal-deficient strains of C. rodentium (λstx2dact) or in iNWKO 
and littermate control mice infected with C. rodentium (λstx2dact).  If actin pedestal 
formation promotes toxin translocation, we would expect there to be more Stx in the 
blood of C57BL/6 mice infected with pedestal-producing strains of C. rodentium 
(λstx2dact) and in littermate control mice infected with C. rodentium (λstx2dact).  Other 
experiments to address the hypothesis could assess toxin translocation across the 
intestinal epithelium with polarized cells.  Potential problems may result from using C. 
rodentium in these experiments because of C. rodentium’s preference to attach to and 
infect murine cells (E.M. unpublished observations; D.B.S. and B. McCormick personal 
comm.).  Use of murine epithelial cells such as CT26 (colorectal carcinoma cells) would 
remedy this problem.  Alternatively, one might quantitate toxin translocation across 
polarized monolayers (e.g. T84, CaCo2) using EHEC in the presence and absence of 
EspFu.  Finally, one could treat cells with inhibitors of actin polymerization (e.g. 
cytochalasin D) and examine the effects on toxin translocation. 
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Final conclusions 
 For the first time, a clearly defined a role of Tir-mediated actin polymerization in 
colonization and toxin-mediated disease has been identified.  We have shown that actin 
pedestal formation is required for colonization of the colonic but not cecal mucosa.  
While we have discussed many hypotheses for how actin pedestal formation facilitates 
lethal disease, future research needs to be conducted to determine the exact mechanism.  
These studies will give insight into the long-standing questions of EHEC pathogenesis 
and offer suggestions for future treatment options.  
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APPENDIX 
The following data is from other work I conducted while I was in the lab that was not an 
integral component to the stories presented in this thesis and will not be submitted for 
publication at this time.  However, it represents initial forays into research avenues that 
may have impact on future work conducted in the lab.   
 
I would like to acknowledge the people who helped with this work here: 
 
Tim Blood (a BU master’s student who I trained) offered technical assistance with the 
studies shown in Figures 1, 2, and 3. 
 
Egil Lien for provided us with TLR4-/- and MyD88-/- mice. 
 
Loranne Magoun created the first C. rodentium (λstx2dact)Δtir complementation vectors. 
 
Vijay Vanguri assisted with viewing and analyzing histological sections. 
 
Katie Schlieper and Megan McBee offered technical assistance with the initial mouse 
infections.  
 
Jennifer Ritchie performed the infant rabbit infections using the EHECΔespF ΔespFU 
double mutant. 
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A. C. RODENTIUM (λSTX2DACT) EFFECTOR KNOCKOUT STUDIES 
Summary 
Many type III secreted effectors injected into host cells are implicated in 
disruption of the host cell cytoskeleton.  Some of these effector proteins include: EspF, 
EspG, EspK, and EspH.  One well known function of EspF is to disrupt epithelial barrier 
function, presumably by altering the distribution of tight junction proteins and 
modulating the architecture of intermediate filament networks within cells (Guttman et 
al., 2006a; McNamara et al., 2001; Viswanathan et al., 2004a).  Additionally, it has been 
suggested that EspF promotes colonization of C. rodentium in mice early in infection and 
appears to control EHEC-induced inflammation in infant rabbits (Deng et al., 2004; 
Mundy et al., 2004; Ritchie and Waldor, 2005).  EspG has been shown to destabilize 
microtubule networks, induce the formation of stress fibers, and cause damage to the 
Golgi apparatus (Clements et al., 2011; Matsuzawa et al., 2004).  Previous data also 
suggests that EspG contributes to colonization and colonic hyperplasia in murine 
infection with C. rodentium (Hardwidge et al., 2005; Mundy et al., 2004) and 
colonization of the small intestine of infant rabbits by EHEC (Ritchie and Waldor, 2005).  
While EspK has no apparent effect on actin nucleation in HeLa cells in vitro, it has been 
shown to promote persistence in an orally infected calf model (Vlisidou et al., 2006b).  
On the other hand, there is evidence that EspH diminishes filopodium formation, 
enhances actin pedestal formation, and plays a role in brush border microvilli remodeling 
(Shaw et al., 2005a; Tu et al., 2003).  Furthermore, while the role of EspH in murine 
infection by C. rodentium has been controversial (Deng et al., 2004; Mundy et al., 2004), 
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EspH has been suggested to promote colonization and diarrhea in infant rabbits (Ritchie 
and Waldor, 2005). 
 To assess the function of these cytoskeletal modulating effector proteins in our 
model of EHEC toxin-mediated disease, we generated complete, in-frame deletions in C. 
rodentium (λstx2dact) strain using lambda red recombination (Datsenko and Wanner, 
2000).  We first assessed the ability of each of these mutants to form actin pedestals in 
vitro.  Mouse embryonic fibroblasts infected with either C. rodentium (λstx2dact)ΔespF, C. 
rodentium (λstx2dact)ΔespG, C. rodentium (λstx2dact)ΔespK, or C. rodentium 
(λstx2dact)ΔespH all generated actin pedestals indistinguishable from wild type C. 
rodentium (λstx2dact) (data not shown), indicating that EspF, EspG, EspK, and EspH are 
not required for actin pedestal formation in vitro. 
 Because alterations in the host cell cytoskeleton are thought to facilitate toxin 
translocation, we next assessed the function of these effector proteins on colonization and 
weight loss, a common finding in murine intoxication with Stx (Keepers et al., 2006; 
Mohawk and O'Brien, 2011; Sauter et al., 2008).  C57BL/6 mice were inoculated with 
approximately 5x109 CFU of each mutant C. rodentium (λstx2dact) strain and fecal 
colonization was monitored every other day throughout infection.  C. rodentium 
(λstx2dact)ΔespF, C. rodentium (λstx2dact)ΔespG, C. rodentium (λstx2dact)ΔespK, and C. 
rodentium (λstx2dact)ΔespH colonized mice to levels comparable to colonization by C. 
rodentium (λstx2dact), indicating that EspF, EspG, EspK, and EspH are dispensable for 
colonization by C. rodentium (λstx2dact) (Figure 1A).  Likewise, each of these 
cytoskeletal modulating effector proteins were dispensable for weight loss in mice 
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infected with C. rodentium (λstx2dact) (Figure 1B).  These results indicate that EspF, 
EspG, EspK, and EspH are not required for colonization and Stx-mediated disease in 
murine infection with C. rodentium (λstx2dact). 
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Figure 1.  T3SS cytoskeletal modulating effector proteins are not required for 
colonization or weight loss upon colonization by C. rodentium (λstx2dact).   (A) 
Colonization of eight-week-old female C57BL/6 mice by C. rodentium (λstx2dact), C. 
rodentium (λstx2dact)ΔespF, C. rodentium (λstx2dact)ΔespG, C. rodentium (λstx2dact)ΔespK, 
and C. rodentium (λstx2dact)ΔespH was determined by viable stool counts.  Shown are the 
averages CFU (± SEM) of five mice.  (B) Body weight during infection of C57BL/6 mice 
by C. rodentium (λstx2dact), C. rodentium (λstx2dact)ΔespF, C. rodentium (λstx2dact)ΔespG, 
C. rodentium (λstx2dact)ΔespK, and C. rodentium (λstx2dact)ΔespH expressed as percent 
change from day zero body weight.  Shown are the averages (±SEM) of five mice per 
group.  Data are representative of a single experiment that was performed in triplicate. 
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B.  IMMUNE STUDIES WITH C. RODENTIUM (λSTX2DACT) 
Summary 
The innate immune system is a non-specific first line of defense against microbial 
pathogens.  It is comprised of natural anatomic barriers (e.g. normal flora), non-specific 
immune cells (e.g. neutrophils, mast cells, and macrophages), inflammation, the 
complement system, and Toll signaling through Toll-like receptors (TLRs).  TLRs are 
pattern recognition receptors that identify molecules associated with microbial pathogens 
(Takeda and Akira, 2004).  One of the main adapter molecules for all TLRs except TLR3 
is MyD88 (Adachi et al., 1998).  Signaling through MyD88 is important for protection 
against microbial pathogens as mice deficient in MyD88 are more susceptible to infection 
(Gibson et al., 2008; LaRosa et al., 2008).  TLR4, which signals through MyD88, is an 
innate signaling molecule responsible for sensing lipopolysaccharide, the main 
component in the outer bacterial membrane of gram negative bacteria.  Additionally, 
TLR4 signaling has been implicated in mediating much of the inflammation during 
murine infection of C. rodentium (Khan et al., 2006).   
Given the importance of MyD88 and TLR4 in defense against microbial 
pathogens, we tested their requirement for colonization and disease by C. rodentium 
(λstx2dact).  Since C. rodentium (λstx2dact) infection of wild type C57BL/6 mice always 
results in lethal infection, infection with C. rodentium (λstx2dact)Δtir/pTirY471F only results 
in 5% mortality, and C. rodentium (λstx2dact)Δtir results in virtually no mortality (see 
Chapters III and IV), we used these three strains in our experiments in order to measure 
severity of disease.  
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C. rodentium (λstx2dact) and C. rodentium (λstx2dact)Δtir/pTirY471F infected  
MyD88-/- mice became colonized, lost weight, and succumbed to lethal infection to 
similar levels (Figure 2).  This is in contrast to infection of wild type mice where C. 
rodentium (λstx2dact)Δtir/pTirY471F caused only 5% mortality (Chapter IV).  On the other 
hand, MyD88-/- mice infected with C. rodentium (λstx2dact)Δtir did not become colonized, 
lose weight, or succumb to lethal infection, similar to wild type C57BL/6 mice infected 
with this strain (Figure 2, see Chapters III and IV).  These results suggest that the 
MyD88 pathway plays a critical role in the recognition and clearance of pedestal-
deficient C. rodentium (λstx2dact)Δtir/pTirY471F bacteria. 
We next assessed the function of TLR4-mediated signaling in our model of 
toxigenic disease by infecting TLR4-/- mice with C. rodentium (λstx2dact).  In order to 
evaluate the severity or attenuation of disease, we infected TLR4-/- mice with C. 
rodentium (λstx2dact)Δtir/pTirY471F and C. rodentium (λstx2dact)Δtir.  We found that TLR4
-
/- mice infected with C. rodentium (λstx2dact) became highly colonized, lost weight, and 
succumbed to lethal infection (Figure 3), similar to wild type C57BL/6 mice infected 
with this strain.  TLR4-/- mice infected with the pedestal-deficient mutant (C. rodentium 
(λstx2dact)Δtir/pTirY471F) became less colonized, did not lose weight, and survived 
infection, similar to C57BL/6 mice infected with the same strain (Figure 3).  Finally, 
TLR4-/- mice infected with the tir mutant failed to become colonized, did not lose weight 
and survived infection (Figure 3).  These data suggest that TLR-mediated signaling is 
dispensable for defense against pedestal-deficient C. rodentium (λstx2dact) in contrast to 
MyD88 signaling. 
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Figure 2.  MyD88 protects mice against pedestal-deficient bacteria.  (A) Colonization 
of MyD88-/- mice by C. rodentium (λstx2dact), C. rodentium (λstx2dact)Δtir/pTirY471F, and 
C. rodentium (λstx2dact)Δtir was determined by viable stool counts.  Shown are the 
averages CFU (± SEM) of five mice.  (B) Body weight during infection of MyD88-/- mice 
by C. rodentium (λstx2dact), C. rodentium (λstx2dact)Δtir/pTirY471F, and C. rodentium 
(λstx2dact)Δtir expressed as percent change from day zero body weight.  Shown are the 
averages (±SEM) of five mice per group.  (C) Percent survival of MyD88-/- mice that 
were infected with C. rodentium (λstx2dact), C. rodentium (λstx2dact)Δtir/pTirY471F, and C. 
rodentium (λstx2dact)Δtir.  For all panels, data are representative of one experiment that 
was performed twice using strains C. rodentium (λstx2dact) and C. rodentium 
(λstx2dact)Δtir/pTirY471F, and once using C. rodentium (λstx2dact)Δtir. 
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Figure 3.  Stx-mediated colonization and mortality in TLR4-/- requires pedestal 
formation.  (A) Colonization of TLR4-/- mice by C. rodentium (λstx2dact), C. rodentium 
(λstx2dact)Δtir/pTirY471F, and C. rodentium (λstx2dact)Δtir was determined by viable stool 
counts.  Shown are the averages CFU (± SEM) of five mice.  (B) Body weight during 
infection of TLR4 KO mice by C. rodentium (λstx2dact), C. rodentium 
(λstx2dact)Δtir/pTirY471F, and C. rodentium (λstx2dact)Δtir expressed as percent change from 
day zero body weight.  Shown are the averages (±SEM) of five mice per group.  (C) 
Percent survival of TLR4 KO mice that were infected with C. rodentium (λstx2dact), C. 
rodentium (λstx2dact)Δtir/pTirY471F, and C. rodentium (λstx2dact)Δtir.  For all panels, data 
are representative of one experiment that was performed twice using strains C. rodentium 
(λstx2dact) and C. rodentium (λstx2dact)Δtir/pTirY471F, and once using C. rodentium 
(λstx2dact)Δtir. 
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Not only is the innate immune system is the first line of defense against bacterial 
pathogens, but the actions of the innate immune systems are also implicated in the 
pathogenesis of HUS.  For instance, it has been established that Stx induces secretion of 
the neutrophil chemoattractant, IL-8, from human colonic epithelial cells (Thorpe et al., 
1999) and evidence suggests that neutrophil transmigration enhances Stx translocation 
across the intestinal epithelium (Hurley et al., 2001).  To test this hypothesis in vivo, we 
infected 12-lypoxygenase (12-LOX) knockout mice, which are deficient in the pathway 
to generate the neutrophil chemoattractant hepoxilin A3 (McCormick, 2007), and 
therefore do not promote efficient neutrophil migration, with C. rodentium (λstx2dact) and 
compared the outcome of infection to C57BL/6 mice infected with C. rodentium 
(λstx2dact).  We found that elimination of the 12-LOX pathway did not influence Stx-
mediated colonization or disease.  Both wild type C57BL/6 mice and 12-LOX-/- mice 
became highly colonized, exhibited significant weight loss, and succumbed to lethal 
infection (Figure 4).  Moreover, there were no significant differences in renal and 
intestinal histology upon infection between the two strains of mice (data not shown).   
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Figure 4.  The 12-LOX pathway does not influence Stx-mediated colonization and 
disease by C. rodentium (λstx2dact).   (A) Colonization of 12-LOX KO (blue) and 
C57BL/6 (black) mice by C. rodentium (λstx2dact) was determined by viable stool counts.  
Shown are the averages CFU (± SEM) of five mice.  (B) Body weight during infection of 
12-LOX KO (blue) and C57BL/6 (black), expressed as percent change from day zero 
body weight.  Shown are the averages (±SEM) of five mice per group.  (C) Percent 
survival of 12-LOX KO (blue) and C57BL/6 (black) mice that were infected with C. 
rodentium (λstx2dact).  For all panels, results are representative of one experiment. 
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C. OTHER ATTEMPTS AT ASSESSING THE FUNCTION OF ACTIN 
PEDESTAL FORMATION 
Table 1.  Attempts at assessing the function of actin pedestals in vivo. 
Experiment Objective Results Repetitio-
ns 
EHECΔespF ΔespFU To assess 
whether the 
residual pedestal 
formation in an 
espFU mutant is 
due to EspF.  
This mutant was 
tested in an 
infant rabbit 
infection (J. 
Ritchie). 
In a FAS assay, EHECΔespF 
ΔespFU has some, residual 
pedestal formation similar to an 
espFU mutant.  Pedestal 
formation was restored by 
providing EspFU in trans.  There 
was no phenotype in infant 
rabbit model in single or 
competition experiments (J. 
Ritchie). 
FAS (3); 
rabbit 
infection-
2 single 
infections 
and 2 
compet-
ition 
experime-
nts) 
    
Murine infection 
with C. rodentium 
(λstx2dact)Δtir/pTirEH
EC OR pTirCR (L. 
Magoun and K. 
Schlieper) 
To test whether 
Tir is required 
for infection by 
C. rodentium 
(λstx2dact). 
None of these strains were able 
to colonize wild type mice, most 
likely because these 
complementation vectors were 
pBR322-derived. 
1 
    
Murine infection 
with C. rodentium 
(λstx2dact)Δtir/pTirEH
EC 
To test whether 
EHEC Tir can 
complement a C. 
rodentium 
(λstx2dact) tir 
mutant. 
Infection resulted in intermediate 
colonization that peaked at levels 
of ~104-107 CFU/g six-to-eight 
days post-infection.  There was 
very little weight loss and no 
mortality. 
5 
    
Murine infection 
with C. rodentium 
(λstx2dact)Δtir/pTirEH
EC + pEspFU (2 
plasmids) 
To test whether 
EHEC Tir and 
EspFU can 
rescue a tir 
mutant for high-
level 
colonization, 
weight loss, and 
death. 
Colonization peaked at ~104-107 
CFU/g six-to-eight days post-
infection.  In one experiment 
mice infected C. rodentium 
(λstx2dact)Δtir/pEHEC Tir + 
pEspFU appeared sicker and 
experienced more death (60% 
vs. 0%) than mice infected with  
C. rodentium (λstx2dact)Δtir 
complemented with only EHEC 
Tir.  Infection resulted in 
3 
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incomplete complementation of 
colonization, weight loss, and 
lethality (e.g. <60% mortality) in 
the other two experiments.  
    
Murine infection 
with C. rodentium 
(λstx2dact)Δtir/pTirEH
EC + EspFU (1 
plasmid) 
To test whether 
EHEC Tir and 
EspFU can 
rescue a tir 
mutant for high-
level 
colonization, 
weight loss, and 
death. 
There was no difference in 
colonization, weight loss, and 
death compared to mice infected 
with C. rodentium (λstx2dact)Δtir 
expressing EHEC Tir alone. 
3 
    
Murine infection 
with C. rodentium 
(λstx2dact)Δtir/pCr 
TirY471F + pEspFU (2 
plasmids) 
To test whether 
the addition of 
EspFU can 
rescue a 
TirY471F mutant 
for high-level 
colonization, 
weight loss, and 
death. 
This strain did not colonize well 
and did not complement for 
weight loss, fecal water 
phenotype (see Chapter III), or 
mortality. 
2 
    
Murine infection 
with C. rodentium 
(λstx2dact)Δtir/pCr 
TirY471F + EspFU (1 
plasmid)  
To test whether 
the addition of 
EspFU can 
rescue a 
TirY471F mutant 
for high-level 
colonization, 
weight loss, and 
death. 
This strain did not colonize well 
or clearly complement for 
weight loss, fecal water 
phenotype, or mortality.  
However, there was some 
evidence of better colonization 
with the addition of EspFU, 
specifically in an in vivo binding 
study (done once) where the 
addition of EspFU allowed for 
higher (but not statistically 
significant) colonization of the 
colon compared to C. rodentium 
(λstx2dact)Δtir expressing 
TirY471F alone.  
3 
    
Infection of iNWKO 
mice with C. 
rodentium (λstx2dact) 
To test if the 
defect in 
colonization 
Not all mice became colonized 
with each strain and therefore, it 
was difficult to evaluate results.  
1 
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+ pEspFU (1 
plasmid) 
observed in 
iNWKO mice 
infected with C. 
rodentium 
(λstx2dact) (see 
Chapter IV) 
could be rescued 
by the addition 
of EspFU.  To 
assess the N-
WASP 
independent 
pathway of 
pedestal 
formation in 
vivo. 
It may be best to repeat 
experiment using chromosomal 
copy of EspFU.  This strain is 
available with EspFU inserted 
into the XylE gene. 
    
Murine infection 
with C. rodentium 
(λstx2dact)Δtir/pCr 
TirY451A and murine 
infection with C. 
rodentium 
(λstx2dact)Δtir/pCr 
TirY471F/Y451A 
To assess the 
function of both 
actin 
polymerization 
pathways in the 
context of Stx-
mediated disease 
(also assessed in 
the non-
toxigenic strain 
and results were 
similar). 
Infection with C. rodentium 
(λstx2dact)Δtir/pCr TirY451A was 
not different than infection with 
C. rodentium (λstx2dact)Δtir/pCr 
Tir.  Infection with C. rodentium 
(λstx2dact)Δtir/pCr TirY471F/Y451A 
was the same as infection with 
C. rodentium (λstx2dact)Δtir/pCr 
TirY471F.  Histology and mucosal 
colonization of colon and cecum 
were not assessed in these 
experiments. 
1 
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